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Involvement of the gene CaRLM1 in Candida albicans virulence 
 
Abstract 
The cell wall is an essential structure that maintains the viability of fungal cells, conferring their typical 
morphology and protection. As the most external cellular structure of pathogenic microorganisms, it 
also carries important antigenic determinants and mediates adhesion to the host tissues, being crucial 
to initiate colonization and to cause disease. Saccharomyces cerevisiae and Candida albicans 
respond to cell wall perturbations by activation of the cell wall integrity (CWI) mitogen-activated protein 
(MAP) kinase pathway (also known as the PKC pathway). In S cerevisiae one of the transcription 
factors of this signalling cascade is the MADS-box protein Rlm1, of which an orthologue was identified 
in C. albicans based solely in sequence homology. In this thesis we aimed at studying the molecular 
diversity and functional characterization of the RLM1 gene as well as its involvement in C. albicans 
cell wall maintenance and virulence. 
 
Candida albicans Rlm1 is a transcription factor that presents a great variability at its C-terminus, 
conferred by the CAI microsatellite. One hundred twenty-three C. albicans isolates were genotyped 
with CAI microsatellite (CAA/G)n and 35 alleles were found with repeat units varying from 11 to 49. 
Interestingly the strains with higher number of (CAA/G) repetitions displayed higher tolerance to cell 
wall stress agents. These observations suggested that CAI repetitive region confers a high genetic 
variability to the RLM1 gene, which is reflected in different strain susceptibilities to different stress 
conditions, conferring a higher plasticity to C. albicans isolates. 
 
To determine if C. albicans RLM1 is involved in the CWI pathway, as described for S. cerevisiae, a 
rlm1∆/rlm1∆ mutant was constructed, using the SAT1-flipping strategy to avoid the use of auxotrophic 
markers, and its functional characterization was performed. The wild-type (WT), mutant (rlm1∆/rlm1∆) 
and complemented (rlm1∆/rlm1∆+RLM1) strains were tested with several cell wall stress agents in 
parallel with S.cerevisiae rlm1∆ mutant and WT strains. Candida albicans rlm1Δ/rlm1Δ mutant 
displayed phenotypes associated to cell wall deficiency such as, hypersensitivity to Congo red, 
caspofungin and calcofluor white. Upon osmotic stabilization with 1M sorbitol, the caspofungin 
phenotype was reverted, suggesting cell wall weakening in the mutant. Quantification of cell wall 
components showed a two-fold increase in chitin and mannans in the C. albicans rlm1Δ/rlm1Δ mutant 
in comparison with the WT strain. The S. cerevisiae rlm1∆ mutant displayed several phenotypic 
differences in comparison with the rlm1Δ/rlm1Δ mutant of C. albicans: insensitivity to Congo red and 
caspofungin, more resistance to calcofluor white, and higher sensitivity to SDS. In agreement with a 
transcription factor function, we found evidence indicating nuclear localization of the Rlm1-GFP fusion 
protein. Microarray analysis showed that the absence of a functional C. albicans RLM1 significantly 
increased transcription of genes involved in cell adhesion, like ECE1, ALS1, ALS3, HWP1, RBT1, and 
decreased transcription of genes involved in the catabolism of carbohydrates, DAK2, GLK4, NHT1 
and TPS1. The increased transcription of genes involved in cell adhesion correlated well with 
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adhesion and biofilm assays. These results and the homology with other MADS-box Rlm1 
transcription factors strongly suggest that C. albicans RLM1, like the S. cerevisiae orthologue, is 
involved in cell wall remodeling. Furthermore, the increase of cell adhesion binding proteins involved 
in biofilm formation was confirmed in the rlm1Δ/rlm1Δ mutant in comparison with the WT strain, 
suggesting that C. albicans Rlm1 acts as a negative biofilm regulator. 
 
The involvement of the Rlm1 transcription factor of the human fungal pathogen C. albicans in 
virulence was evaluated in a murine model of disseminated candidiasis. Mice infected with 
rlm1∆/rlm1∆ mutant cells presented a higher survival time than mice infected with the WT and 
complemented strains, both presenting higher fungal burden and invasive micelial growth through 
kidneys in hystopathological analysis. Additionally, in the murine macrophage-like cell line J744A, the 
TNF-α was lower in response to rlm1∆/rlm1∆ mutant and the cellular toxicity, measured as 
extracellular lactate dehydrogenase activity, caused by this mutant was significantly lower in 
comparison with the WT and complemented strains. Finally, qRT-PCR determination showed that the 
expression of the cell wall-related genes, CRH11 and PHR2, was clearly higher in rlm1∆/rlm1∆ mutant 
in relation to WT strain, in mRNA of kidney samples after 7 days post-infection. Since these proteins 
are part important of the cell wall and in vivo the yeast cells are under constant cell wall stress by the 
immune system, it is conceivable that the mutant presents a higher expression of these genes, which 
may compensate the weakened cell wall. Overall, these results showed that the transcription factor 
Rlm1 is involved in the stability of the cell wall in the interaction with the host, being important for the 
virulence of C. albicans and invasion of the kidneys during hematogenously disseminated candidiasis. 
 
Altogether, the objective proposted in this thesis were achieved, demonstrating that RLM1 gene is an 
important transcription factor involved in C. albicans cell wall remodelling, such that the mutant is 
practically avirulent. Additionally, we also think that this yeast developed a way of increasing the 
genetic variability of this important gene (through CAI repetitive region), confering a high plasticity to 
C. albicans isolates. 
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Participação do gene CaRLM1 na virulênce de Candida albicans  
 
Resumo 
A parede celular é uma estrutura essencial responsável pela manutenção da viabilidade das células 
fúngicas, conferindo-lhes morfologia típica e protecção. Como estrutura celular mais externa de 
microrganismos patogénicos, contém determinantes antigénicos importantes e medeia a adesão aos 
tecidos do hospedeiro, sendo essencial para iniciar a colonização e, portanto, causar doença. As 
células de Saccharomyces cerevisiae e Candida albicans respondem a perturbações da parede 
celular através da activação da via “mitogenic activated protein kinase” (MAPK) da integridade da 
parede celular (CWI), também conhecida como a via da PKC. Um dos factores de transcrição 
presente nesta cascata de sinalização é a proteína MADS-box Rlm1, cujo ortólogo em C. albicans foi 
identificado apenas por homologia de sequência. A presente tese teve como objectivo o estudo da 
diversidade molecular e caracterização funcional do gene RLM1, bem como estudo da sua 
participação na manuntenção da parede celular e virulência de C. albicans. 
 
A proteína Rlm1 de C. albicans é um factor de transcrição que apresenta uma grande variabilidade na 
sua extremidade terminal C, conferida pelo microssatélite CAI. Cento e vinte e três isolados de C. 
albicans foram genotipados com microssatélite CAI (CAA/G)n e 35 alelos foram encontrados com 
unidades repetitivas variando entre 11 a 49. È interessante notar que as estirpes com maior número 
de repetições (CAA/G) apresentaram maior tolerância a agentes de stresse da parede celular. Estas 
observações sugeriram que a região repetitiva CAI confere uma alta variabilidade genética ao gene 
RLM1, que se reflecte em diferentes susceptibilidades das estirpes a diferentes condições de stresse, 
conferindo uma elevada plasticidade aos isolados de C. albicans. 
 
De forma a determinar se o gene RLM1 de C. albicans está envolvido na via CWI, como descrito para 
S. cerevisiae, foi construído o mutante rlm1Δ/rlm1Δ utilizando a estratégia SAT1-flipping, de modo a 
evitar o uso de marcadores de auxotrofia. A estirpe selvagem (WT), a estirpe mutante (rlm1Δ/rlm1Δ) e 
a complementada (rlm1Δ/rlm1Δ+RLM1) foram testadas com vários agentes de stresse da parede 
celular em paralelo com as estirpes WT e rlm1Δ de S. cerevisiae. O mutante de C. albicans 
rlm1Δ/rlm1Δ apresentou fenótipos associados à deficiência de parede celular, tais como, a 
hipersensibilidade ao Congo red, à caspofungina e ao calcofluor white. O fenótipo com caspofungina 
foi revertido por estabilização osmótica com sorbitol 1M, indicando enfraquecimento da parede celular 
no mutante. A quantificação de componentes da parede celular mostrou um aumento de duas vezes 
em quitina e mananos no mutante rlm1Δ/rlm1Δ de C. albicans em comparação com a estirpe WT. A 
estipe mutante rlm1Δ de S. cerevisiae exibiu várias diferenças fenotípicas em comparação com o 
mutante rlm1Δ/rlm1Δ de C. albicans: insensibilidade ao Congo red e caspofungina, uma maior 
resistência ao calcofluor white e uma maior sensibilidade ao SDS. De acordo com a função de factor 
de transcrição, encontramos dados indicando a localização nuclear da proteína de fusão Rlm1-GFP. 
A análise de “microarrays” demonstrou que a ausência do gene RLM1 em C. albicans induziu um 
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aumento significativo na transcrição de genes envolvidos na adesão celular, tais como, ECE1, ALS1, 
ALS3, HWP1, RBT1 e uma diminuição na transcrição de genes envolvidos no catabolismo de hidratos 
de carbono, tais como, DAK2 GLK4, NHT1 e TPS1. O aumento na transcrição de genes envolvidos 
na adesão celular foi confirmados por resultados em ensaios de aderência celular e formação de 
biofilme. Estes resultados e a homologia com outros factores de transcrição MADS-box do mesmo 
tipo sugerem fortemente que o gene RLM1 de C. albicans, bem como o seu ortólogo em S. 
cerevisiae, estão envolvidos na remodelação da parede celular. Além disso, observou-se um aumento 
de proteínas de adesão celular envolvidas na formação de biofilme no mutante rlm1Δ/rlm1Δ em 
comparação com a estirpe WT, sugerindo que o RLM1 de C. albicans actua como um regulador 
negativo da formação de biofilme. 
 
Por fim o envolvimento do factor de transcrição Rlm1 de C. albicans na virulência foi avaliado num 
modelo murino de candidíase disseminada. Ratinhos infectados com células mutantes rlm1Δ/rlm1Δ 
apresentaram um maior tempo de sobrevivência do que ratinhos infectados com as estirpes WT e 
complementada, estas últimas apresentando uma maior carga fúngica e crescimento micelial invasivo 
através dos tecidos na análise histopatológica dos rins. Além disso, na linha celular murine 
macrophage-like J744A, a produção de TNF-α foi menor em resposta ao mutante rlm1Δ/rlm1Δ e a 
toxicidade celular, medida pela actividade extracelular do lactato desidrogenase, foi significativamente 
mais baixa em comparação com as estirpes WT e complementada. Mais, a quantificação por qRT-
PCR demonstrou que a expressão dos genes relacionados com parede celular, CRH11 e PHR2, foi 
claramente maior no mutante rlm1Δ/rlm1Δ em relação à estirpe WT, em mRNA de amostras de rim 
após 7 dias pós-infecção. Uma vez que estas proteínas são parte importante da parede celular e que 
in vivo as células de levedura estão sob stresse constante pelo sistema imunitário, é plausível que o 
mutante apresente uma expressão maior de estes genes, podendo compensar o enfraquecimento da 
parede celular. Em conclusão, estes resultados mostraram que o factor de transcrição Rlm1 está 
envolvido na estabilidade da parede celular, na interacção com o hospedeiro, sendo importante para 
a virulência de C. albicans e invasão durante a candidíase hematogenicamente disseminada. 
 
No seu conjunto, os objetivos propostos desta tese foram alcançados, demostrando que o gene 
RLM1 é um importante factor de transcrição em C. albicans, sendo essencial na remodelação da 
parede celular, de tal modo que o respectivo mutante é praticamente avirulento. Além disso, 
verificamos tambiém que nesta levadura o gene RLM1 apresenta uma elevada variabilidade genética 
(região repetitiva CAI), conferindo desta forma uma maior plasticidade aos isolados de C. albicans. 
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1. An overview of fungal infections 
Fungi play a critical role impacting nearly all other forms of life in virtually all ecosystems as either 
beneficial or detrimental. Saprotrophic fungi are important in the environment in the cycling of nutrients 
through the decomposition of organic material, especially the carbon that is sequestered in wood and 
other plant tissues. Mutualistic symbiont fungi through relationships with prokaryotes, plant (including 
algae) and animals have enabled a diversity of other organisms to exploit novel habitats and 
resources. Indeed, the establishment of mycorrhizal associations may be a key factor that enabled 
plants to make the transition from aquatic to terrestrial habitats. Other groups are pathogenic and 
parasitic fungi that attack virtually all groups of organisms such as, bacteria, plants, other fungi, and 
animals, including humans. The economic impact of such fungi is massive either beneficial by the 
production of antibiotics or extremely detrimental by the devastating impacts in diseases (Pirozynski 
and Malloch, 1975; Moss, 1987; Alexopoulos, 1996; Blackwell, 2000). 
 
Human fungal infections have been increasing over the past decades. Fungi are gaining importance 
with the rising incidence of chronic mycoses, often fatal in immunocompromised patients, decreasing 
their chance of recovery and seriously hampering their quality of life. These problems are a 
consequence of the introduction of a variety of therapeutic modalities into clinical medicine (invasive 
technologies, anticancer drugs and therapy prior to organ transplantation). Additionally, fungal 
infections increased dramatically with the emergence of acquired immune deficiency syndrome (AIDS) 
and the widespread use of injectable illicit drugs, such as heroin (Ghannoum and Abu-Elteen, 1990; 
Edwards, 1991; Zaoutis et al., 2005; Pfaller and Diekema, 2007). Different fungal species are found 
associated with human diseases. Candida spp. and Cryptococcus spp. are the yeast species most 
frequently isolated in clinical practice. Aspergillus spp. are the most frequent ﬁlamentous fungi 
(moulds) isolated, but Fusarium spp., Scedosporium spp., Penicillium spp. and Zygomycetes are 
increasingly seen (Marr et al., 2002; Husain et al., 2003). 
 
Candida albicans is a diploid eukaryotic yeast of the Kingdom Fungi (phylum Ascomycota: subphylum 
Saccharomycotina: class Saccharomycetes: order Saccharomycetales: family Saccharomycetaceae). 
A distinctive characteristic of C. albicans is its ability to grow in three distinct morphologies that include 
unicellular budding yeast (blastospore), true hyphae, and pseudohyphae (Fig. 1.1). Candida albicans 
also can form chlamydospores, that is to say, asexual spores that develop on pseudohyphal support 
cells and appear under unfavourable environmental conditions (Kurtz, 1990; Sudbery et al., 2004). 
This fungus is an opportunistic pathogen, which exists as part of the normal flora of the 
mucocutanous, gastrointestinal and genitourinary areas in a significant part of the population, where it 
behaves as a harmless commensal organism (Odds, 1988; Calderone and Fonzi, 2001). However, 
when the normal host defence mechanisms are impaired, C. albicans is capable of causing a range of 
infections, from superficial thrush to dangerous systemic candidiasis (Larriba et al., 2000; Calderone, 
2002). 
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The diploid C. albicans has eight pairs of homologous chromosomes, with a genome size of 14.3 Mb, 
based on the genome sequencing of SC5314 strain. Candida albicans has a genome with a GC 
content of 33.5%, 6,107 genes, an average gene size of 1,468 bp and an intergenic average size of 
858 bp (Magee, 1993; Butler et al., 2009). Candida albicans present a non-canonical codon usage, 
translating the normally leucine-specific codon CUG as serine (Santos and Tuite, 1995). Despite the 
demonstration that an elaborate mechanism for mating is still operational in C. albicans (Magee and 
Magee, 2000; Johnson, 2003; Kim and Sudbery, 2011), to date, a complete sexual cycle has not been 
observed. Therefore, C. albicans has been reported as presenting parasexual cycle (mating of diploid 
cells followed by mitosis and chromosome loss instead of meiosis) (Noble and Johnson, 2007; Kim 
and Sudbery, 2011). 
 
     A)                                                                                                   B) 
  
 
Figure 1.1. Different growth morphologies of C. albicans A) Diagrammatic representation of the cell cycle of 
yeast and of the first cycle after induction of pseudohyphae and hyphae B) Differential interference (DIC) images 
of cells in hyphae, pseudohyphae, and yeast morphologies. Adapted from Sudbery et al., 2004. 
 
 
1.1. Candida albicans as a pathogenic agent 
The genus Candida is ubiquitous and approximately 200 species are known, of which nearly 20 have 
been identified as etiologic agents of infections, but the list of medically important yeasts continues to 
grow (Calderone, 2002). Candida albicans is the most common fungal pathogen, representing a global 
average of 66% of all Candida species isolated in clinical practice, even though other species of 
Candida are increasing in prevalence, such as: C. glabrata, C. parapsilosis, C. tropicalis and C. krusei 
(Pfaller and Diekema, 2002; Morgan, 2005; Tortorano et al., 2006; Pfaller and Diekema, 2007; Pfaller 
et al., 2010; Pfaller et al., 2011; Tortorano et al., 2011). 
 
As an opportunistic pathogen C. albicans may establish an infection when adaptative and constitutive 
host defenses are compromised, for example, in haematological disorders, chemotherapy, transplant, 
diabetes, or patients with AIDS, among others. 
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1.1.1. Types of candidiasis 
Candidiasis can range from superficial disorders to invasive infections, mainly in immunocompromised 
hosts, and usually are classified into two main groups as follows: 
 
Superficial candidiasis  
Candida albicans, as a commensal organism, is not normally a problem however it can cause 
symptomatic infections of mucosal membranes (Odds, 1988). These infections affect the different 
systems and have several clinical manifestations, namely thrush, a superficial infection of one or more 
epithelial surfaces (Schwebke, 1996); oropharyngeal candidiasis (OPC), which occurs in 
approximately 70% of patients with AIDS; vulvo vaginitis candidiasis, that may affect up to 70% of 
women (with or without AIDS) at least once in their life time and 20% will experience recurrent disease 
(Fidel et al., 1999), and cutaneous candidiasis. Recurrent Candida infections of mucous membranes, 
skin and nails can lead to chronic mucocutaneous candidiasis (Ruhnke, 2002). 
 
Invasive Candidiasis  
Invasive candidiasis (also known as systemic candidiasis or hematogenously disseminated 
candidiasis) involves the infection and spread of Candida via the bloodstream to multiple organs, such 
as the brain, kidneys, heart, lungs, liver and spleen (Parker et al., 1976). Invasive candidiasis can be 
further classified as candidemia or disseminated candidiasis. 
 Candidemia. Blood stream infections by C. albicans are known as candidemia. In normal 
healthy individuals, adequate protection against such infections is provided by the action of the innate 
immune system. However, candidemia can develop in patients who have abnormally low numbers of 
neutrophils as a result of certain blood cancers or immunosuppressant therapy (Kim and Sudbery, 
2011). Candidemia represents 10-20% of all candidiasis and is considered as the tip of the iceberg of 
Candida spp. infections (Eggimann et al., 2003). 
 Disseminated candidiasis. Candidemia may give rise to hematogenous spread of 
Candida to one or multiple organs. In this case, it is referred as acute disseminated candidiasis. 
Multiple organs are frequently involved, and discrete persistent microabscesses occur in the liver, 
spleen, and kidneys (Parker et al., 1976; Bodey et al., 1992; Filler, 2002; Hedayati, 2009). 
 
1.1.2. Epidemiology of candidemia 
Fungal infections have been increasing over the past decades and today represent a serious health 
problem even in industrialized countries. Candida infections have been documented as the fourth 
most common hospital-acquired infections, and the second most common cause of death from such 
infections in the United States (Pfaller et al., 1998). In fact, over the past two decades the incidence of 
Candida bloodstream infections among immunocompromised patients has increased 15 to 20-fold 
(Perlroth et al., 2007) and is presently the third most common nosocomial infection in the United 
States (Wisplinghoff et al., 2004; Perlroth et al., 2007). Despite the widespread use of antifungals for 
prophylaxis and treatment of invasive fungal infections, candidemia and disseminated candidiasis 
have a high mortality rate of 30–50% (Pfaller et al., 1998; Kibbler et al., 2003). 
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Although C. albicans has been, in the past, the most common causative organism of fungemia and 
disseminated candidiasis, other Candida species are becoming increasingly more prevalent. A 
worldwide study of bloodstream infections from 1997 to 1999 showed that at least 45% of yeast 
infections were caused by other Candida species than C. albicans (Pfaller et al., 2001). The most 
commonly isolated species, apart from C. albicans, are C. parapsilosis (20 to 40% of all reported 
episodes of candidemia), C. glabrata (5 to 40%), C. tropicalis (10 to 30%), C. krusei (10 to 35%), C. 
guilliermondii (2 to 10%) and C. lusitaniae (up to 8%) (Sandven, 2000; Krcmery and Barnes, 2002). 
 
Studies of candidemia in Europe reported frequent association of candidemia with patients undergoing 
surgical interventions, patients with intensive care treatments, and patients suffering from solid tumor 
and haematological malignancies all of which were deeply immune suppressed. The rates of 
candidemia in Europe ranged from 0.20 to 0.38 per 1000 admissions and 0.31 to 0.44 per 10,000 
patient-days. These values are however lower than the ones reported in the USA, which are 1.5 per 
10,000 patient-days (Tortorano et al., 2006). Compared to 20 years ago, a larger proportion of 
Candida bloodstream infections is presently caused by C. glabrata in the United States (Trick et al., 
2002) and by C. parapsilosis and C. tropicalis in European, Canadian and Latin American hospitals 
(Wingard, 1995; St-Germain et al., 2001; Almirante et al., 2006). In Portugal, the candidemia rate 
found in acute leukemia patients (6.3%) was similar to rates published in the literature (Ribeiro et al., 
1997; Costa-de-Oliveira et al., 2008). A recent epidemiological study in a Portuguese oncology 
hospital during a 6-year period by Sabino et al., 2010 found that solid tumors and hematological 
disease were the most common underlying medical conditions. The most frequent species found was 
C. albicans (48.7%), followed by C. Parapsilosis (20.2%), C. Tropicalis (.8.4%), C. krusei (6.7%) and 
C. glabrata (5.0%) but Saccharomyces cerevisiae and Rhodotorula mucilaginosa were also isolated. 
Candida albicans was more frequently associated with solid tumors of the gastrointestinal and 
genitourinary tracts and breast, while non-albicans Candida species were most frequently recovered 
from hematological patients. During a six-year survey, they found that in the Portuguese oncology 
hospital the incidence of candidemia and nosocomial candidemia were 2.02 and 1.49 per 1,000 
hospital admissions, respectively, and the mortality rate associated with candidemia was 31.9% 
(Sabino et al., 2010). 
 
1.1.3. Antifungal therapy 
The massive emergence of fungal diseases associated with AIDS in the 1980s and the rising 
frequency of fatal mycoses associated with increasing use of immunosuppressive medical therapies 
since the 1970s stimulated research directed towards the discovery of novel antifungal agents. The 
antifungal drugs available to treat fungal infections frequently cause deleterious side-effects because 
of the close biological similarity between the fungal cell and the mammalian cell. For that reason, an 
important goal in antifungal drug discovery is the identification of new suitable fungal targets with no 
mammalian homologies. All the antifungal agents currently available are classified, according with 
their specific mode of action. 
 
General introduction 
7 
The azoles act by inhibiting the fungal cytochrome P450-dependent ergosterol biosynthesis, 
specifically by blocking 14-α sterol demethylase. The primary differences between the azoles 
(itraconazole, imidazoles, fluconazole and ketoconazole) involve their spectrum of activity, 
pharmacokinetics, and chemical formulations. Amphotericin B, a polyene, works by binding to 
ergosterol in the fungal cell membrane, making the membrane more permeable. Despite of the 
conformational difference between cholesterol and ergosterol, and the major binding affinity of 
amphotericin B for the latter, this antifungal agent has potential toxicity for mammalian cells, so a 
variety of reformulated versions of the agent have been introduced in the last years, to overcome 
amphotericin B nephrotoxicity. Echinocandins (caspofungin, anidulafungin and micafungin) inhibit β-
(1,3)-D-glucan synthase, an essential enzyme for the synthesis of the fungal cell wall. Echinocandins 
have a broad spectrum of activity and tend not to affect human cells due to their targeted mechanism 
of action (Dupont, 2002; McPheeters, 2005; Perlroth et al., 2007). 
 
Emerging resistance to some antifungals might further limit the options available. For example, 
reduced susceptibility to fluconazole, one of the preferred drugs in the treatment of fungal infection, is 
frequent among non-albicans Candida spp. The mechanisms of resistance include changes in the cell 
wall or plasma membrane leading to an impaired uptake of antifungals, efflux pumps that take 
antifungals outside the cell, overexpression of the antifungal targets, mutations in the antifungal target 
that decrease its binding ability, activation of alternative pathways that increase the metabolism of the 
antifungal, sequestration of the antifungal in organelle-like vacuoles, or chromosomal changes that 
increase the number of copies of the required gene (Eggimann et al., 2003). A 5-year retrospective 
review published recently by Forrest et al., (2008) showed significant correlations between increased 
caspofungin usage and an increased incidence of C. parapsilosis candidemia and reduction of C. 
tropicalis and C. glabrata candidemia. According to Pfaller et al., (2008) Candida parapsilosis is 
innately less susceptible to the echinocandins than many other species of Candida, although the vast 
majority of isolates remain susceptible to all three echinocandins in medical use. Several data suggest 
that C. orthopsilosis and C. metapsilosis are more susceptible to echinocandins and amphotericin B 
but probably less sensitive to fluconazole than C. parapsilosis, C. metapsilosis being the less 
susceptible to this azole (Tavanti et al., 2007; Gomez-Lopez et al., 2008; Lockhart et al., 2008; Szabo 
et al., 2009; van Asbeck et al., 2009). Candida glabrata can be resistant to usual doses of triazoles, 
but sensitive to higher doses (Eggimann et al., 2003; Tortorano et al., 2006). 
 
1.2. Candida albicans virulence factors 
The definition of virulence is the ability of a microorganism to cause disease, and is determined by 
many factors. Virulence describes the degree of pathogenicity, where some strains may be more, or 
less, virulent than others. Most pathogens, including Candida spp, possess a wide range of putative 
virulence factors and specific mechanisms that assist in their ability to colonize host tissues, causing 
disease, and overcoming host defences (Romani et al., 2002). The interaction between virulence 
factors of C. albicans and host defense mechanisms plays a central role in determining whether 
colonization remains harmless or leads to infection of the epithelium and ultimately to systemic 
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infection. These virulence determinants include adherence to host cells, morphogenesis, biofilm 
formation, phenotypic switching, secretion of degradative enzymes and quorum sensing (Calderone 
and Fonzi, 2001; Schaller et al., 2005; Chauhan et al., 2006; Lim et al., 2011). 
 
1.2.1. Adherence 
Adherence of Candida spp. to host cells and tissues is an initial step that assist colonization or the 
establishment of infection (Kamai et al., 2002). Adherence involves the interaction between 
complementary molecules present in both the pathogen and the host surfaces (Gozalbo et al., 1998; 
Lopez-Ribot et al., 1999). Candida albicans is known to bind to different subendothelial extracellular 
matrix proteins such as fibronectin, laminin, entactin, and collagens, and these proteins are used as 
possible target molecules in the process of dissemination (Gozalbo et al., 1998; Klotz et al., 2001), 
penetrating into blood vessel walls and organs in systemic infections (Sundstrom, 1999; Calderone 
and Fonzi, 2001). 
 
Adhesins may be defined as cell surface biomolecules that promote the adherence of C. albicans to 
host cells or host–cell ligands (Calderone and Fonzi, 2001) such as polysaccharides (Fukazawa and 
Kagaya, 1997), lipids (Ghannoum et al., 1986), and glycoproteins (Agglutinin-Like Sequence, Als, 
family or Hwp1) (Gaur and Klotz, 1997; Staab et al., 1999; Hoyer, 2001). The Als protein family is 
encoded by eight genes, ALS1–7, and ALS9 (Hoyer, 2001), which are differentially expressed 
depending on the yeast growth conditions. Als proteins were shown to be expressed in vivo in the 
kidney, spleen, heart, liver and lung following systemic infection in a mouse model, and Als1 was also 
important for the adherence of C. albicans to the oral mucosa during the early stage of the infection 
(Hoyer et al., 1999; Kamai et al., 2002). HWP1 encodes a cell-surface adhesin that promotes strong 
interactions between C. albicans and host oral and vaginal epithelial cells. (Staab et al., 1999; Naglik 
et al., 2006). 
 
1.2.2. Secreted degradative enzymes 
The secretion of degradative enzymes during infections may be used as a virulence attribute that 
promotes degradation of host surfaces allowing adhesion and invasion, destruction of host immune 
factors, and nutrient acquisition (Hube and Naglik, 2001). The three most significant hydrolytic 
enzymes produced by C. albicans are secreted aspartic proteinases (SAP), phospholipases (PLs), 
and lipases (Lip) (Mavor et al., 2005). 
 
Proteinases belonging to the SAP family are responsible for the proteolytic activity of different Candida 
species (Hube and Naglik, 2001). Proposed functions of SAP during infection include digestion of host 
proteins on host surface for nitrogen nutrient supply (Backman, 2005), evasion of host defences by 
degrading immunoglobulins and complement proteins, resisting antimicrobial attack when 
phagocitosed (Kaminishi et al., 1995), and adherence and degradation of host barriers during invasion 
(Colina et al., 1996; Morschhauser et al., 1997). The SAP family has ten members (Sap1 to Sap10) 
and is the most extensively studied group of hydrolytic enzymes and has been linked with the 
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virulence of the fungus, since its discovery (Staib, 1969; Kwon-Chung et al., 1985). The genes exhibit 
differential expression profiles under various conditions, in different in vivo models and in patients with 
candidiasis (Naglik et al., 2003; Naglik et al., 2004; Mavor et al., 2005). In vivo SAP expression has 
been mainly studied using the mouse model of systemic infection (Felk et al., 2002; Naglik et al., 
2003). In the model of bloodstream disseminated candidiasis, SAP4 to SAP6 were the main SAP 
activated genes, while SAP5 was the main gene activated in a disseminated intraperitoneal infection, 
both at the initial time of inoculation and during invasion and subsequent dissemination to the kidneys 
(Staib et al., 2000). SAP1 to SAP3 were observed in a later phase of the infectious process (Staib et 
al., 2000). This pattern of SAP gene activation during systemic infections suggested a role for SAP4 to 
SAP6 during the initial phases of invasion and organ colonization and for SAP1 to SAP3 in later 
phases, when C. albicans had already established the infection (Staib et al., 2000; Naglik et al., 2003). 
The contribution of the SAP gene family to disease was also confirmed with sap mutants, which 
showed attenuated virulence in a mouse model of systemic infection (Hube et al., 1997; Sanglard et 
al., 1997). However, Correia et al., (2010) suggested a limited role of Sap1 to Sap6 in Candida 
albicans virulence and host immune response in murine hematogenously disseminated candidiasis, 
since that no clear difference in the virulence of the different mutants was observed in comparison with 
the wild-type strain. 
 
Putative roles of microbial extracellular lipases include the digestion of lipids in nutrient acquisition, the 
adhesion to host cells and tissues, the initiation of inflammatory processes by affecting immune cells, 
and self-defense by lysing competing microflora (Trofa et al., 2008). Like SAP, lipases are also 
encoded by a gene family LIP1 to LIP10, and in a similar manner to the SAP gene family, the LIP 
genes are differentially expressed at different stages and sites of infection (Mavor et al., 2005). 
Expression of LIP5, LIP6, LIP8, and LIP9, but not the other members was detected in the mouse 
model of C. albicans peritonitis (Hube et al., 2000). 
 
Phospholipases are enzymes capable of hydrolyzing one or more ester linkages in 
glycerophospholipids. Four PLs have been identified so far in C. albicans (PLA, PLB, PLC, and PLD), 
although only PLB1 has been shown to be necessary for virulence, in which, Plb1activity was detected 
at the tips of hyphae during tissue invasion (Ghannoum, 2000). The function of phospholipases during 
infection is not well understood, although it is believed that they are involved in the adhesion, 
disruption of host membranes and penetration through host cells (Trofa et al., 2008; van Asbeck et al., 
2009). 
 
1.2.3. Morphogenesis 
Candida albicans is a polymorphic diploid fungus that can grow either as unicellular budding yeast 
(blastospores), as hyphae or as pseudohyphae (Lee et al., 1975; Odds, 1988; Calderone and Fonzi, 
2001; Romani et al., 2003; Sudbery et al., 2004). The ability to switch rapidly from yeast-to-
filamentous growth or vice versa has been often considered to be a critical virulence factor for this 
fungus (Lo et al., 1997; Mitchell, 1998; Odds et al., 2001; Rooney and Klein, 2002; Nemecek et al., 
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2006). The yeast form is important for dissemination through the bloodstream (Bendel et al., 2003; 
Saville et al., 2003), and adheres to endothelial surfaces (Grubb et al., 2009) while the filamentous 
forms, on the other hand, is more adapted for invasion through the host epithelial tissue (Rooney and 
Klein, 2002), and also have a higher resistance to phagocytosis (Lorenz et al., 2004). Several 
environmental factors can induce yeast cells to form hyphae and pseudohyphae (Romani et al., 2003; 
Sudbery et al., 2004). Hyphal growth is promoted by a variety of environmental conditions such as the 
temperature of 37°C, the presence of serum, neutral pH, high CO2 and growth on N-
acetylglucosamine. Yeast form growth is favoured by a 30°C growth temperature and acidic pH (pH 
4.0), while pseudohyphae are triggered by amino acid starvation, high phosphate concentrations and 
by growth at pH 6.0 and 35ºC (Sudbery et al., 2004; Whiteway and Oberholzer, 2004; Kim and 
Sudbery, 2011). 
 
In the last 10 years, the use of gene knockout mutagenesis and transcriptional studies, revealed 
signalling pathways, transcriptional factors, as well as other regulatory components that collectively 
drive the yeast-to-hyphal transition (Gow, 2009). The roles of signalling pathways and transcriptional 
regulators on C. albicans morphogenesis have been discussed in many review articles (Brown and 
Gow, 1999; Ernst, 2000; Liu, 2001; Navarro-Garcia et al., 2001; Liu, 2002; Biswas et al., 2007; Roman 
et al., 2007; Alonso-Monge et al., 2009; Hogan and Sundstrom, 2009; Wang, 2009; Han et al., 2011). 
 
1.2.4. Phenotypic switching 
In addition to the yeast-hyphae transition, C. albicans is capable of undergoing a different type of 
morphological change that has been termed phenotypic switching (Slutsky et al., 1985; Soll et al., 
1987; Soll, 1992; Soll, 1997; Soll, 2001). This change involves the spontaneous and reversible 
generation of different morphological and physiological states, expressing different patterns of 
pathogenicity-related traits, such as virulence factors, antigens, and resistance to antifungal drugs 
(Braun and Johnson, 1997; Lo et al., 1997). The white–opaque transition in the WO-1 strain is the 
most widely studied phenotypic switching and this switch gives rise to distinct cellular forms (Soll, 
1997). White-opaque switching contributes to a better adaptation of C. albicans to new host niches. 
While white cells are much more virulent than opaque cells after intravenous infection, opaque cells 
are better able to infect skin (Kvaal et al., 1997; Kvaal et al., 1999). Moreover, switching has been 
demonstrated to regulate a number of phenotypic characteristics involved in pathogenesis such as 
adhesion, expression of cell surface hydrophobicity and proteinases and phospholipases secretion 
(Antony et al., 2009). 
 
Both processes, dimorphic transition and switching, confer C. albicans cells the ability to generate 
variants which allow a better selective adaptation to changing environmental conditions, and 
particularly to evade the host immune system (Braun and Johnson, 1997; Lo et al., 1997). 
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1.2.5. Biofilm formation 
Biofilms are universal, complex, interdependent communities of surface-associated microorganisms. 
Candida albicans, is able to form a biofilm when free-living cells, called planktomic cells, rearrange in 
to a complex structure of yeast and filamentous cells that coexist as an organized community with a 
complex three-dimensional architecture that is enveloped within an exopolysaccharide matrix, 
attached to a solid substratum (Chandra et al., 2001; Blankenship and Mitchell, 2006; Nobile and 
Mitchell, 2006). Biofilms, with their elaborate architecture present a serious medical problem in treating 
patients with systemic infections because they have a higher resistance to both antifungal drugs and 
the host immune response (Baillie and Douglas, 1999; Chandra et al., 2001; Ramage et al., 2001; 
Kuhn et al., 2002; Mishra et al., 2007). The ability of C. albicans to switch from the yeast form to the 
hyphal form, which is one of the major virulence determinants of this fungal species (Lo et al., 1997; 
Saville et al., 2003), is a key factor for C. albicans biofilm development (Baillie and Douglas, 1999; 
Ramage et al., 2001). 
 
Biofilm-forming potential is cited as a reason for catheters removal in patients with Candida-infected 
catheters, particularly C. parapsilosis, because the ability to grow as a biofilm is directly related to 
clinically significance of the disease (Kuhn et al., 2002). 
 
1.2.6. Quorum sensing 
Quorum sensing is the phenomenon of cell-to-cell communication and signalling in microorganisms. 
Quorum sensing is often referred to as autoinduction, a process by which individual cells release small 
diffusible molecules into their environment and these molecules are sensed by all cells in the 
population (Fuqua et al., 1994; Gray et al., 1994; Hense et al., 2007). The existence of quorum 
sensing in prokaryotes has been studied extensively, but quorum sensing research in eukaryotes, 
especially in the medically important diploid fungi Candida spp., has gained momentum only recently 
(Hornby et al., 2001; Chen et al., 2004). Tryptophol and phenylethyl alcohol were the first quorum-
sensing molecules (QSMs) identified in C. albicans (Lingappa et al., 1969), three additional QSMs 
have been isolated from C. albicans, farnesol, tyrosol and farnesoic acid (Hornby et al., 2001; Oh et 
al., 2001; Chen et al., 2004; Hornby and Nickerson, 2004). Initially, it was thought that QSMs such as 
farnesol could be manipulated to treat invasive candidiasis as a fungistatic agent (Hornby et al., 2001), 
but the discovery that endogenous farnesol actually contributed to C. albicans virulence has redirected 
recent research into understanding QSMs as an important new virulence factor of systemic 
candidiasis. 
 
1.3. Host immune response 
Effective host response against fungal organisms requires the coordinated contribution of both innate 
and adaptative immunity (Antachopoulos and Roilides, 2005). The initial mechanism of innate 
immunity against Candida infections includes the barrier function of the skin and mucosal epithelial 
surfaces, the microbial antagonism of the resident flora and the local defence mechanisms (Romani, 
2004). Local defences include proteins, such as lactoferrin, beta-defensins, lysozyme, transferrin, 
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lactoperoxidase, mucins, and secretory immunoglobulin A. Together, these mechanisms contribute to 
avoid adhesion and growth of Candida cells on mucosa surfaces (Steele et al., 2000). If these barriers 
in the body are damaged by surgery, polytrauma, drug treatment, or spreading from biofilms produced 
on medical devices, Candida cells may enter the bloodstream by direct penetration from epithelial 
tissues (Mavor et al., 2005). Neutrophils, macrophages and monocytes are fundamentally important 
antifungal effector cells and constitute the second barrier that Candida cells have to overcome. 
Phagocytes already residing in target organs at the time of infection, attempt to kill or damage fungi. 
Additional effector cells, including neutrophils and monocytes, are recruited to sites of infection by the 
action of inflammatory signals, such as cytokines, chemokines and complement components. Hyphae 
are capable of inducing production of inflammatory cytokines to a higher extent than phagocytosed 
yeasts (Romani., 2002). 
 
Phagocytic cells recognize and engulf yeast cells via cell-surface pattern recognition receptors. 
Binding to those receptors activates specialized antifungal effector functions on neutrophils and other 
phagocytes (Bellocchio et al., 2004). Neutrophils usually lack the machinery required to present 
antigen to T cells, being their primary function to engulf and kill Candida cells (Oehler et al., 1998). At 
a site of infection, after the resident macrophages, other exudative monocytes are recruited, several 
hours after neutrophils, which persist for a longer period (van Burik and Magee, 2001). Macrophages 
possess the machinery required for antigen presentation, being their central role the killing and 
presentation of pathogen antigens. Whereas neutrophils appear to be able to phagocytose the fungal 
yeasts, the filamentous forms are not easily phagocytosed. After recognition, C. albicans is 
internalized into the phagosome, which fuses with the lysosome creating the phagolysosome, an 
organelle with acidic pH and several antimicrobial compounds (Lorenz and Fink, 2002). Degradation 
of phagocytosed C. albicans cells is carried out by oxidative mechanisms, including generation of 
reactive oxygen and nitrogen intermediates, as nitric oxide, and by non-oxidative mechanisms 
(Kobayashi et al., 2004). Fungi are then killed or damaged by production and/or release of reactive 
oxygen intermediates and antimicrobial peptides (Diamond et al., 1980; Mambula et al., 2000). 
Whether the cells use intracellular or extracellular antifungal mechanisms depends upon the infecting 
species, morphotype, and route of exposure (Diamond et al., 1978; Schaffner et al., 1982; Kan and 
Bennett, 1988). Quantitative and qualitative abnormalities of neutrophils and monocytes are 
associated with systemic candidiasis. Thus, patients with lymphoma, leukaemia, chronic 
granulomatous disease, and recipients of intensive cancer chemotherapy with resultant neutropenia 
are at increased risk for disseminated infection. 
 
Complement system is also an important part of the innate resistance to infection (Romani., 2002). 
Candida cells or antibodies directed against mannan antigens activate the complement cascade, 
leading to destruction of the pathogen directly through the membrane attack complex or by phagocytic 
cells called by complement fragments that recognize complement opsonized Candida cells. 
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Upon microorganism interaction, phagocytes secrete cytokines and chemokines that polarize the 
immune response through interaction with T-cells. Thus, macrophages and dendritic cells are the 
phagocytes with a greater responsibility in presenting antigen and inducing a T-cell mediated 
response, with cytokines production (Kim et al., 2005). This adaptative immunity is composed by 
adaptive T helper-cell responses that can be mainly classified as pro-inflammatory (Th1 and Th17 
responses) or anti-inflammatory (Th2 response). Dendritic cells that ingest the yeast form induce 
differentiation of CD4+ T cells toward a Th1 pathway. In contrast, hyphae induce Th2 responses 
(d'Ostiani et al., 2000). Moreover, development of Th1 or Th2 responses is an important determinant 
of the host’s ability to contain infection. Th1 responses are correlated with protection and their 
development is influenced by the concerted action of several cytokines such as INF-γ (interferon 
gama), IL (interleukin)-6, TNF-α (Tumor necrosis factor alfa), IL-12 and IL-17, in the relative absence 
of Th2 cytokines, such as IL-4, IL-5, IL-10 and IL-13, which inhibit the induction of Th1 responses 
(Romani., 2002). INF-γ, IL-6, and TNF-α are proinflammatory cytokines readily produced upon 
interaction of phagocytes with fungal cells and are detected in Candida sepsis. The anti-inflammatory 
responses involve the production of Th2 cytokines that are known to reduce the ability of 
macrophages to produce nitric oxide (Cenci et al., 1993) and elicit the production of non-opsonizing 
antibodies and allergic reactions. Regulatory T-cells allow the balance between the two responses, 
operating from commensalism to infection. Although neutropenia is a major predisposing factor to 
candidemia, the propensity for persistence of the fungus in infected tissues may be a consequence of 
cell-mediated immune deregulation with suppression of Th1 and overexpression of Th2 responses 
(Shoham and Levitz, 2005). Future therapies for invasive fungal infections may include agents that 
augment antifungal activity of effector cells and alter Th balance. 
 
1.4. Cell wall 
1.4.1. Molecular structure 
The cell wall is an essential structure that maintains the viability of fungal cells, conferring their typical 
morphology, osmotic stabilization and protection against external injuries (Klis et al., 2001; Klis et al., 
2002; Netea et al., 2008). As the most external cellular structure of pathogenic microorganisms, it also 
carries important antigenic determinants and mediates adhesion to the host tissues, being therefore 
crucial to initiate colonization and therefore, cause disease (Calderone and Fonzi, 2001; Sundstrom, 
2002). The cell wall is the structure sensed by the host immune cells. As a consequence, it 
participates in triggering the whole innate and adaptive immune response against the microorganism. 
Structurally, the yeast cell wall accounts for 15–30% of the cell dry weight and in C. albicans the cell 
wall is made of 80-90% polysaccharides, 6-25% proteins, and in a minor amount of 1-7% lipids 
(Chaffin et al., 1998). The major polysaccharides of the cell wall are represented by three basic 
constituents, (i) branched polymers of D-glucose containing β-1,3 and β-1,6 linkages (β-glucans), (ii) 
unbranched polymers of N-acetyl-D-glucosamine (GlcNAc), containing β-1,4 bonds (chitin), and (iii) 
polymers of mannose (also called phosphopeptidomannan) covalently associated with proteins (gluco 
or mannoproteins). β-1,3- and β-1,6-glucans and chitin, represent the inner structural components of 
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the fungal cell wall to which a protective mannoprotein layer is attached (Fig. 1.2) (Casanova et al., 
1992; Klis et al., 2001; Klis et al., 2002; Netea et al., 2008). 
 
The glucan polymer network is composed of β-1,3-glucan linear chains interconnected by means of 
modules of β-1,6-glucans, accounting for 50–60% of the total cell wall. The enzyme responsible for the 
synthesis of β-1,3-glucan is the glucan synthase (GS) whose catalytic subunit is encoded by the 
genes FKS1 and FKS2. The function of β-1,6-glucans is the connection of the network of β-1,3-glucan 
with some cell wall proteins. β-1,3-glucans are distributed through the cell surface and are covalently 
linked to some chitin chains, providing a scaffold to which mannoproteins are also covalently attached 
(Fig. 1.2). Glucans form the structural skeleton of the cell wall and their importance was recognized by 
the fact that inhibition of glucan synthesis or degradation of its chains confers cell fragility and 
morphological alterations on Candida cells (Lipke and Ovalle, 1998; Kapteyn et al., 1999; Klis et al., 
2001; Klis et al., 2002; Gozalbo et al., 2004). 
 
 
Figure 1.2. The structure of the Candida albicans cell wall. The schematic shows the major components of 
the cell wall and their distributions. β-1,3-glucan and chitin (poly-β-1,4-N-acetylglucosamine) are the main 
structural components, and these are located towards the inner layer of the cell wall. The outer layers are 
enriched with cell wall proteins (CWP) that are attached to this skeleton mainly via glycosylphosphatidylinositol 
remnants to β-1,6-glucan or, to mannoproteins with internal repeat domains (Pir-CWP), via alkali-sensitive 
linkagers to β-1,3-glucan. The inserts show the structure of glucan and mannan components. Adapted from Netea 
et al., 2008. 
 
 
The external outer layer is composed of mannoproteins (35-40% of the total cell wall), also called cell 
wall proteins (CWPs), which are normally highly glycosylated (either O- or N-glycosylated) with 
mannose-containing polysaccharides that can account for up to 90% of the mannoproteins molecular 
mass (Arana 2009). Mannans are largely responsible for determining the porosity of the cell wall and 
protecting the glucan layer of the action of degradative enzymes. In addition, mannans are the main 
molecules responsible for the adherence ability, as well as for resistance to a wide range of 
environmental conditions (Lipke and Ovalle, 1998; Kapteyn et al., 1999; Klis et al., 2002). In C. 
albicans, CWPs frequently contain internal repeats (named Pir-CWPs) that are directly linked to β-1,3-
glucan, whereas others contain a glycosylphosphatidylinositol derived-structure (GPI-CWPs) and are 
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attached to the β-1,6-glucan. Mannans exist as glucoconjugates and were first identified as the major 
cell surface antigen of C. albicans, even before the revelation of their chemical structure (Whiteway 
and Oberholzer, 2004). Receptors for mannans are found on the surface of macrophages, suggesting 
their involvement in the phagocytosis of Candida cells (Masuoka, 2004). 
 
Chitin is an essential component (1-2% of the total cell wall) found dispersed in the cell wall, in the bud 
neck, in the primary septum and in bud scars (Cabib and Duran, 2005). This particular localization 
together with the fact that upon stress the content in chitin can increase considerably (Aguilar-
Uscanga and Francois, 2003), suggest that chitin is the material used for cell wall remodelling. Chitin 
and β-1,3-glucans are mainly responsible for providing the cell wall strength and rigidity, which 
ultimately determine the morphology of the cell, therefore their synthesis play a fundamental role in 
maintaining fungal cell integrity during growth and morphogenesis as well as in adaptation to stress 
(Shaw et al., 1991). 
 
1.4.2. The signalling MAP kinase cascade 
Cells have developed mechanisms that sense external stimuli and trigger cellular responses that allow 
a rapid adaptation to new extracellular conditions. These responses involve changes in gene 
expression and precise routes that translate the signal from the cell surface to the nucleus, the site of 
the transcriptional machinery. The sensor proteins located in the plasma membrane are responsible 
for detecting the signals produced by environmental disturbances. Once a stimulus is detected, the 
signal is transmitted to cellular targets by different protein kinases. In some cases these kinases are 
organized in a module, conserved throughout evolution, known as cascade of MAP kinases (mitogen-
activated protein), which are highly conserved among eukaryotic cells (Kultz and Burg, 1998). The 
structure comprises three kinases that work by sequential phosphorylation. Upon receiving a 
stimulatory signal, the MAP kinase kinase kinase (MAPKKK or MEKK) is phosphorylated by different 
upstream modules, which frequently involve the PAK (p21 activated kinase) family of protein kinases 
and small GTPases. Phosphorylation of MAPKKK triggers the phosphorylation of the MAP kinase 
kinase (MAPKK or MEK), which in turn phosphorylates the MAP kinase (MAPK). The signal is finally 
transferred to downstream effectors, normally a transcription factor or other molecules, which either 
activate or relieve the repression of the corresponding target genes, modulating gene expression. The 
expression of the target genes is essential in the adaptive response of the cell to the activating 
stimulus (Marshall, 1994). 
 
These pathways have been extensively characterized in non-pathogenic model yeasts such as S. 
cerevisiae (Gustin et al., 1998) and Schizosaccharomyces pombe (Ikner and Shiozaki, 2005). In S. 
cerevisiae, MAPK pathways have been implicated in at least five different processes: i) the cell 
integrity mitogen-activated protein (MAP) kinase pathway or protein kinase C (PKC) pathway; ii) the 
adaptation to stress (osmotic, but also oxidative, acid and heat) mainly occurs through the high 
osmolarity glycerol (HOG) pathway; iii) the pheromone response pathway or mating and iv) the 
filamentous growth pathway, that share many members of the central module of MAP kinases; and v) 
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the sporulation pathway, also called nutrient deprivation, controls the formation of spores when 
extracellular environmental conditions are adverse. Each of these pathways detects and translates 
specific signals from different types of stimuli (Posas et al., 1998; Schmidt and Hall, 1998; Heinisch et 
al., 1999; Millar, 1999; O'Rourke et al., 2002; Perez and Calonge, 2002; Edmunds and Mahadevan, 
2004; Schwartz and Madhani, 2004; Levin, 2005). 
 
In the pathogenic yeast C. albicans, genetic analysis allowed the identification of different routes, 
especially by the phenotypic characterization of mutants altered in the Mkc1, Cek1/2 and Hog1 MAP 
kinases (Fig. 1.3). The cell integrity pathway is mediated by Mkc1, in a manner dependent of the 
presence of Pkc1, and is primarily involved in the biogenesis of the cell wall (Navarro-Garcia et al., 
1995; Diez-Orejas et al., 1997; Navarro-Garcia et al., 1998; Navarro-Garcia et al., 2005). The HOG 
pathway participates in the response to osmotic stress while the Cek1/2 pathway mediates mating and 
filamentation (Whiteway et al., 1992; San Jose et al., 1996; Chen et al., 2002; Alonso-Monge et al., 
2003; Smith et al., 2004; Arana et al., 2005). Their actual functions are, however, much broader. Mkc1 
senses several types of stress, while Hog1 is also responsive to other stress conditions and 
participates in two morphogenetic programs: filamentation and chlamydospore formation (Alonso-
Monge et al., 1999; Calera et al., 2000; Alonso-Monge et al., 2003; Arana et al., 2005). Furthermore, it 
has been recently shown that Cek1 participates in a putative pathway involved in the construction of 
the cell wall, which seems to be operative under basal conditions (Chen et al., 2002; Roman et al., 
2005). 
 
 
 
Figure 1.3. MAP kinase pathways in fungi. The central core genes of MAPK pathways in two selected fungal 
models are shown: Saccharomyces cerevisiae (black) and Candida albicans (pink). The functions associated to 
each of them are shown beneath the core genes. Adapted from Román et al., 2007. 
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1.4.3. Cell Wall integrity (CWI) pathway  
Wall remodeling is monitored and regulated mainly by the cell wall integrity (CWI) signaling, which 
activates a MAP kinase cascade. The cell integrity or Pkc1-mediated pathway responds to 
perturbations in the cell surface, so the first components of the pathway must be membrane- or cell 
wall-associated proteins that would function as sensors. This is well understood from studies in the 
budding yeast S. cerevisiae, where the CWI pathway comprises the sensors Mid2 and Wsc1 in the 
plasma membrane, which, upon cell wall damage, interact with the GDP/GTP exchange factor Rom2, 
leading to the conversion of the G protein Rho1 to its activated GTP-bound state. Interaction with 
Rho1 activates the control kinase Pkc1 that phosphorylates the MAPKKK Bck1, which, at least in vitro, 
is phosphorylated in multiple sites (Levin et al., 1994). It is assumed that Bck1 phosphorylates serine 
and threonine residues of two redundant MAPKK, Mkk1 and Mkk2 (Irie et al., 1993; Kamada et al., 
1995; Paravicini et al., 1996), which in turn phosphorylate the MAP kinase. MAPK Slt2 (also called 
Mpk1) is simultaneously phosphorylated on both threonine and tyrosine conserved residues present in 
subdomain VIII of the kinase superfamily, a distinctive feature that separates this one from other 
kinases (Lee et al., 1993; Marshall, 1994). 
 
Mutants defective in elements of CWI pathway display an osmotic-remediable lytic phenotype caused 
by defective cell wall biogenesis (de Nobel et al., 2000; Levin, 2005). This route, among other 
functions, is involved in the biosynthesis of the new cell wall when polarized growth is required, as well 
as in maintenance of the cell wall integrity under stress conditions. This pathway is activated upon 
heat shock (Kamada et al., 1995), hypoosmotic conditions (Davenport et al., 1995) and treatment with 
mating pheromone due to cell wall remodelling during pheromone-induced morphogenesis (Buehrer 
and Errede, 1997). Agents that interfere with cell wall biogenesis such as the chitin antagonist 
calcofluor white (Ketela et al., 1999), Congo red, caffeine or zymolyase stimulate this pathway (de 
Nobel et al., 2000; Martin et al., 2000). 
 
In C. albicans, Mkc1, the homologue of the S. cerevisiae Slt2/Mpk1 MAPK, mediates the CWI 
pathway. The kinase Mkc1 becomes activated in response to several types of stress (oxidative, 
osmotic, cell wall damage, calcium ions and temperature) (Navarro-Garcia et al., 2005). Oxidative 
stress-mediated phosphorylation of Mkc1 is partially dependent on an intact HOG pathway (Arana et 
al., 2005; Navarro-Garcia et al., 2005). Moreover, Mkc1 becomes activated when cells contact solid 
surfaces, therefore being related to biofilm formation (Kumamoto, 2005); and it is also activated in the 
presence of rapamycin, an inhibitor of the Tor kinase (Tsao et al., 2009). Mutants affected in MKC1 
are more sensitive to cell wall-degrading enzymes and antifungals, and display surface alterations 
when grown under restrictive conditions such as high temperature (Navarro-Garcia et al., 1995; 
Navarro-Garcia et al., 1998). Not surprisingly, mkc1 mutants display a reduced virulence in the mouse 
model of systemic infection (Diez-Orejas et al., 1997). 
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CWI signaling pathway induces activation of the two known transcription factors: the transcription 
factor heterodimer complex SBF (Swi4-Swi6 cell cycle Box binding Factor), which is involved in the 
activation of expression of cell cycle-regulated genes in the G1/S phase, including genes involved in 
cell wall synthesis, (Nasmyth and Dirick, 1991; Madden et al., 1997; Baetz et al., 2001) and the 
MADS-box transcription factor Rlm1, which regulates the expression of genes involved in the cell wall 
integrity pathway (Dodou and Treisman, 1997; Watanabe et al., 1997). 
 
1.4.4. The MADS-box transcription factor Rlm1 
The MADS-box proteins have been identified in yeasts, plants, insects, nematodes, lower vertebrates 
and mammals. These proteins are characterized by a domain that presents DNA binding and 
dimerization conserved regions named the MADS-box (Schwarz-Sommer et al., 1990) because of the 
five founding members of the family: Mcm1 (yeast) (Passmore et al., 1989), Arg80 (yeast) (Dubois et 
al., 1987) or Agamous (plant) (Yanofsky et al., 1990), Deficiens (plant) (Sommer et al., 1990) and SRF 
(human) (Norman et al., 1988). In animal and fungi, two distinct types of MADS-box genes have been 
identified, the SRF-like (type I) and the MEF2-like (type II) (Shore and Sharrocks, 1995; Alvarez-Buylla 
et al., 2000). MADS-box family members generally recognize AT rich consensus sequences, with a 
highly conserved core of 10 bp, the CC(A/T)6GG is the binding site of SRF-like proteins known as 
CArG box (Treisman, 1990), and the CTA(A/T)4TAG is the binding site of MEF2-like proteins (Pollock 
and Treisman, 1991). Transcription factors of the MADS box family can act by forming homodimers or 
heterodimers with other proteins. Their association with different proteins can selectively direct the 
transcription regulation of various genes. In S. cerevisiae four MADS-box proteins have been found: 
Mcm1 and Arg80 which are related to the SRF human, and Rlm1 and Smp1 which belong to the 
MEF2-like family (Alvarez-Buylla et al., 2000). 
 
RLM1 was first identified as a gene conferring resistance to lethality of Mkk1
S386P
 overexpression 
(Watanabe et al., 1995). The Rlm1 protein has three distinct domains: an N-terminal DNA-binding 
domain related to the MADS-box family of transcriptional regulators that, in S. cerevisiae, is known to 
regulate the expression of genes involved in the cell wall integrity pathway (Watanabe et al., 1995; 
Dodou and Treisman, 1997). The C-terminal part of the protein contains the transcriptional activation 
domain and the central part of the protein that is the target for Slt2/Mpk1-dependent phosphorylation 
(Watanabe et al., 1997). Moreover, the Rlm1 present a repetitive region next to the C-terminal end. 
Rlm1 is most closely related to mammalian factor MEF2, sharing the same in vitro binding specificity 
(CTAW4TAG) (Dodou and Treisman, 1997). In S. cerevisiae Rlm1 is localized in the nucleus 
irrespective of its activation or phosphorylation status. Rlm1 is regulated through phosphorylation by 
the protein kinase Slt2p/Mpk1 at two residues within its transcriptional activation domain (Ser 427 and 
Thr 439), which stimulates its activity (Watanabe et al., 1997; Jung et al., 2002). Genome-wide 
analysis of gene expression from activation of Slt2/Mpk1 revealed that Rlm1 regulates the expression 
of at least 25 genes, most of which encode cell wall proteins or have been implicated in cell wall 
biogenesis in response to cell wall stress (Watanabe et al., 1997; Jung and Levin, 1999). Moreover, it 
has also been determined that the transcription factor Rlm1 can act as both activator and repressor of 
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the gene expression (Watanabe et al., 1997; Jung and Levin, 1999). On the other hand, although 
Rlm1 mediates gene expression regulated by CWI signaling, its deletion does not produce 
characteristic cell lysis phenotype of CWI pathway mutants. Therefore, it is assumed that there are 
other transcription factors that mediate the regulation of CWI pathway-dependent cell wall gene 
expression. 
 
Putative RLM1 orthologues were identified in C. albicans, Paracoccidioides brasiliensis, Aspergillus 
niger and C. glabrata (Damveld et al., 2005; Fernandes et al., 2005; Bruno et al., 2006; Miyazaki et al., 
2010). An in silico analysis of sequence comparison showed that RLM1 homologe sequences are 
present in all yeasts belonging to Ascomycota, as well as in yeasts belonging to Basidiomycota and 
"Zygomycota" (taxonomy still being studied). This observation would indicate that the presence of this 
gene is important in the maintenance of cell wall integrity in other fungi (Chávez-Galarza, 2009). In C. 
albicans the role of RLM1 gene is not well established yet but it seems to be required for cell wall 
integrity, at least under caspofungin and Congo red stress (Bruno et al., 2006). 
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1.5. Objectives and outline of the thesis 
Three main objectives were outlined for this work. The first one was the determination of the influence 
of the genetic variability of CAI microsatellite, the repetitive region of RLM1 in C. albicans, in cell wall 
stress resistance. The second one was the evaluation of the RLM1 role in C. albicans and its 
molecular and functional characterization regarding the remodeling of the cell wall under stress 
conditions. Finally, the third objective was the investigation of the involvement of RLM1 in C. albicans 
virulence in the disseminated model of systemic infection. To accomplish these objectives this thesis is 
organized in five chapters. Chapter 1 encloses an overview about fungal infection particularly the 
pathogen C. albicans covering, types of candidiasis, epidemiology, an outline on virulence factors and 
host response, as well as a description of the cell wall integrity pathway. Chapter 2 regards the 
correlation of increased number of glutamine repeats in the C-terminus of Rlm1 with the resistance to 
stress agents. Chapter 3 presents information concerning the role of RLM1 in C. albicans cell wall 
integrity and includes the methods to disrupt RLM1 gene, the phenotypic characterization against cell 
wall damaging stress agents, the subcellular localization and genome-wide expression regulated by 
Rlm1 in C. albicans. Chapter 4 presents data and discussion of the role of RLM1 in C. albicans 
virulence by using the murine model of hematogenously disseminated candidiasis. Chapter 5 
presents the concluding remarks, regarding the results of Chapter 2, 3 and 4 in the context of the 
initially proposed objectives. 
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Abstract 
The highly polymorphic microsatellite CAI described for Candida albicans genotyping was found to be 
located within the RLM1 gene which codes for a transcription factor from the MADS box family that, in 
Saccharomyces cerevisiae, is known to regulate the expression of genes involved in the cell wall 
integrity pathway. The aim of this work was to study CAI genetic variability in a wide group of C. 
albicans isolates and determine the response of genetic variants to cell wall damaging stress agents. 
One hundred twenty-three C. albicans isolates were genotyped with CAI microsatellite (CAA/G)n, and 
35 alleles were found with repeat units varying from 11 to 49. Alleles with less than 29 repetitions were 
the most frequent, while the longer ones were underrepresented and had a more complex internal 
structure. Combinations of RLM1 alleles generated 66 different genotypes. Significant differences 
(P < 0.05) in the susceptibility patterns to menadione, hydrogen peroxide, SDS, acetic acid, and CFW, 
stress agents affecting cell integrity, were found between strains harbouring alleles ranging from 17 to 
28 repetitions and strains with longer alleles, suggesting that an increased number of repetitive units in 
the C. albicans RLM1 gene could be related to stress response. 
 
Keywords: Allelic frequency - Candida albicans - RLM1 gene - Stress resistance. 
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Introduction 
Candida albicans is part of the human commensal flora with carriage rates in healthy individuals of 
around 50% in the gastrointestinal tract, and between 10 and 20% in the oral cavity, anorectal tract, 
and vagina. However, in immunocompromised patients this species is one of the most important 
opportunistic fungal pathogen, being responsible for both superficial and systemic infections (Pelroth 
et al., 2007). Molecular epidemiology studies showed that C. albicans isolates exhibit a high level of 
genetic diversity. Microsatellite length polymorphism and multilocus sequence typing have been used 
to discriminate C. albicans strains and to detect small genetic changes or micro variations that may be 
indicative of adaptability processes (Sampaio et al., 2005; Bougnoux et al., 2006; Garcia-Hermoso et 
al., 2007). One of the most polymorphic microsatellites described in C. albicans was designated as 
CAI, which, together with other loci in a multiplex system, proved to be an excellent tool for strain 
discrimination and for the detection of microevolutionary events (Sampaio et al., 2003, 2005). It was 
reported that sequential isolates from patients with recurrent infections presented changes at CAI 
locus, suggesting a possible role of this locus in strain adaptation to stress in the host environment. 
Furthermore, this repetitive region was found to be located within the RLM1 gene which codes for a 
transcription factor from the MADS (Mcm1p-Agamous-Deficiens-Serum response factor) box family 
that, in S. cerevisiae, is known to regulate the expression of genes involved in the cell wall integrity 
pathway (Watanabe et al., 1995; Dodou and Treisman 1997). In C. albicans the role of RLM1 gene is 
not established yet but it also seems to be required for cell wall integrity, at least under caspofungin 
and Congo red stress (Bruno et al., 2006). It is likely that the presence of a repetitive region confers 
genetic variability to RLM1 gene and may contribute to the adaptation of C. albicans strains if some 
genetic variations of this gene confer a better response to stresses affecting the cell integrity, like 
antifungal agents, oxidative stress, or others. Thus, the objectives of the present work were, (1) to 
determine the extent of genetic variability of CAI microsatellite, the repetitive region of RLM1, by 
studying 123 C. albicans clinical isolates from different geographic and anatomic origins; and (2) to 
investigate if the genetic variants behave differently regarding cell damaging stress agents. 
 
 
Materials and methods 
Yeast strains 
A total of 123 C. albicans unrelated clinical isolates with different geographical origins and collected 
from distinct body locations were used in this study (Table 2.1). Reference strains WO-1 and PYCC 
3436 (ATCC 18804) were also included. Stock cultures were maintained on Sabouraud glucose agar 
medium at 4°C and cryopreserved in 30% glycerol (w/w) at −80°C. 
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Table 2.1. Candida albicans isolates studied, their origins and CAI genotypes. 
 
Strain Country of origin Isolated from CAI genotype Strain Country of origin Isolated from CAI genotype 
ATCC-18804 Uruguay Skin lesion 17/23 31C Portugal VE 21/25 
WO1 EUA – 16/27 36C Portugal VE 11/18 
3 Portugal VE 17/23 39C Portugal VE 20/28 
7 Portugal VE 30/30 45C Portugal VE 11/18 
8 Portugal VE 30/32 46C Portugal VE 27/27 
11 Portugal VE 27/45 49C Portugal VE 21/26 
12 Portugal VE 18/25 52C Portugal VE 22/34 
17 Portugal VE 21/21 53C Portugal VE 27/47 
18 Portugal VE 20/29 55C Portugal VE 27/42 
20 Portugal VE 26/26 57C Portugal VE 11/28 
22 Portugal VE 23/27 58C Portugal VE 28/47 
27 Portugal VE 22/23 60C Portugal VE 21/21 
29 Portugal VE 20/20 62C Portugal VE 28/47 
31 Portugal VE 21/26 64C Portugal VE 20/28 
35 Portugal VE 25/25 69C Portugal VE 27/42 
37 Portugal VE 18/27 70C Portugal VE 21/25 
39 Portugal VE 21/22 72C Portugal VE 21/24 
41 Portugal VE 23/27 140A Portugal Blood 34/34 
45 Portugal VE 25/25 CIPO46 Portugal Feces 30/42 
H58 Portugal Blood 22/22 CIPOX Portugal Blood 11/11 
H37 Portugal RT 25/27 IPOL13 Portugal Blood 40/40 
1M Portugal Urine 21/25 IPOL15 Portugal Blood 35/44 
5M Portugal RT 13/32 IPOL33 Portugal VE 32/46 
8M Portugal Urine 21/25 IPOL35 Portugal VE 38/48 
10M Portugal RT 17/17 FC27 USA – 28/49 
13M Portugal Urine 21/25 122.072 Switzerland – 21/21 
26M Portugal RT 20/28 180.004 USA – 18/24 
33M Portugal VE 23/24 FC29 USA – 21/26 
35M Portugal RT 24/27 FC8 USA – 20/31 
39M Portugal RT 18/18 152.082 USA – 11/20 
41M Portugal Urine 21/22 178.042 USA – 21/26 
49M Portugal Urine 36/36 FC12 USA – 27/27 
52M Portugal Urine 21/21 157.039 Brazil – 26/34 
61M Portugal RT 17/21 FC11 USA – 27/45 
62M Portugal RT 28/28 152.085 Canada – 18/18 
63M Portugal Urine 25/27 175.006 Spain – 21/25 
64M Portugal RT 22/22 180.012 USA – 26/34 
88M Portugal Urine 20/28 FC23 USA – 24/29 
69M Portugal RT 21/25 FC6 USA – 17/27 
74M Portugal Urine 20/28 122.095 Germany – 26/32 
77M Portugal RT 18/18 176.079 USA – 25/25 
79M Portugal RT 18/34 FC15 USA – 27/41 
82M Portugal Urine 18/47 175.010 Belgium – 21/25 
90M Portugal RT 24/24 175.031 Italy – 11/21 
91M Portugal RT 21/27 122.077 United kingdom – 18/25 
1C Portugal VE 17/21 FC19 USA – 21/25 
2C Portugal VE 26/33 FC20 USA – 25/25 
3C Portugal VE 20/37 FC17 USA – 29/33 
5C Portugal VE 18/18 175.071 Italy – 18/25 
6C Portugal VE 21/26 157.096 Portugal – 21/26 
7C Portugal VE 25/26 180.021 Italy – 25/25 
9C Portugal VE 24/26 FC13 USA – 27/27 
10C Portugal VE 27/49 FC7 USA – 21/26 
11C Portugal VE 21/25 A1587 Angola VE 15/15 
13C Portugal VE 20/27 A1598 Angola VE 15/15 
14C Portugal VE 39/46 A1605 Angola VE 15/15 
16C Portugal VE 21/26 A1618 Angola VE 15/15 
19C Portugal VE 27/27 A1634 Angola VE 15/15 
24C Portugal VE 17/21 A8450 Angola VE 15/15 
27C Portugal VE 16/27 M11 Madagascar VE 15/15 
  M1615 Madagascar VE 15/15 
M8627 Madagascar VE 15/15 
 
VE vaginal exudate, RT respiractory tract, – unknown 
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Microsatellite amplification and fragment analysis 
DNA extraction and PCR reactions were performed as previously described (Sampaio et al., 2005). 
PCR products were run on an ABI 310 Genetic Analyser (Applied Biosystems) together with the 
GeneScan-500 (TAMRA) size standard (Applied Biosystems). Fragment sizes were determined 
automatically using the GeneScan 3.7 analysis software. Alleles have been designated by the number 
of trinucleotide repeats. 
 
DNA sequence analysis 
Amplified DNA fragments were separated by electrophoresis in polyacrylamide gels (T6C5) in 
denaturing conditions and DNA fragments visualized by a silver staining method (Budowle et al., 
1991). Fragment bands were cut individually from the gel, eluted in 250μl of TE buffer, frozen and 
thawed three times, reamplified, and purified with Microspin S-300 HR columns (Pharmacia). The 
purified products were submitted to dideoxy cycle sequencing reaction using the BigDye Terminator 
Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems). Sequence analysis was performed 
on an ABI 310 Genetic Analyzer using the Sequencing 3.7 Analysis software. Direct sequencing was 
performed on both DNA strands for all the fragments analyzed. 
 
Susceptibility assays 
Candida albicans cells were grown overnight in YEPD medium (0.5% w/v yeast extract, 1% w/v 
peptone and 2% w/v glucose) at 30ºC and 160 rpm. 2x10
7
 cells were overlayed on YEPD agar plates 
prepared with and without 200μg/ml Congo red (CR). Six millimeter diameter paper discs imbibed in 
10μl of either 99.8% (v/v) acetic acid (Merck), 0.5 M menadione (Sigma), 0.5 M SDS (BDH 
Chemicals), 35% (v/v) hydrogen peroxide (Merck) and 10mg/ml calcofluor white (CFW) were loaded 
over the C. albicans cells. Halos of growth inhibition were measured after 24h of incubation at 37ºC. 
The results presented are the mean of three independent experiments. Statistical analysis was 
performed with SPSS software version 13.0 (SPSS Inc., Chicago, IL, USA). 
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Results 
Location of CAI microsatellite within Candida albicans RLM1 gene 
A search in C. albicans genome revealed that CAI microsatellite is located within a gene coding for a 
transcription factor from the MADS box protein family, designated by RLM1. A comparison of DNA and 
protein homology between C. albicans RLM1 and the S. cerevisiae ortholog was performed by using 
the program T-COFFEE Version 5.05. Saccharomyces cerevisiae RLM1 gene and protein sequences 
were obtained from SGD (Saccharomyces Genome Database). The DNA sequence homology is very 
low, (nucleotide identity of 47%) as well as the protein identity (29%). However, some characteristic 
features of this family are present, namely the MADS box region at the 5′-terminus, responsible for the 
DNA binding, and a repetitive region at the 3′-terminus (Fig. 2.1). 
 
 
 
Figure 2.1. A) Schematic representation of C. albicans RLM1 gene. The scheme is based on the sequence of 
strain SC5314. The repetitive CAI region is highlighted with the correspondent variable regions (VRs) for allele 45. 
B) DNA sequence alignment of C. albicans and S. cerevisiae RLM1 gene showing the MADS box and the 
repetitive region, the zones with higher homology. 
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The variability within the 3′-terminus of RLM1 gene was assessed by amplification of the CAI 
microsatellite, which constitutes the main repetitive region of this gene. CAI allele length variation was 
analysed by sequencing all the different PCR fragments obtained. This analysis showed that the 
RLM1 repeat region had a complex structure, with trinucleotide and nanonucleotide regions varying 
simultaneously (Table 2.2). Independently of the complexity of the variable regions the repeat unit 
present, CAA or CAG, codes only for glutamines, resulting a protein with a stretch of 11–49 
glutamines in its C-terminus. These variable regions (VRs) are indicated in Fig. 2.1A and Table 2.2. 
 
Table 2.2. Sequence alignment of C. albicans RLM1 alleles, showing the defined variable 
regions, VR1 to VR6 
 
Alleles   : Sequence             Group 
      VR1 VR2 VR3  VR4 VR5 VR6 
11 to 15  :CTGcaacaactg(CAA)n(caacaacag)                                (CAG)4-----------------c------------g               I 
16 to 29  :CTGcaacaactg(CAA)n(caacaacag)2                               (CAG)2----------------c/t-----------t/g            II 
30 to 49  :CTGcaacaactg(CAA)n(caacaacag)2CAA(caacaacag)3(CAG)2------------------t-------------t               III 
Lowercase letters indicate the nanonucleotide variable motifs 
 
Allelic and genotypic frequencies 
One hundred and twenty-one C. albicans independent clinical isolates and two reference strains 
collected from different geographic origins and anatomical sites were genotyped using the CAI 
microsatellite. A total of 35 different alleles were obtained with repeat units varying from 11 to 49 (Fig. 
2.2). Alleles presenting 11–28 repeat units represented 82% of all alleles typed, being the most 
frequently observed the ones with 21, 25 and 27 repetitions. The remaining alleles corresponded to 
only 18%, and were clearly underrepresented. In these isolates 66 different genotypes were observed 
from which 44 were detected only once (Table 2.1). All strains from Angola and Madagascar 
presented the genotype 15/15. This genotype constitutes a curious case since allele 15 was observed 
exclusively in this particular group of strains. No association between allele length and geographic 
origin or body location of the isolates was observed except for allele 15 that was exclusively identified 
in isolates from Angola and Madagascar. 
 
Figure 2.2. RLM1 allele frequencies based on CAI microsatellite analysis. 
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Susceptibility to stress agents 
In order to investigate whether the variability found at the RLM1 locus could be correlated with 
susceptibility we tested three groups of strains formed according to the length and complexity of RLM1 
alleles. One group representative of genotypes presenting alleles with less than 16 repetitions (group 
I), one including strains with alleles from 17 to 28 repetitions (group II), and a third with strains 
presenting genotypes composed of longer alleles, more than 28 repetitions (group III). Only strains 
presenting the two alleles within the same allelic group were tested in this analysis. The susceptibility 
to menadione, hydrogen peroxide, SDS, acetic acid, and CFW was tested in ten strains of each group. 
The stress agents were used alone or combined with CR, an additional cell wall damaging agent. 
 
The results (Fig. 2.3) obtained when testing the stress agents alone showed that strains within group I 
were significantly more susceptible than strains from the other groups, except the case of CFW. 
Comparing strains from groups II and III no significant differences were observed in the susceptibility 
to all the stress agents (Fig. 2.3). 
 
 
Figure 2.3. Susceptibility of C. albicans strains presenting alleles within groups I, II and III to menadione, acetic 
acid, hydrogen peroxide, SDS and Calcofluor White (CFW) at 37ºC. Susceptibility was determined measuring the 
inhibition halo (cm) and results are shown in Box plots. Standard error bars * P < 0.05. The values displayed are 
the mean of three independent experiments. 
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On the contrary, in the presence of CR the susceptibility of strains from group II to the stresses tested 
was significantly enhanced (P > 0.05), while no significant differences were observed in the growth 
inhibition halos of strains from group III (Figs. 2.4 and 2.5). Curiously, in the presence of CR no growth 
was observed in strains from group I, indicating a hypersensitivity to the combination of the different 
stresses with CR (Fig. 2.5). 
 
 
Figure 2.4. Susceptibility of C. albicans strains within groups II and III to hydrogen peroxide, SDS, menadione, 
Calcofluor White (CFW) and acetic acid at 37°C in the absence (−) and in the presence (+) of Congo red (CR). 
Susceptibility was determined by measuring the inhibition halo (cm). Standard error bars * P < 0.05. The values 
displayed are means of three independent experiments. 
 
Figure 2.5. Representative pictures of the susceptibility of C. albicans strains within groups I, II, and III to 
hydrogen peroxide, SDS, menadione, Calcofluor White (CFW) and acetic acid in the presence and absence of 
Congo red (CR). Diameter of the blank paper disk is 0.6 cm.  
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Discussion 
Candida albicans is an opportunistic fungus responsible for serious infections and the identification of 
strains with a particularly well-adapted genotype is of great interest to understand local epidemiology, 
pathogenicity and host interactions (Odds 1988; Pujol et al., 1993). The microsatellite used in this 
study is located inside RLM1, a gene from the MADS box family. The MADS box genes encode a 
family of eukaryotic transcriptional regulators involved in diverse and important biological functions, 
controlling gene expression and cell development (Messenguy and Dubois 2003). In S. cerevisiae, 
RLM1 is the major effector of the cell wall integrity pathway, responsible for the regulation of genes 
required in the repair of damages of the cell wall. Since the composition of the cell wall of both C. 
albicans and S. cerevisiae is very similar the role of C. albicans RLM1 in the maintenance of the cell 
wall integrity is expectedly conserved. A previous work reported that RLM1 is required for normal 
growth of C. albicans at least in the presence of caspofungin and CR, but surprisingly although the 
apparent conserved biological function, very few caspofungin-inducible RLM1 dependent genes were 
identified (Bruno et al., 2006). We found that C. albicans RLM1 presents a great variability at its 3′-
terminus. The allelic frequencies of the 35 different alleles did not follow the typical Gaussian 
distribution, since alleles with more than 28 repetitions were clearly underrepresented. These longer 
alleles presented a complex internal structure with 3–5 CAG units interrupting the CAA simple tract 
due to the incorporation of nanonucleotide tracts among the trinucleotide repeats (see Table 2.2). As a 
consequence, these alleles are likely to present a lower mutational rate. In fact, it has been described 
that the incorporation of variants in the simple repetitive tract of a microsatellite greatly contributes to 
its stabilization, lowering its mutational rate (Petes et al., 1997). Although the longer alleles had lower 
frequencies they represented the majority of the alleles found among the strains studied, suggesting 
that they may have a positive role in strain adaptation. In fact, results from the susceptibility tests 
showed that strains possessing longer alleles were significantly more resistant to the tested stress 
agents indicating that, at least in vitro, the longer alleles may confer advantages to the strains. 
Candida albicans is a diploid species and the majority of the strains presenting long alleles are 
heterozygotic, with the other allele within group II (i.e., 27/49). This suggests that the diploid genome 
of C. albicans allows to create further variability and adaptation by differential evolution of even the 
two alleles of a single gene as reported previously for ALS3, ALS7 and SAP2 (Staib et al., 2002; 
Zhang et al., 2003; Oh et al., 2005). It is noteworthy to refer also the susceptibility of Group I strains to 
almost all stresses tested, particularly in the presence of CR. All strains included in this group were 
from Angola and Madagascar and belonged to the so-called atypical C. albicans group that has been 
proposed to constitute a new species, C. africana (Tietz et al., 2001). Our results support the view that 
these strains present different characteristics not only in their hypersensitivity but also in the fact that 
they were all homozygous to allele 15 that possessed a unique internal structure. 
 
Candida albicans Rlm1 is a combinatory transcription factor that presents a great variability at its C-
terminus, conferred by the CAI microsatellite. The C-terminus of proteins from the MADS box family is 
necessary for dimerization and required for transcriptional activation (Messenguy and Dubois 2003). It 
is known that their regulatory specificity depends on accessory factors and in many cases the cofactor 
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with which the protein interacts specifies which genes are regulated, when they are regulated and if 
these genes are transcriptionally activated or repressed (Shore and Sharrocks 1995). This 
characteristic may account for the different susceptibility pattern observed among strains from the 
three groups of alleles, if the interaction of accessory factors with Rml1 is somehow correlated with the 
C-terminus length, conditioning the transcriptional activity. 
 
The functional importance of the C-terminal domain of MADS-box genes has already been 
demonstrated in other organisms. The loss-of-function observed in alleles that carried mutations in the 
C-terminus or the dominant-negative phenotypes that were generated by overexpressing MADS box 
genes lacking the C-terminus in plants and humans are some of the examples (Vandenbussche et al., 
2003; Wang et al., 2003). 
 
In conclusion, we demonstrated that the CAI repetitive region confers a high genetic variability to 
RLM1 gene, which is reflected in strain susceptibility to different stress conditions. Although the role of 
RLM1 gene in C. albicans is not well established yet our observations suggest that an increased 
number of repetitive units in the C. albicans RLM1 gene enhances the resistance to stress agents. 
Additional work is under development by using isogenic strains in order to confirm the phenotypes 
seen and further investigate whether RLM1 gene variability may be related to C. albicans 
pathogenicity. 
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Abstract 
Saccharomyces cerevisiae and Candida albicans respond to cell wall perturbations by activation of the 
cell wall integrity (CWI) mitogen-activated protein (MAP) kinase pathway. One of the transcription 
factors of this signalling cascade is the MADS-box protein Rlm1, which function has been 
characterized mainly in S. cerevisiae. In this work we studied the involvement of the C. albicans 
orthologue, also named Rlm1, in cell wall remodelling. 
 
Candida albicans rlm1Δ/rlm1Δ mutant was tested with several cell wall-perturbing agents in parallel 
with S. cerevisiae rlm1Δ mutant. Results showed that C. albicans mutant was hypersensitive to Congo 
red, caspofungin and calcofluor white. Caspofungin phenotype was reverted in the presence of 1M of 
sorbitol, indicating that C. albicans RLM1, like the S. cerevisiae orthologue, is important for the 
maintenance of cell wall integrity. Quantification of cell wall components showed a two-fold increase in 
chitin and mannans in the C. albicans rlm1Δ/rlm1Δ strain in comparison with the WT. In agreement 
with a transcription factor function, we found evidence indicating nuclear localization of Rlm1-GFP 
fusion protein. Microarray analysis showed that the absence of a functional C. albicans RLM1 
significantly up regulated genes involved in cell adhesion, like ECE1, ALS1, ALS3, HWP1, RBT1, and 
down regulated genes involved in the catabolism of carbohydrates, DAK2, GLK4, NHT1 and TPS1. 
Accordingly, transcription of GAL4, coding for a transcription factor involved in the control of glycolytic 
enzymes, was also up regulated. These results suggest that deletion of RLM1 induces a 
rearrangement in metabolic pathways allowing the use of alternative carbon sources. The up-
regulation of genes involved in cell adhesion correlated with adhesion and biofilm assays in which an 
increase in the amount of adhering cells and biofilm biomass was observed in the mutant strain in 
comparison with the WT. 
 
This study suggests that, in the absence of RLM1 C. albicans activates a “compensatory mechanism” 
involving the increase in cell wall chitin and mannoproteins, changing the metabolism of the mutant to 
cope with it, as observed for S. cerevisiae. Furthermore, the increase of cell adhesion binding proteins 
involved in biofilm formation and the confirmation that the rlm1Δ/rlm1Δ mutant biofilm biomass is much 
higher, suggests that Rlm1 acts as a negative biofilm regulator, a function that has not been detected 
for S. cerevisiae. 
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Introduction 
The yeast cell wall is an essential cellular structure in the osmotic stabilization, protection against 
mechanical damage, maintenance of cell shape, adhesion and invasive growth (Klis et al., 2006). 
Polysaccharides, β-1,3- and β-1,6-glucan and chitin, represent the inner structural components of the 
fungal cell wall to which a protective mannoprotein layer is attached. Mannoproteins may account to 
nearly half of the cell wall mass and may be non-covalently bound, covalently bound and GPI-modified 
and covalently linked to the β-1,3-glucan network. The polysaccharide β-1,3-glucan comprises the 
inner layer, highly elastic, that serves as a scaffold for the protective outer layer of mannoproteins 
(Lipke and Ovalle, 1998). Chitin is found dispersed in the cell wall, in the bud neck, in the primary 
septum and in bud scars (Cabib and Duran, 2005). This particular localization together with the fact 
that upon stress, the content in chitin can increase considerably (Aguilar-Uscanga and Francois, 
2003), suggest that chitin is the material used in cell wall remodelling. Chitin and β-glucans provide the 
strength and rigidity to the cell wall, which ultimately determine the morphology of the cell, therefore 
their synthesis play a fundamental role in maintaining fungal cell integrity during growth and 
morphogenesis and in stress adaptation (Shaw et al., 1991). 
 
The cell wall is a dynamic structure since it changes with alterations of the surrounding growth 
conditions (Garcia et al., 2004) and is remodeled as the cell increases in size and during 
morphogenetic processes such as mating, sporulation, or pseudohyphal growth. Upon cell wall 
damage, cells activate the cell wall integrity (CWI) mitogen-activated protein (MAP) kinase pathway 
(also known as the PKC pathway) so that the cell wall is repaired and cell integrity maintained. This 
response involves several processes (Garcia et al., 2004): (i) the balance between cell wall 
polysaccharides is modified, as indicated by hyper-accumulation of chitin; (ii) the type of association 
between β-glucan, mannoproteins, and chitin is changed; (iii) an increase of cell wall proteins occurs; 
and (iv) the β-1,3-glucan synthase complex is transiently redistributed throughout the cell (Garcia et 
al., 2004; Martinez-Lopez et al., 2004). The response to cell wall damage is well understood from 
studies with the budding yeast S. cerevisiae, where the CWI pathway comprises the sensors Mid2 and 
Wsc1 in the plasma membrane, which, upon cell wall damage, interact with the GDP/GTP exchange 
factor Rom2, leading to the conversion of the G protein Rho1 to its activated GTP-bound state. 
Interaction with Rho1 activates the control kinase Pkc1 that phosphorylates Bck1, the first component 
of the MAP kinase cascade three-component module. Sequential phosphorylations of the components 
of the MAP kinase cascade activate downstream kinases: the redundant Mkk1 and Mkk2 and the final 
kinase Slt2. The targets of the CWI pathway are the transcription factor heterodimer complex SBF 
(composed by Swi4 and Swi6), and the MADS-box transcription factor Rlm1 (Reinoso-Martin et al., 
2003; Levin, 2005). The SBF transcription factor (Sw4-Swi6 cell cycle Box binding Factor) is involved 
in the activation of expression of cell cycle-regulated genes in the G1/S phase, including genes 
involved in cell wall synthesis (Nasmyth and Dirick, 1991), and the MADS (Mcm1p-Agamous-
Deficiens-Serum Response Factor) box transcription factor Rlm1 (Schwarz-Sommer et al., 1990) 
activates genes involved in cell wall reinforcement and remodeling in response to cell wall stress 
(Jung and Levin, 1999; Garcia et al., 2004). 
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The C. albicans CWI counterpart is the Mkc1 signaling pathway (Navarro-Garcia et al., 1995; Navarro-
Garcia et al., 1998; Navarro-Garcia et al., 2005) which is important for virulence since the disruption 
mutant in MKC1, the SLT2 homolog, is less virulent than the wild-type (Diez-Orejas et al., 1997). The 
Pkc1 and Mkc1 components of this pathway were identified based on sequence and functional 
homologies with S. cerevisiae CWI pathway components (Navarro-Garcia et al., 1995; Paravicini et 
al., 1996), while other components with sequence homology in C. albicans remain to be characterized. 
Targets of Mkc1 have not yet been identified, however the presence of sequence homologues of S. 
cerevisiae SWI4, SWI6 and RLM1 in the C. albicans genome suggests that these could act as final 
effectors of the signaling cascade. Accordingly, C. albicans mutant in the homologue of RLM1 displays 
higher sensitivity to caspofungin and Congo red (Bruno et al., 2006). This is the only study including 
the characterization of RLM1 in C. albicans and results indicated that RLM1 does not appear to be 
involved in the cell wall remodelling after caspofungin treatment. In this study our aim is to extend the 
characterization the C. albicans RLM1 in a new set of rlm1 mutants from the prototrophic wild-type 
model strain SC5314 constructed using the SAT1-flipping strategy (Reuss et al., 2004). This study 
was made in parallel with the rlm1∆ mutant in the S. cerevisiae orthologue in order to assess 
parallelism between sequence homology and function. 
 
 
Materials and Methods 
Strains and growth conditions 
Candida albicans and S. cerevisiae strains used in this study are listed in table 3.1. All strains were 
stored as frozen stocks with 15% w/v glycerol at -80ºC and cultured on yeast extract-peptone-dextrose 
(YPD) agar plates (1% w/v yeast extract, 2% w/v peptone, 2% w/v dextrose and 2% w/v agar) at 30°C. 
For routine growth, YPD liquid medium, lacking agar, was used. Selection of C. albicans 
nourseothricin-resistant (Nou
R
) transformants was performed on YPD agar plates containing 200µg/ml 
nourseothricin (Werner Bioagents, Jena, Germany). To obtain nourseothricin-sensitive (Nou
S
) 
derivatives in which the SAT1 flipper was excised by FLP-mediated recombination, transformants 
were grown overnight on YCB–BSA–YE medium (2.34% w/v yeast carbon base, 0.4% w/v bovine 
serum albumin, 0.2% w/v yeast extract, pH 4.0) without selective pressure to induce the SAP2 
promoter controlling caFLP expression. One hundred to two hundred cells were then spread on YPD 
plates containing 10µg/ml nourseothricin and grown for 2 days at 30ºC. Nou
S
 clones were identified by 
their small colony size and confirmed by re-streaking on YPD plates containing 200µg/ml 
nourseothricin as described previously (Reuss et al., 2004). For integration of GFP for gene fusion 
constructions we used strain CAI4 (ura3Δ::imm434/ura3Δ::imm434) as a host. This strain was grown 
on YPD agar plates supplemented with uridine (50μg/ml) while strains carrying the RLM1-GFP fusion 
genetic construct were grown on solid or liquid synthetic complete medium without uridine (SC-uridine; 
0.67% w/v yeast nitrogen base without amino acids (DIFCO), supplemented with dropout mix without 
uridine) with 2% w/v glucose. Liquid cultures (lacking agar) were incubated at 30ºC, 200 revolutions 
per min (rpm) and growth was monitored by optical density at 640nm (OD640). 
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Table 3.1. Strains used in this study. 
 
Strain Parental strain Relevant characteristics or genotype
a
 Source or reference 
C. albicans    
SC5314  Wild-type C. albicans model strain Gillum et al. (1984) 
SCRLM1M1A SC5314 rlm1Δ::SAT1-FLIP/RLM1 This study 
SCRLM1M1B SC5314 RLM1/rlm1Δ::SAT1-FLIP This study 
SCRLM1M2A SCRLM1M1A rlm1Δ::FRT/RLM1 This study 
SCRLM1M2B SCRLM1M1B RLM1/rlm1Δ::FRT This study 
SCRLM1M3A SCRLM1M2A rlm1Δ::FRT/rlm1Δ::SAT1-FLIP This study 
SCRLM1M3B SCRLM1M2B rlm1Δ::SAT1-FLIP/rlm1Δ::FRT This study 
SCRLM1M4A SCRLM1M3A rlm1Δ::FRT/rlm1Δ::FRT This study 
SCRLM1M4B SCRLM1M3B rlm1Δ::FRT/rlm1Δ::FRT This study 
SCRLM1K1A SCRLM1M4A rlm1Δ::FRT/RLM1-SAT1-FLP This study 
SCRLM1K1B SCRLM1M4B RLM1-SAT1-FLP/rlm1Δ::FRT This study 
SCRLM1K2A SCRLM1K1A rlm1Δ::FRT/RLM1-FRT This study 
SCRLM1K2B SCRLM1K1B RLM1-FRT/ rlm1Δ::FRT This study 
    
124a  Wild-type C. albicans clinical isolate Sampaio et al. (2010) 
124aRLM1M1A 124a rlm1Δ_::SAT1-FLIP/RLM1 This study 
124aRLM1M1B 124a RLM1/rlm1Δ::SAT1-FLIP This study 
124aRLM1M2A 124aRLM1M1A rlm1Δ_::FRT/RLM1 This study 
124aRLM1M2B 124aRLM1M1B RLM1/rlm1Δ::FRT This study 
124aRLM1M3A 124aRLM1M2A rlm1Δ_::FRT/rlm1Δ_::SAT1-FLIP This study 
124aRLM1M3B 124aRLM1M2B rlm1Δ::SAT1-FLIP/rlm1Δ::FRT This study 
124aRLM1M4A 124aRLM1M3A rlm1Δ_::FRT/rlm1Δ_::FRT This study 
124aRLM1M4B 124aRLM1M3B rlm1Δ::FRT/rlm1Δ::FRT This study 
124aRLM1K1A 124aRLM1M4A rlm1Δ::FRT/RLM1-SAT1-FLP This study 
124aRLM1K1B 124aRLM1M4B RLM1_::SAT1-FLIP/rlm1∆_::FRT This study 
124aRLM1K2A 124aRLM1K1A rlm1Δ::FRT/RLM1-FRT This study 
124aRLM1K2B 124aRLM1K1B RLM1-FRT/ rlm1Δ::FRT This study 
    
CAI4 SC5314 ura3Δ::imm434/ura3Δ::imm434 Fonzi and Irwin (1993) 
CAI4-RLM1-GFP CAI4 RLM1/RLM1-GFP-URA This study 
    
S. cerevisiae    
BY4741  MATa   his3Δ1  leu2Δ0  met15Δ0  ura3Δ0 Brachmann et al. (1998) 
rlm1 BY4741 MATa   his3Δ1  leu2Δ0  met15Δ0  ura3Δ0  
YPL089c::kanMX4 
EUROSCARF 
a
 SAT1-FLIP denotes the SAT1 flipper cassette. 
 
Plasmids construction 
For the deletion of RLM1, ca. 0.5 kb of upstream and downstream flanking sequences were amplified 
from the genomic DNA of strain SC5314 with the primers pairs RLM1-1/RLM1-2 and RLM1-3/RLM1-4, 
respectively (Table 2), and the SacI/SacII- and XhoI/ApaI-digested PCR products were cloned on both 
sides of the SAT1-flipper cassette of pSFS5 (Sasse et al., 2011) to generate pRLM1M1. For 
reintroduction of RLM1 into rlm1 mutants, the RLM1 coding region and ca. 0.5 kb of upstream and ca. 
1.0 Kb downstream sequences were amplified with the primers RLM1-1 and RLM1-compl (Table 2). 
The PCR product was digested with SacI and SacII and used to replace the RLM1 upstream region in 
pRLM1M1, resulting in pRLM1K1A. 
 
To chromosomally tag Rlm1 with GFP, RLM1-specific sequences were added to the universal primer 
sequences described previously (Gerami-Nejad et al., 2001) to generate the oligonucleotide RLM1-
GFPfwd and RLM1-GFPrev (Table 2). These primers were used in combination with the template 
pGFP-URA3 to generate the RLM1-GFP cassettes by PCR (Gerami-Nejad et al., 2001). The RLM1-
GFP cassettes were transformed into CAI4 cells to create the C. albicans strain CAI4-RLM1-GFP 
(Table 3.1). Correct integration at the RLM1 locus was confirmed by diagnostic PCR, using RLM1-CAI 
primer, which anneals to the target gene locus upstream the altered region and RLM1-GFP primer, 
which anneals within the transformation module (Table 3.2). 
Candida albicans transcription factor Rlm1 is involved in cell wall remodelling and behaves as a negative biofilm regulator 
53 
Table 3.2. Primers used in this study. 
 
Primer Sequence
a,b
 
RLM1-1 5´-TAGCTGAGCTCAAACCAATATAGTGA-3´ 
RLM1-2 5´-CGTCTGTCCGCGGTTCTATTTCAATC-3´ 
RLM1-3 5´-TTCAACTCGAGCAGATGTCAATAAC-3´ 
RLM1-4 5´-AGTAGGGCCCTAGCCCTAAGTCACG-3´ 
RLM1-compl 5´-TGTCACCGCGGATAAACTAGTCCTTCAT-3´ 
RLM1-GFPfwd 5´-TCCAACCACAGCAGGAAGTTCAAGTTCAGCAGATGTCAATAACACCAACAATGGACCTAATAAAAA 
    TACAGGTGGTGGTTCTAAAGGTGAAGAATTATT-3´ 
RLM1-GFPrev 5´-TCAAAAACAAGGTGACTCTTTATGCTTGTTCTTTCTTTCTATTCACTTGTGAAAATCATGCACAATC 
     AAATCTAGAAGGACCACCTTTGATTG-3´ 
RLM1-CAI 5´-ATGCCATTGAGTGGAATTGG-3´ 
RLM1-GFP 5´-TACCGTAAGTAGCATCACCT 3´ 
a
 Restriction sites introduced into primers are underlined. 
b 
The sequence to GFP plasmid templates is shown bold. 
The gene-specific sequences included in the primers used in this study were approximately 70 nucleotides in length. 
 
Candida albicans transformation 
Candida albicans strains were transformed by electroporation (Kohler et al., 1997) with gel-purified 
SacI-ApaI fragments from pRLM1M1 used to delete the RLM1 gene, in strains SC5314 and 124a. The 
SacI-ApaI fragment from pRLM1K1A was used to reintroduce a functional RLM1 copy into rlm1 
mutants. Nourseothricin-resistant transformants were selected on YPD agar plates containing 
200μg/ml nourseothricin as described previously (Reuss et al., 2004). The correct genomic integration 
of all constructs was confirmed by Southern hybridization with gene-specific probes. 
 
Southern hybridization 
Genomic DNA from C. albicans strains was isolated as described previously (Millon et al., 1994). Ten 
mg of DNA were digested with EcoRI, separated in a 1% w/v agarose gel and, after ethidium bromide 
staining, transferred by vacuum blotting onto a nylon membrane and fixed by UV crosslinking. The gel-
purified SacI-SacII RLM1 upstream fragment and XhoI-ApaI RLM1 downstream fragment from 
pRLM1M1 were used as probes. Southern hybridization with enhanced chemiluminescence-labeled 
probes was performed with the Amersham ECL
TM
 Direct Nucleic Acid Labelling and Detection System 
(GE Healthcare, Braunschweig, Germany) according to the instructions of the manufacturer. 
 
Susceptibility assays 
Cultures were incubated overnight in liquid YPD medium at 30ºC, 200rpm, and diluted to OD640=1 with 
fresh medium. Drop tests were performed by spotting 5μl of the serially diluted cell suspension onto 
20% YPD (0.4% w/v peptone, 0.4% w/v glucose, 0.2% w/v yeast extract and 2% w/v agar) and YPD 
plates supplemented with the following compounds: 70μg/ml calcofluor white (CFW), 100μg/ml Congo 
red (CR), 30ng/ml caspofungin (CFG), 10mM caffeine, 0.035% (w/v) SDS, 1.5M NaCl or 2M sorbitol. 
Plates were incubated 48h at 30ºC before observation. Starvation sensitivity on solid media was 
assayed using a nitrogen starvation medium (2% w/v dextrose, 0.17% w/v yeast nitrogen base without 
amino acids and ammonium sulfate) (Toda et al., 1985). Carbon source utilization was checked by 
addition (2% v/v glycerol) to YP medium (YPD devoid of dextrose. Diffusion test assays were 
performed using YPD agar plates with an overlay of 2x10
7
 cells. Paper discs (6 mm diameter), 
imbibed with 10μl of 0.5M menadione or 35% v/v hydrogen peroxide, were loaded on the agar plates 
and halos of growth inhibition were measured after 24h incubation at 30ºC. 
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Filamentation tests 
Candida albicans cells were grown for 24h on modified Lee medium (0.5% w/v (NH4)2SO4, 0.02% w/v 
MgSO4.7H2O, 0.25% w/v K2HPO4, 0.5% w/v NaCl, 1.25% w/v D-galactose, 0.05% w/v L-alanine, 
0.13% w/v L-leucine, 0.1% w/v L-lysine, 0.01% w/v L-methionine, 0.007% w/v L-ornithine, 0.05% w/v 
L-proline, 0.05% w/v L-threonine and 0.0001% w/v biotin, pH 5.0) at 26ºC and 150rpm in order to 
maintain cells in the yeast morphology. Filamentation was induced by plating approximately 30 colony-
forming units (CFUs) on Spider medium (1% w/v nutrient broth, 1% w/v mannitol, 0.2% w/v K2HPO4, 
1.35% w/v Bacto Agar, pH 7.2) or YPD supplemented with 10% v/v fetal bovine serum (FBS) medium. 
Plates were incubated at 37ºC for 72h and photographed. 
 
Sensitivity to zymolyase and quantification of cell wall components 
Sensitivity to zymolyase was tested following the method described previously (van der Vaart et al., 
1995). Briefly, cultures at mid-logarithmic growth phase were adjusted to OD640=0.5 in tris buffer 
(100mM tris-Cl, 1mM dithiothreitol, pH 7.4), containing 5U zymolyase 20T and incubated at 30ºC, 
200rpm. Sensitivity of strains to zymolyase was determined by the decrease of OD640 of the cell 
suspension as a result of cell lysis along time. The amounts of the different cell wall sugar polymers 
was quantified in cells exponentially grown on YPD liquid medium at 30ºC by HPLC, following 
chemical hydrolysis with concentrated sulphuric acid, as previously described (Francois, 2006). 
 
Fluorescence microscopy and immunofluorescence 
Cultures of cells bearing the RLM1-GFP fusion construct were grown for 18h at 30ºC, 200rpm, in SC-
uridine with 5μg/ml CR and aliquots were collected for nuclei staining with 1μg of 4’,6’-diamino-2-
phenylindol (DAPI; Sigma, St. Louis, MO) per ml of cell suspension. Control cultures were grown on 
medium lacking CR. Cells were visualized with a Leica-DM 5000B fluorescence microscope. For 
immunofluorescence cultures of cells bearing the RLM1-GFP fusion construct were grown as 
previously and stationary phase cells were harvested by centrifugation at 5,000rpm, 4ºC, and fixed 
with 4 % w/v paraformaldehyde for 2h. After wash with PBS 3 times (5min each), cells were 
permeabilized with 0.2% w/v Triton X-100 in PBS for 15min. After blocking non-specific binding sites 
by incubation with 0.5% w/v BSA in PBS for 10min, cells were incubated with the primary antibody for 
1h at room temperature (mouse anti-GFP antibody diluted 1:100 in PBS, Santa Cruz, CA) followed by 
washing with PBS and incubation with the secondary antibody for 30min at room temperature (anti-
mouse IgG2a Alexa-Flour 488, 1:500 in PBS, Molecular Probes, Inc., OR; USA). One μg/ml of DAPI 
(Sigma, St. Louis, MO) was used to stain nuclei and the immunolabeling was visualized with a Zeiss 
Axiovert 200M fluorescence microscope. 
 
Microarray analysis 
RNA isolation and sample labeling 
Candida albicans yeast cells from the wild-type SC5314 and mutant SCRLM1M4 (rlm1Δ/rlm1Δ) strain 
were grown in YPD liquid medium overnight at 30ºC. Each overnight culture was used to inoculate 
20ml of YPD to an initial OD640=0.4, and incubated at 30ºC for an additional 4h period at 200 rpm. The 
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cells were then harvested and immediately stored at -80ºC. RNA extraction was performed by using 
the hot acidic phenol method (Ausubel, 1993). cDNA synthesis and labelling were carried out as 
described elsewhere (van de Peppel et al., 2003). Briefly, cDNA was synthesized from 40μg of total 
RNA in the presence of 2-aminoallyl-dUTP. Samples were purified using Microcon-30 (Millipore) 
columns prior to coupling to NHS ester activated Cyanine 3 (Cy3) and Cy5 fluorofores. Before 
hybridization, free dyes were removed using Chromaspin-30 (Clontech) columns and the efficiency of 
cDNA synthesis and dye incorporation was measured by spectrophotometry (NanoDrop). All samples 
had a degree of labelling (labelled nucleotides per 100 nucleotides) of around 5.0 ± 1.5. 
 
DNA microarrays 
Samples were hybridized onto customized Agilent 44K microarrays with probes designed for the C. 
albicans (Assembly 21) genome sequence. The microarray design was developed by the group of 
Prof. Geraldine Buttler at the School of Biomolecular and Biomedical Science, Conway Institute, 
University College, Dublin, and was made available upon request 
(http://www.ucd.ie/biochem/gb/Lab/). The hybridizations were conducted following Agilent 
Technologies recommendations. Two independent microarray hybridizations for the comparison of 
SC5314 and SCRLM1M4 strains were carried out using dye-swap labeling. Microarray images were 
obtained at a 5μm resolution using the Agilent G2565AA scanner. Fluorescence intensity was 
measured using the Agilent Feature Extraction Software (version 10.5.1.1) and signal and background 
quantitation was performed according to protocol Agilent recommendations (GE2_105_Dec08). Local 
background subtraction, Lowess normalization and averaging of replicate probes were performed 
using BRB Array Tools 3.8.0 (http://linus.nci.nih.gov/BRB-ArrayTools.html). The processed signal was 
annotated using the data downloaded from the Candida Genome Database 
(http://www.candidagenome.org/). 
 
Statistical analysis and functional annotation of the data 
The log2 intensity ratios were used for identification of differentially expressed genes, using the one 
class t-test implemented in TM4 Microarray SoftwareSuite (MeV) v4.6.1 and a P-value cut-off of 0.05. 
Only genes with a fold variation above 2 were considered for discussion. The web based tool 
Genecodis2 (http://genecodis.dacya.ucm.es/) was used for functional enrichment analysis of the 
differentially expressed genes. P-values were calculated using the hypergeometric distribution and 
were corrected using the simulation-based approach (Carmona-Saez et al., 2007). Enrichment results 
were filtered using a corrected P-value cut-off of 0.05. 
 
Adhesion and biofilm formation 
Adhesion and biofilm formation ability was assessed through quantification of total biomass by crystal 
violet (CV) staining (Stepanovic et al., 2000; Silva et al., 2009) and by determining the number of 
cultivable cells (Silva et al., 2010). For this, standardized cell suspensions (1ml containing 1x10
7
 
cells/ml
 
in YPD) were placed into selected wells on 12 polystyrene plates (Orange, Braine-l`Alleud, 
Belgium) and incubated at 37ºC, 120 rpm. Adhesion ability was measured after 2h of incubation and 
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biofilm formation ability was inspected after 24h and 48h. Regarding the 48h sample, an extra step 
was performed, at 24h, in which 500µl of YPD medium was removed and an equal volume of fresh 
YPD was added. After the defined times of incubation, the medium was aspirated and non-adherent 
cells removed by washing the wells with ultra-pure water. Regarding total biomass quantification, first 
the biofilms were fixed with 1ml of methanol, which was removed after 15min of contact. The plates 
were allowed to dry at room temperature, and 1ml of CV (1% v/v) was added to each well and 
incubated for 5min. The wells were then gently washed with ultra-pure water and 1ml of acetic acid 
(33% v/v) was added to release and dissolve the dye. The absorbance of the obtained solution was 
read in triplicate in a microtiter plate reader (Bio-Tek Synergy HT, Izasa, Lisbon, Portugal) at 570nm. 
Results were presented as absorbance/area of the wells (abs/cm
2
). Regarding the number of 
cultivable biofilm cells, the biofilms were resuspended in 1ml phosphate buffer saline (PBS pH 7, 
0.1M) by repeated pipetting (complete removal of the biofilm was confirmed by subsequent CV 
staining), and vigorously vortexed for 5min to disrupt the matrix. Serial decimal dilutions (in PBS) were 
plated onto YPD agar plates and incubated for 24h at 37ºC. Results are presented as the total number 
of CFUs enumerated (Log/cm
2
). Experiments were repeated in three independent assays and the 
results were compared using a one-way analysis of variance (ANOVA) by applying Levene´s test of 
homogeneity of variance and the Tukey multiple-comparions test, using SPSS software (SPSS Inc., 
Chicago, IL). All tests were performed with a confidence level of 95%. 
 
Phylogenetic analysis 
Retrieval of sequences 
In order to compare the similarity level between orthologous genes for CaRLM1 a search in several 
fungal genomes was performed by using the algorithm BLASTP and BLOSUM62 matrix. Species and 
database used were: C. albicans (Candida Database), Broad Institute (Aspergillus nidulans, 
Magnaporthe grisea), Genolevures (Candida glabrata, Kluyveromyces lactis), Saccharomyces 
Database (S. cerevisiae), NCBI (Aspergillus niger). Moreover, MCM1, SMP1 and ARG80 genes, also 
belonging to MADS-box transcription factor family and present in S. cerevisiae, were recovered in 
Saccharomyces database for a further searching of orthologous genes for fungus above mentioned. 
 
Alignment and phylogenetic inference 
The amino acid sequences of each gene were aligned by using MUSCLE (Edgar, 2004) and manually 
edited in MEGA (Tamura et al., 2007). The phylogenetic topology was inferred by Maximum Likelihood 
in PHYML 3.0 (Guindon et al., 2010), with a nodal support estimated by 100 bootstrap analyses. The 
best-fit protein evolutionary model for Maximum Likelihood was JTT, with value gamma, amino acid 
frequencies and presence of invariable sites, which was obtained with PROTTEST 2.1 (Abascal et al., 
2005). 
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Results 
Construction of the C. albicans rlm1 mutant 
To determine the role of Rlm1 in C. albicans, rlm1∆ mutants were constructed from the prototrophic 
wild-type model strains SC5314 and 124a, using the SAT1-flipping strategy (Reuss et al., 2004) to 
avoid the use of auxotrophic markers. For each RLM1 allele we generated two independent 
heterozygous mutants (strains SCRLM1M2A and B) in which one of the RLM1 alleles was deleted 
(Table 3.1; Fig. 3.1, lanes 3 and 7). A second round of gene deletion resulted in the homozygous rlm1 
mutants SCRLM1M4A and B (Table 3.1; Fig. 3.1, lanes 5 and 9). Two complemented strains 
(SCRLM1K2A and B), after reintegration of RLM1 ORF, were generated (Table 3.1). After each round 
of insertion and FLP-mediated excision of the SAT1 flipper cassette the resulting strains were 
analyzed by Southern hybridization to confirm their specific excision and to exclude, as far as 
possible, undesired recombination events involving the previously inactivated loci (Fig. 3.1). The 
absence and reintegration of the target genes from the genome of the mutants was also confirmed by 
PCR amplification (not shown). The same strategy was applied to strain 124a (Table 3.1 and Fig. 3.1). 
 
Before the phenotyping tests, the constructed strains from SC5314 and 124a, were assessed for 
growth in YPD liquid medium, both at 30ºC and 37ºC, and in filament inducing media. Results showed 
that, in both genetic backgrounds, the growth rate of C. albicans rlm1Δ/rlm1Δ mutant was unaffected 
in YPD at both temperatures and that strains did not lose its ability to filament in solid media (Fig. 3.2A 
and 3.2B). 
 
 
Figure 3.1. Southern hybridization of EcoRI-digested genomic DNA from wild-type strains SC5314, 124a (lane 1 
and 10 respectively), heterozygous (lanes 3,7,12 and 16) and homozygous (lanes 5,9,14 and 18) rlm1 mutants, 
with the RLM1-specific probe (XhoI-ApaI RLM1 downstream fragment from pRLM1M1). The sizes (in kb) of the 1-
kb ladder (lane M), which was also labeled, are shown on the left side of the blot. The positions of the original 
wild-type RLM1 alleles and the inactivated rlm1∆ alleles are shown on the right side of the blot. 
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Figure 3.2. (A) Growth curve of C. albicans SC5314 (wt; circles), homozygous mutant SCRLM1M4A 
(rlm1Δ/rlm1Δ; squares), complemented SCRLM1K2A (rlm1Δ/rlm1Δ+RLM1; triangles), 124a (wt; open circles), 
homozygous mutant 124aRLM1M4A (rlm1Δ/rlm1Δ; open squares) and complemented 124aRLM1K2A 
(rlm1Δ/rlm1Δ+RLM1; open triangles) strains in YPD liquid medium at 30ºC and, (B) morphology on Spider 
medium (B1) and YPD containing 10% serum (B2) after 6 days of incubation at 30ºC. Photographs of the colony 
edge were taken by phase-contrast microscopy at 20X magnification. 
 
Response of rlm1 mutants to agents that affect cell integrity 
To determine if C. albicans Rlm1 is involved in the CWI pathway, as described for S. cerevisiae, we 
compared the sensitivity of the constructed mutant strains against a range of cell wall-perturbing 
agents as well as to agents known to be associated with altered cell walls. As depicted in Fig. 3.3, the 
absence of a functional RLM1 in C. albicans results in hypersensitivity to Congo red (CR) and 
Calcofluor White (CFW) for both genetic backgrounds. On the contrary, the S. cerevisiae rlm1Δ 
mutant displayed slightly higher resistance to CFW and unaffected growth in the presence of CR (Fig. 
3.3). 
 
Figure 3.3. Sensitivity of C.albicans and S. cerevisiae strains against agents that affect cell integrity. Serial 10-
fold dilutions of YPD overnight cultures were spotted on YPD plates without or with 100μg/ml Congo red, 70μg/ml 
calcofluor white, 30ng/ml caspofungin, 10mM caffeine, 0.035% SDS and 1M sorbitol with 30ng/ml caspofungin. 
After incubation for 2 days at 30ºC plates were photographed. Candida albicans strains obtained from SC5314 (1) 
(RLM1/RLM1) were two independently constructed homozygous mutant strains (rlm1∆/rlm1∆) SCRLM1M4A (2) 
and SCRLM1M4B (3), and two independently constructed complemented strains (rlm1∆/rlm1∆+RLM1) 
SCRLM1K2A (4) and SCRLM1K2B (5). Candida albicans strains obtained from 124a (6) (RLM1/RLM1) were two 
independently constructed homozygous mutant strains (rlm1∆/rlm1∆) 124aRLM1M4A (7) and 124aRLM1M4B (8) 
and two independently constructed complemented strains (rlm1∆/rlm1∆+RLM1) 124aRLM1K2A (9) and 
124aRLM1K2B (10). Saccharomyces cerevisiae strains were wild-type BY4741 and the derived rlm1∆ mutant. 
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The SC5314- and 124a-derived rlm1Δ/rlm1Δ mutants from C. albicans were also more sensitive than 
the complemented and parental strains to the presence of Caspofungin (CFG). Curiously, S. 
cerevisiae rlm1Δ mutant showed no sensitivity to CFG under the same conditions as C. albicans (Fig. 
3.3). The hypersensitivity of the C. albicans mutant to CFG was reverted with the osmotic protection 
by 1M sorbitol (Fig. 3.3). In the tests with caffeine and SDS, both genetic backgrounds of C. albicans 
rlm1Δ/rlm1Δ mutant were equally resistant to caffeine and unaffected by SDS, while for S. cerevisiae 
rlm1Δ these compounds caused decreased growth. Together, these results suggest that C. albicans 
RLM1 is involved in cell wall biogenesis but its function in this process seems to be different from its S. 
cerevisiae orthologue. 
 
Effect of osmolarity and oxidative stress on rlm1 mutant strains 
Cell wall-deficient yeast cells become more sensitive to osmotic stress due to a decreased physical 
support of the plasma membrane by the cell wall when changes in cellular volume compensate for the 
osmotic gradient. Upon high osmolarity, the CWI signalling pathway becomes activated, leading to 
phosphorylation of the MAPK Mkc1 (Navarro-Garcia et al., 2005), the orthologue of Slt2 that in S. 
cerevisiae activates Rlm1. Therefore, we investigated the involvement of C. albicans RLM1 in 
response to high and low osmolarity conditions (Fig. 3.4). Strains were tested for growth on hyper-
osmotic media by incorporation of 1.5M NaCl and 2M sorbitol, as well as on hypo-osmotic medium, by 
diluting five-fold the components of YPD medium (20% YPD; Davenport et al., 1995). Candida 
albicans strains displayed the same growth under all conditions, unlike S. cerevisiae, in which rlm1∆ 
mutant displayed higher sensitivity to hyperosmotic stress imposed by NaCl. Hypo-osmolarity did not 
affect growth of the mutant strains relatively to the parental strain in both species (Fig. 3.4). These 
results suggest that in the absence of Rlm1, and without any other stress, the cell wall is sufficiently 
strong to support the hypo and hyper-osmotic stresses imposed. 
 
Figure 3.4. Sensitivity of C.albicans and S. cerevisiae strains to osmotic stress. Serial 10-fold dilutions of YPD 
overnight cultures of the strains were spotted on YPD plates without or with 1.5M NaCl, 2M sorbitol and 20% YPD 
and were incubated for 2 days at 30ºC. Candida albicans strains obtained from SC5314 (1) (RLM1/RLM1) were 
two independently constructed homozygous mutant strains (rlm1∆/rlm1∆) SCRLM1M4A (2) and SCRLM1M4B (3), 
and two independently constructed complemented strains (rlm1∆/rlm1∆+RLM1) SCRLM1K2A (4) and 
SCRLM1K2B (5). Candida albicans strains obtained from 124a (6) (RLM1/RLM1) were two independently 
constructed homozygous mutant strains (rlm1∆/rlm1∆) 124aRLM1M4A (7) and 124aRLM1M4B (8) and two 
independently constructed complemented strains (rlm1∆/rlm1∆+RLM1) 124aRLM1K2A (9) and 124aRLM1K2B 
(10). Saccharomyces cerevisiae strains were wild-type BY4741 and the derived rlm1∆ mutant. 
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In a previous study a connection between oxidative stress and the CWI pathway has been reported 
(Vilella et al., 2005). Moreover, it has been described that the transcription of S. cerevisiae RLM1 is 
activated upon treatment with hydrogen peroxide (Staleva et al., 2004). To explore the involvement of 
RLM1 (from S. cerevisiae and C. albicans) in oxidative stress response, strain growth was tested in 
the presence of the superoxide-generating agents, menadione, and hydrogen peroxide (Staleva et al., 
2004; Navarro-Garcia et al., 2005; Vilella et al., 2005; Westwater et al., 2005), in diffusion test assays. 
For both species, mutants affected in RLM1 were insensitive to the presence of 0.5M menadione and 
35% hydrogen peroxide (Fig. 3.5). 
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Figure 3.5. Sensitivity to oxidative stress of wild-type strains SC5314 and 124a (RLM1/RLM1), mutants 
SCRLM1M4A and 124aRLM1M4A (rlm1Δ/rlm1Δ), and complemented strains SCRLM1K2A and 124aRLM1K2A 
(rlm1Δ/rlm1Δ+RLM1) of C. albicans, and the haploid parental BY4741 (RLM1) and mutant (rlm1Δ) strains of S. 
cerevisiae. Diffusion test assays were performed using YPD agar plates with an overlay of 2x10
7
 cells. Paper 
discs (6 mm diameter), imbibed with 10μl of 0.5M menadione or 35% v/v hydrogen peroxide, were loaded on the 
agar plates and halos of growth inhibition were measured after 24h incubation at 30ºC. 
 
 
Response of rlm1 mutants to temperature, glycerol and nitrogen starvation 
In S. cerevisiae, deletion of several genes involved in the cell wall integrity pathway confer typical 
phenotypes, such as failure to grow at elevated temperatures in the absence of an osmostabilizer, 
failure to grow on glycerol medium, and sensitivity to nitrogen starvation (Lee and Levin, 1992; Irie et 
al., 1993; Lee et al., 1993; Martin et al., 1993; Costigan and Snyder, 1994). However, for the S. 
cerevisiae rlm1Δ mutant the only phenotype in common with the other PKC1 pathway mutants is 
caffeine sensitivity. Thus, in this study we also tested C. albicans rlm1Δ/rlm1Δ mutant susceptibility to 
these parameters. Since our previous results showed no difference neither between phenotypes of 
SC5314 and 124a strains nor between phenotypes of the independent clones A and B, the following 
tests were performed only with clones A from wild-tipe SC5314 (SCRLM1M4A and SCRLM1K2A). 
Results showed that C. albicans mutant strains were able to grow on glycerol, resist nitrogen 
starvation (Fig. 3.6A), and had reduced thermotolerance (Fig. 3.6B). Curiously, regarding 
thermotolerance, the complemented and mutant strains behaved similarly, suggesting that gene 
dosage seems to be important for this phenotype. Overall, these results indicate that the function of 
RLM1 in C. albicans and S. cerevisiae differ in the response to temperature and caffeine. The 
phenotype on glycerol is not clear since our results indicate that S. cerevisiae rlm1Δ is sensitive while 
the literature indicates that it grows normally. 
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 A 
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Figure 3.6. A) Ability to grow on glicerol (YPG) and sensitivity to nitrogen starvation (YCB) of wild-type strain 
SC5314 (RLM1/RLM1), homozygous SCRLM1M4A (rlm1Δ/rlm1Δ) rlm1 mutant, and complemented strain 
SCRLM1K2A (rlm1Δ/rlm1Δ+RLM1) of C. albicans and the haploid parental BY4741 (RLM1) and mutant rlm1 
(rlm1Δ) strains of S. cerevisiae. Serial 10-fold dilutions of YPD overnight cultures of the strains were spotted on 
YPD, YPG and YCB plates and incubated for 2 days at 30ºC. B) Thermal shock and thermotolerance of C. 
albicans rlm1Δ/rlm1Δ mutant. Exponentially grown cells at 30ºC were spotted on YPD plates and incubated at 
different temperatures for 2 days or subjected to a pre-treatment at 37ºC or 42ºC for 30 minutes, then spotted on 
YPD, shocked at 55ºC for 40 and 50 min before incubation at 30ºC for 2 days. 
 
 
Sensitivity to zymolyase and quantification of cell wall components 
Our results with agents affecting the cell wall integrity suggest the involvement of RLM1 in the cell wall 
remodeling therefore, we investigated the sensitivity of rlm1Δ/rlm1Δ mutant cells against the -1,3-
glucan degrading enzyme zymolyase (Fig. 3.7). Deletion of RLM1 slightly increased resistance to the 
enzyme in both species. Moreover, after 30 min of incubation around 50% of S. cerevisiae cells were 
lysed, whereas for C. albicans the percentage was higher than 75%. It has been previously reported 
that the decrease in susceptibility to zymolyase could be due to rearrangements in the amount of 
glucan and/or mannoprotein in the cell wall (Navarro-Garcia et al., 1995; van der Vaart et al., 1995). 
Thus, we quantified the amounts of the different cell wall sugar polymers in cells exponentially growing 
in YPD liquid medium. 
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Figure 3.7. Zymolyase sensitivitiy of yeast strains assessed by decrease of optical density along time. Cells of (A) 
wild-type strain SC5314 (RLM1/RLM1; squares), homozygous mutant SCRLM1M4A (rlm1Δ/rlm1Δ; triangles) and 
complemented strain SCRLM1K2A (rlm1Δ/rlm1Δ+RLM1; circles) of C. albicans; and (B) wild-type BY4741 (RLM1; 
squares) and mutant rlm1 (rlm1Δ; triangles) strains of S. cerevisiae were harvested at the exponential growth 
phase and were incubated with 5U zymolyase 20T at 30ºC, 200rpm. Decrease of optical density of cell 
suspensions was monitored along time at 640nm as indication of cell lysis upon cell wall digestion by zymolyase. 
 
 
As observed in Table 3.3, deletion of RLM1 in C. albicans resulted in an increase of about 2-fold in the 
amount of chitin and mannans and of only 1.3 in glucans, in comparison with the parental strain. 
These results indicate that the content of the different cell wall components changed in C. albicans 
rlm1Δ/rlm1Δ mutant strain mostly regarding chitin and mannan content, which correlates with the 
hypersensitivity with CFW and the low sensitivity to zymolyase. The thicker outer layer of mannans in 
the C. albicans mutant may impede zymolyase the access to glucans but not CFG, making the mutant 
hypersensitive to CFG and only slightly sensitive to zymolyase. 
 
Table 3.3. Polysaccharides cell wall composition of C. albicans rlm1 mutant, wild-type and 
complemented strains. 
 
 
 
 
 Chitin 
(% of the wall mass) 
Mannan 
(µg/mg wall mass) 
Glucan 
(µg/mg wall mass) 
SC5314 17.8+1.2   71.34+3.3 189.67+3.6 
SCRLM1M4A (rlm1Δ/rlm1Δ) 38.9+3.9 137.33+3.6 254.92+1.9 
SCRLM1K2A (Δrlm1Δ/rlm1+RLM1Δ) 13.46+3.6   63.23+4.1 165.61+0.6 
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Subcellular localization of Rlm1P-GFP 
To assess the cellular localization of Rlm1 in CAI4 C. albicans strain, we inserted the GFP-encoding 
gene in an in-frame fusion with RLM1, leading to the production of a fusion protein with GFP in the C-
terminal of Rlm1. Two independent transformants with Rlm1-GFP fusion were grown to stationary 
phase on SC-uridine culture with CR (5μg/ml) and then assessed by fluorescence microscopy. Green 
fluorescence was present mainly in the nucleus (identified by DAPI staining), appearing also in the 
cytoplasm as granules (Fig. 3.8A). In order to increase sensitivity, the fusion protein was detected by 
indirect immunfluoresce. Detection of the Rlm1-GFP fusion protein with mouse anti-GFP by the anti-
mouse IgG2a Alexa-Flour 488 secondary antibody revealed the same pattern of subcellular localization 
(Fig. 3.8B). The nuclear localization is in accordance with a transcription factor function and the 
presence of cytoplasmic granules suggests that Rlm1 might be recruited to the nucleus when 
activated, as previously observed for S. cerevisiae (Jung et al., 2002). 
 
 
 
Figure 3.8. Subcellular localization of the Rlm1-GFP fusion protein in C. albicans. A) Cells of strain CAI4 bearing 
a chromosomally integrated RLM1-GFP cassette were grown to stationary phase in SC-uridine culture with 
5μgCR/ml and then visualized by microscopy in bright field and for GFP and DAPI fluorescences. B) Cells from 
the same strain were grown under the conditions described above and fixed (in control experiments CR was 
omitted). Indirect immunodetection was performed using mouse anti-GFP antibody and anti-mouse IgG2a Alexa-
Flour 488–conjugated secondary antibody. Nuclear DNA was stained with DAPI. Bf: bright field microscopy. 
 
 
Global gene expression profile 
In order to identify genes whose expression was affected by deletion of C. albicans RLM1 we 
performed gene expression profiling analyses on SC5314 and SCRLM1M4A, its Δrlm1/rlm1Δ mutant. 
Taking into consideration that microarray studies with S. cerevisiae rlm1∆ mutant (Becerra et al., 
2011) were performed in YPD exponential growth phase, the present gene expression analysis was 
performed under the same conditions. Other conditions, such as elevated temperature or the action of 
drugs can also activate this pathway but we have chosen growth on YPD to avoid activating general 
heat shock response or other general responses. 
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After filtering, the entire data set resulted in a total of 772 statistically significant differentially regulated 
ORFs (P-value <0.05). From those, the transcript profiles of genes differentially expressed by a factor 
of 2-fold were analyzed by function. The full data set was deposited in the ArrayExpress database 
from the European Bioinformatics Institute (www.ebi.ac.uk/arrayexpress) with the accession number 
E-MEXP-3247. 
 
Deletion of RLM1 in C. albicans changed the mRNA level of 101 genes with regulation ratios >2.0 (up-
regulated and down-regulated; Appendix 1), which is far above the 20 genes identified for S. 
cerevisiae rlm1Δ mutant grown under the same conditions (Jung and Levin, 1999; Becerra et al., 
2011). Curiously, our data showed that more genes (63.4%) have elevated expression than reduced 
expression, which is exactly the opposite of what was observed for S. cerevisiae by Becerra et al. 
(2011) but similar to Jung and Levin (1999) results. Gene annotation and classification with the GO 
(Gene Ontology) terms for C. albicans was performed in Candida Database. The majority of the up-
regulated genes (53.1%) have no known function. The remaining genes (corrected P-value <0.05) are 
involved in cell adhesion related to biofilm formation (P=0.019) and polyamine transport (P=0.037). 
Regarding down-regulated genes, 48.6% have unknown function, the ones that appeared with 
significant expression encode proteins involved in catalytic activity (43.2%), mainly oxidoreductase 
activity (10.8%, P= 0.026). 
 
Table 3.4 highlights the genes with known function identified in this study. Genes with higher 
expression in the mutant than in the wild-type strain correspond to genes that are activated due to lack 
of Rlm1 and may be involved in a “compensatory mechanism” response (Lagorce et al., 2003). In this 
study we observed that genes with the highest up-regulation encode for proteins involved in the cell 
wall organization and biofilm formation, ALS1, ALS3, HWP1, ECE1 and RBT1, with ECE1 showing an 
increase of around 76 fold. PGA25 that encodes for a GPI-anchored protein member of the PGA 
family displayed also up-regulation in this study. Members of this family are frequently identified in 
studies involving induction of cell wall stress (Bruno et al., 2006) and cell wall regeneration (Castillo et 
al., 2006). Although we observed a two-fold increase in the cell wall chitin content of the mutant strain, 
in which the CHS enzyme family is responsible for the chitin synthesis, only CHS7 was up-regulated in 
the mutant strain. However, it has been described that Chs7 is essential for Chs3 activity, the major 
chitin synthase of C. albicans cells (Sanz et al., 2005). This result suggests that Chs7, directly or 
indirectly, enhance Chs3 activity resulting in the increase in cell wall chitin content observed in this 
study. Additionally, genes involved in the adaptation to osmotic stress were also up regulated GCV2, 
CIT1, ENA21 as well as HGT10, which codes for a glycerol permease. This observation also indicates 
that the absence of Rlm1 can active genes osmotic stress response, reinforcing the role of RLM1 in 
the cell wall maintenance. 
 
Curiously, among the up-regulated genes identified with transporter activity, AGP2 and OPT6 are 
involved in the uptake of amino acids and oligopeptides, respectively. These, together with the action 
of secreted proteases (SAP6), which was also up-regulated, can contribute to the intake of 
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oligopeptides and amino acids. The up-regulation of PUT2 and GCV2, whose products are involved in 
amino acid degradation, may suggest the utilization of alternative carbon or energy sources by C. 
albicans mutant cells. Other genes that could be involved in the interconnection of the pathways 
required to metabolize nonfermentable carbon sources, i.e. involved in the gluconeogenesis, the 
glyoxylate cycle, and beta-oxidation, are CIT1, coding for citrate synthase, ACS1 an acetyl-CoA 
synthetase, and SOU1 a sorbose redutase, which are also up-regulated. Interestingly, DAK2, GLK4, 
GPD1, NTH1 and TPS1, which products are involved in carbohydrate catabolism appeared as down-
regulated (Table 3.4). This observation agrees with the fact that carbohydrates are necessary as 
building blocks for cell wall remodeling. Gal4, one of the transcription factors known to be involved in 
the control of glycolytic enzymes in pathogenic species (Askew et al., 2009), was also up-regulated in 
our analysis. These observations suggest that sugar metabolism is under tight control of Rlm1 and 
metabolic pathways for the utilization of alternative carbon and energy sources may be activated in the 
mutant cells. 
 
Table 3.4. Selected Rlm1p regulated genes. 
 
ORF 
 
Gene 
name 
S.cerevisiae 
ortholog 
Function / Discription 
 
Ratio 
mutant/ 
wild-type 
Rlm1 binding sequence 
(location upstream gene 
sequence) 
orf19.1228 HAP2 HAP2 
Unknown / CCAAT-binding factor involved in low-
iron response 
3,0 TAWWWWTAGM (-919R) 
orf19.1321 HWP1 -- 
Protein binding / Hyphal cell wall protein involved in 
host defense 
37,4 TAWWWWTAGM (-938R) 
orf19.1327 RBT1 -- Unknown / Cell wall protein with similarity to Hwp1 10,4 - 
orf19.1569 UTP22 UTP22 
Unknown/ Putative U3 snoRNP protein involved in 
rRNA processing 
2,6 - 
orf19.1743 ACS1 ACS1 Ligase activity / Putative acetyl-CoA synthetase 2,3 - 
orf19.1816 ALS3 SAG1 
Protein binding / Adhesin from the ALS family; role 
in epithelial adhesion, endothelial invasiveness 
14,1 
CTAWWWWTAG (-0 F;-10R) 
TAWWWWTAGM (-9 F;-1R) 
orf19.2444 CHS7 CHS7 
Protein binding / Protein required for wild-type chitin 
synthase III activity 
2,7 - 
orf19.2606 HDA1 HDA1 Hydrolase activity / Histone deacetylase 2,8 - 
orf19.2896 SOU1 SPS19 
Oxidoreductase activity / Enzyme involved in 
utilization of L-sorbose 
6,3 - 
orf19.3265 TRM1 TRM1 
Transferase activity / Protein described as an 
N2,N2-dimethylguanine tRNA methyltransferase 
2,8 - 
orf19.3374 ECE1 -- Unknown / Hyphal-specific cell wall protein 76,0 TAWWWWTAGM (-145R) 
orf19.3548.1 WH11 HSP12 
Unknown / Protein expressed specifically in white 
phase yeast-form cells 
5,4 
TAWWWWTAGM (-96F;-
781R) 
orf19.385 GCV2 GCV2 
Oxidoreductase activity / Glycine decarboxylase P 
subunit 
3,7 TAWWWWTAGM (-213F) 
orf19.3974 PUT2 PUT2 
Oxidoreductase activity / delta-1-pyrroline-5-
carboxylate dehydrogenase 
2,2 - 
orf19.3981 MAL31 MAL31 
Transporter activity / Putative high-affinity maltose 
transporte 
2,8 
CTAWWWWTAG (-665F;-
655R) 
TAWWWWTAGM (-566R;-
897R) 
orf19.4093 PES1 NOP7 
Unknown / Pescadillo homolog required for 
filament-to-yeast switching 
3,2 - 
orf19.4211 FET3 FET3 Oxidoreductase activity / Multicopper oxidas 3,1 
CTAWWWWTAG (-784F;-
774R) 
TAWWWWTAGM (-5R) 
orf19.4393 CIT1 CIT1 
Transferase activity / Protein described as citrate 
synthase 
3,9 - 
orf19.4551 CTN1 YAT1 
Transferase activity / Predicted carnitine acetyl 
transferase 
4,9 TAWWWWTAGM (-799R) 
orf19.4655 OPT6 OPT2 
Transporter activity / Putative oligopeptide 
transporter 
2,3 TAWWWWTAGM (-834F) 
orf19.4679 AGP2 AGP2 
Transporter activity / Protein described as an amino 
acid permease 
3,8 - 
orf19.473 TPO4 TPO4 
Transporter activity / Putative sperimidine 
transporter 
2,4 TAWWWWTAGM (-532R) 
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ORF 
 
Gene 
name 
S.cerevisiae 
ortholog 
Function / Discription 
 
Ratio 
mutant/ 
wild-type 
Rlm1 binding sequence 
(location upstream gene 
sequence) 
orf19.4815 YTM1 YTM1 
Unknown / Protein similar to S. cerevisiae Ytm1, 
involved in biogenesis of the large ribosomal 
subunit 
2,1 - 
orf19.5071 NRP1 NRP1 Unknown / Nucleic acid binding 2,1 - 
orf19.5110 OPY2 OPY2 
Unknown / S. cerevisiae ortholog has role in 
osmosensory signaling pathway, cell cycle arrest 
2,6 TAWWWWTAGM (-457F) 
orf19.5170 ENA21 ENA2 
Unknown / Similar to S. cerevisiae sodium 
transporters 
2,5 - 
orf19.5338 GAL4 GAL4 
Transcription regulator activity / Transcription factor 
involved in control of glycolysis 
2,3 - 
orf19.5542 SAP6 BAR1 Hydrolase activity / Secreted aspartyl proteinase 3,2 - 
orf19.5595 SHE3 -- 
RNA binding / mRNA-binding protein that localizes 
specific mRNAs to daughter yeast-form cells and to 
hyphal tips 
2,3 TAWWWWTAGM (-546R) 
orf19.5741 ALS1 SAG1 
Peptide binding / Adhesin; ALS family of cell-
surface glycoprotein 
6,2 TAWWWWTAGM (-853R) 
orf19.5753 HGT10 STL1 
Transporter activity / Glycerol permease involved in 
glycerol uptake induced by osmotic stress, during 
cell wall regeneration 
13,0 
TAWWWWTAGM (-204F;-
976R) 
orf19.6078 POL93 YIL080W Unknown / nucleic acid  binding 7,7 - 
orf19.6139 FRE7 FRE3 Unknown / Protein similar to ferric reductase Fre10 3,2 - 
orf19.6169 ATO1 ATO2 
Unknown / Putative fungal-specific transmembrane 
protein 
4,6 - 
orf19.6336 PGA25 -- Unknown / Putative GPI-anchored protein 8,0 TAWWWWTAGM (-316F) 
orf19.651 LYP1 LYP1 
Unknown / Putative permease, animo acid 
transmembrane transporter 
2,4 - 
orf19.6514 CUP9 CUP9 Unknown / sequence specific DNA binding 2,1 - 
orf19.6577 FLU1 TPO1 
Transporter activity / Multidrug efflux pump of the 
plasma membrane 
2,2 TAWWWWTAGM (-840F) 
orf19.6948 CCC1 CCC1 
Transporter activity / Putative manganese 
transporter 
2,5 TAWWWWTAGM (-209R) 
orf19.918 CDR11 PDR5 
Transporter activity / Putative transporter of PDR 
subfamily of ABC family 
2,1 - 
orf19.2525 LYS12 LYS12 
Oxidoreductase activity / mitochondrial 
homoisocitrate dehydrogenase 
-20,1 - 
orf19.1868 RNR22 RNR2 Unknown / ribonucleoside diphosphate reductase -3,4 - 
orf19.7600 FDH3 SFA1 
Oxidoreductase activity / Putative protein of glycine 
catabolism 
-2,9 - 
orf19.866 RAD32 RAD30 
Nucleotidyl transferase activity / Protein similar to 
S. cerevisiae protein with role in nucleotide excision 
repair 
-2,9 - 
orf19.3749 IFC3 OPT2 Transporter activity / Oligopeptide transporter -2,7 - 
orf19.2770.1 SOD1 SOD1 
Oxidoreductase activity / Cytosolic copper- and 
zinc-containing superoxide dismutase 
-2,6 - 
orf19.1756 GPD1 GPD1 
Oxidoreductase activity / Glycerol-3-phosphate 
dehydrogenase (enzyme of glycerol biosynthesis) 
-2,5 - 
orf19.5248 MSO1 -- Unknown / Unknown -2,5 - 
orf19.4777 DAK2 DAK2 Unknown / Dihydroxyacetone kinase -2,4 - 
orf19.4664 NAT4 NAT4 Transferase activity / Histone acetyltransferase -2,4 - 
orf19.5025 MET3 MET3 
Transferase activity / ATP sulfurlyase of sulfate 
assimilation 
-2,4 - 
orf19.6116 GLK4 GLK1 Hexokinase activity / Glucokinase -2,3 TAWWWWTAGM (-9R) 
orf19.2341 HNT1 HNT1 Hydrolase activity / Protein kinase C inhibitor-I -2,3 - 
orf19.6640 TPS1 TPS1 
Transferase activity / Trehalose-6-phosphate 
synthase 
-2,3 - 
orf19.5228 RIB3 RIB3 
Lyase activity / 3,4-Dihydroxy-2-butanone 4-
phosphate synthase 
-2,3 TAWWWWTAGM (-756R) 
orf19.5001 CUP2 HAA1 
Unknown/ Protein required for normal resistance to 
copper 
-2,2 TAWWWWTAGM (-593R) 
orf19.7479 NTH1 NTH1 Hydrolase activity / Neutral trehalase -2,1 - 
orf19.5000 CYB2 CYB2 
Oxidoredutase activity / Cytochrome b2 precursor 
protein 
-2,1 - 
orf19.3359 ARP8 ARP8 
Hydrolase activity / Chromatin-remodeling enzyme 
complex protein 
-2,1 - 
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Adhesion and biofilm formation 
Since the proteins that showed higher up-regulation in the rlm1Δ/rlm1Δ mutant are involved in 
adhesion and biofilm formation, C. albicans strains were tested regarding their ability to adhere to a 
polystyrene surface (within 2h) and to form biofilm after 24h and 48h (Fig. 3.9A and 3.9B). Candida 
albicans rlm1Δ/rlm1Δ showed a higher ability to adhere to polystyrene surface, presenting a higher 
number of cells compared to the WT strain (P<0.05). However, no differences in biomass production 
were observed in the adhesion process (Fig. 3.9A, 2h). Regarding biofilm formation, a clear difference 
(P<0.05) in the total number of CFUs as well as total biomass formation was observed between the 
mutant and the WT strain. Although the number of CFUs did not change between 24h and 48h, the 
total biomass still increased in both strains with the mutant showing significant (P<0.05) higher amount 
of total biomass than the WT. The complemented strain, SCRLM1K2A, showed once more the 
common phenotype of partial complementation, particularly regarding CFUs counting. The amount of 
total biomass produced at 48h by the complemented strain was similar to the WT, but no significant 
difference (P>0.05) was observed in comparison with the mutant strain. No phenotypic differences 
between the WT and mutant cells were observed when grown in biofilm (Fig. 3.9C). Together, these 
results indicate that Rlm1 acts as a negative regulator of in vitro biofilm formation. 
 
 
Figure 3.9. In vitro adhesion and biofilm formation. Candida albicans cells from SC5314 (RLM1/RLM1), 
SCRLM1M4A (rlm1Δ/rlm1Δ) and complemented strain SCRLM1K2A (rlm1Δ/rlm1Δ+RLM1) were allowed to 
adhere (2h) and to form biofilm (24h and 48h) in polystyrene. Total biomass (A) was then assed by crystal violet 
staining and viable cells (B) by CFUs counting. (C) Morphology of SC5314 and SCRLM1M4A cells after 24h 
biofilm growth stained with CFW and visualized under the fluorescence microscope. The symbol * indicates that 
measurements were significantly different (P<0.005) from the WT strain. 
 
 
Candida albicans genome contains two MADS-box transcription factors while S. cerevisiae has 
four 
Our search in several databases indicated the presence of two MADS-box proteins in C.albicans 
(Rlm1 and Mcm1), and in other fungi belonging to subphylum Saccharomycotina (Kluyveromyces 
lactis, C. glabrata, S. cerevisiae) and Pezizomycotina (Aspergillus nidulans, Aspergillus niger, 
Magnaporte grisea). However, S. cerevisiae and C. glabrata presented two other MADS-box proteins, 
Arg80 and Smp1 besides Rlm1 and Mcm1. These additional MADS-box proteins could have arise as 
consequence of the genome duplication process, since this event has been reported to happened 
after divergence of K.lactis and S.cerevisiae (Wolfe and Shields, 1997; Kellis et al., 2004). 
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In order to evaluate the proximity of C. albicans Rlm1 with the other MADS-box transcription factors 
from closely related species, protein sequence alignment and phylogenetic analysis for the selected 
species was performed (Fig. 3.10). 
 
Figure 3.10. Phylogenetic relationship of MADS-box type I and type II proteins from selected fungal species. This 
phylogeny was obtained by maximum likelihood with a nodal support estimated by 1000 bootstrap analysis. 
 
 
This analyses clearly showed that fungal MADS-box protein are grouped in two groups, according to 
the position of MADS-box within protein sequence (type I or type II) (Alvarez-Buylla et al., 2000). The 
yeast MADS-box sequences present low similarity with their filamentous fungi orthologues, clustering 
in distinct subgroups, except for C. albicans Mcm1 that grouped within the filamentous fungi cluster. 
Candida albicans Rlm1 grouped within the yeast type II cluster, closer to K. lactis Rlm1 orthologue. In 
view of this result we believe that Rlm1 from C. albicans would behave similarly to its K. lactis and S. 
cerevisiae orthologues rather than to the filamentous fungi. 
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Discussion 
Candida albicans RLM1 is required for cell wall remodeling 
In S. cerevisiae the signaling pathway responsible for the CWI is the Slt2 MAP kinase pathway, in 
which the transcription factor Rlm1 plays a key role in the regulation of genes involved in the 
maintenance of integrity and cell wall biosynthesis (Dodou and Treisman, 1997; Watanabe et al., 
1997). In C. albicans this role is accomplished through the functionally and structurally homologous 
Mkc1 MAP kinase pathway (Navarro-Garcia et al., 1995), but the involvement of Rlm1 in CWI 
maintenance has not been completely clarified (Bruno et al., 2006). 
 
The analysis of C. albicans rlm1Δ/rlm1Δ mutant in the presence of compounds that affect the cell wall, 
showed a hypersensitivity to CFW, CFG and CR. The hypersensitivity to CFW has been reported to be 
associated with an increase in the cell wall chitin content, after activation of the so-called 
"compensatory mechanism" in response to the weakening of the cell wall (Popolo and Vai, 1999; 
Selvaggini et al., 2004; Sanz et al., 2005). In this study, C. albicans rlm1Δ/rlm1Δ mutant strain showed 
a 2-fold increase in the cell wall chitin content in comparison with the wild-type strain. In the microarray 
analysis, we did not find an over-expression of the genes directly responsible for chitin synthesis, such 
as CHS1, CHS2, CHS3, or CHS8 (Mio et al., 1996; Munro et al., 2003; Castillo et al., 2006) but we 
found a 2.7 fold over-expression of CHS7 (Chs7p) which is required for wild-type Chs3 activity, the 
major chitin synthase of C. albicans cells (Sanz et al., 2005). This observation suggests that the 
increase in cell wall chitin content observed in this analysis, that is responsible for the CFW 
hypersensitivity, could be due to Chs7 enhancing, directly or indirectly, Chs3 activity. 
 
The hypersensitivity to CR, which interferes with the assembly of β-1,3-glucan, and to CFG, an 
inhibitor of β-1,3-glucan synthase, may suggest an alteration in the composition of the glucans in the 
cell wall of C. albicans rlm1Δ/rlm1Δ mutant. However, no significant differences in resistance to 
zymolyase or in the total amount of cell wall glucans was observed in the mutant strain in comparison 
with the wild-type. Changes in the association between the polysaccharides, particularly the amount of 
mannoproteins, have also been described in response to cell wall weakening (Lagorce et al., 2003). 
Probably this is the case for C. albicans rlm1Δ/rlm1Δ since the total amount of glucans was not 
significantly altered but a two-fold increase in the cell wall mannans was observed in the mutant in 
comparison with the wild-type, suggesting an increase in the amount of mannoproteins in the cell wall 
surface. The thicker outer layer of mannans in C. albicans mutant may make difficult the access of 
zymolyase to glucans but not CFG, rendering the mutant hypersensitive to CFG and slightly sensitive 
to zymolyase. Microarray analysis also pointed towards this hypothesis, showing a significant increase 
of transcripts of cell wall proteins. The genes with the highest up-regulation in the mutant are ALS1, 
ALS3, HWP1, RBT1 and ECE1, which are directly involved in the cell wall organization. These results, 
together with the osmoremediation observed with CFG, indicates that C. albicans RLM1 is involved in 
cell wall remodelling. This regulatory role is further evidenced by the nuclear and cytoplasmic granular 
localization of Rlm1-GFP fusion protein observed in this study, suggesting that Rlm1 might be 
recruited to the nucleus when activated. This pattern of cellular localization agrees with data obtained 
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in S. cerevisiae (Jung et al., 2002) and further supports a functional homology between C. albicans 
and S. cerevisiae Rlm1. 
 
Role of RLM1 in response to cell wall damage is different in S. cerevisiae and C. albicans 
Candida albicans Rlm1 is a putative transcription factor from the MADS-Box family whose function has 
been attributed mainly based on the knowledge from the S. cerevisiae orthologue (Reinoso-Martin et 
al., 2003; Levin, 2005). This is supported by the fact that 74% of C. albicans genes are homologous to 
genes in S. cerevisiae (Jones et al., 2004). The homology between RLM1 from S. cerevisiae and C. 
albicans and phenotypes associated with cell wall defects of the correspondent null mutants, strongly 
suggest that both genes are functionally homologues (Bruno et al., 2006). 
 
Deletions of several S. cerevisiae genes involved in the cell wall integrity pathway such as BCK1, 
MKK1, MKK2 or SLT2/MPK1 confer typical phenotypes such as, failure to grow at elevated 
temperatures in the absence of an osmostabilizer; sensitivity to caffeine in the medium; failure to grow 
on glycerol medium; and sensitivity to nitrogen starvation (Lee and Levin, 1992; Irie et al., 1993; Lee et 
al., 1993; Martin et al., 1993; Costigan and Snyder, 1994). However, unlike PKC pathway mutants, the 
S. cerevisiae rlm1Δ mutant appears to be able to grow normally at elevated temperatures (38ºC), 
grows on glycerol medium and is not sensitive to nitrogen starvation. In C. albicans, the only gene 
involved in the cell wall integrity pathway that has been extensively characterized is MKC1 (SLT2 in S. 
cerevisiae) (Navarro-Garcia et al., 1995; Navarro-Garcia et al., 1998). Candida albicans 
mkc1Δ/mkc1Δ deficient cells also showed temperature sensitivity, reduced thermotolerance and 
caffeine sensitivity. But, contrary to its S. cerevisiae orthologue, C. albicans mkc1Δ/mkc1Δ Ura
+
 
mutant cells survived nitrogen starvation and were also able to grow on glycerol medium. In this study, 
C. albicans rlm1Δ/rlm1Δ mutant showed reduced thermotolerance, no sensitivity to caffeine, ability to 
grow on glycerol and resistance to nitrogen starvation. Recently, the rlm1Δ as well as the slt2Δ 
mutants from C. glabrata have been studied and results showed that they present temperature 
sensitivity in the absence of an osmostabilizer (Miyazaki et al., 2010). We may infer from these results 
that the function of RLM1 in C. albicans and S. cerevisiae differ in response to temperature and 
caffeine. Additionally, the S. cerevisiae rlm1∆ mutant was not affected by the presence of CR and 
CFG, was more resistant to CFW, and unlike C. albicans mutant, S. cerevisiae rlm1∆ was more 
sensitive to SDS. The whole-genome duplication event, may explain the fact that S. cerevisiae has 
four MADS-Box transcriptions factor while C. albicans only two, which suggests that some cellular 
functions in C. albicans may remain in a transcription factor while in S. cerevisiae may be performed 
by the duplicated copy. 
 
RLM1-responsive genes 
In this study, we analyzed gene expression of C. albicans rlm1Δ/rlm1Δ mutant in cells growing in YPD, 
rather than under any cell wall stress condition such as in previous works (Bruno et al., 2006). 
Analysis of genes with expression ratio mutant/wild-type showed a significant (corrected P-value < 
0.05) up-regulation of genes involved in cell adhesion related to biofilm formation (P=0.019) and 
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polyamine transport (P=0.037). Additionally, the genes that revealed the highest up-regulation were 
ALS1, ALS3, HWP1, RBT1 and ECE1, which are involved in the cell wall organization. Another 
important observation was that genes involved in the metabolism of carbohydrates such as DAK2, 
GLK4, GPD1, NTH1 and TPS1 were down-regulated. The products of these genes are involved in the 
several pathways that control the utilization of glucose, thus we believe that the metabolism of C. 
albicans cells without a functional RLM1 could be rearranged so that glucose is deviated from 
utilization as energy source to utilization as building blocks for cell wall. In fact, the microarray analysis 
identified AGP2, OPT6 and SAP6 as up-regulated genes, which together contribute to the intake of 
oligopeptides and amino acids, suggesting the utilization of alternative carbon/energy sources. 
Curiously, GAL4 was identified has an up-regulated gene in this study, which indicates that regulation 
of glycolytic enzymes could be occurring in C. albicans rlm1∆/rlm1∆ mutant. Additionally, it has been 
reported that fungal species lacking GCR1/2 homologs, such as C. albicans, have an enrichment of 
the Gal4 motif in the promoter regions of glycolytic genes (Askew et al., 2009). 
 
These observations showed that C. albicans mutant appears to rearrange the metabolic pathways so 
that glucose is deviated from utilization as energy source, being more available for use as cell wall 
building blocks, as well as increase cell wall protein involved in adhesion. As a consequence the 
association between β-glucan, mannoproteins, and chitin would certainly change. Additionally, we 
identified several genes involved in stress response, particularly genes involved in the adaptation to 
osmotic stress and that are regulated by Hog1 such as GCV2, ECE1, CIT1, ENA21 and predominantly 
HGT10, which codes for a glycerol permease with an up-regulation of more than ten fold. 
 
As discussed above, we concluded that RLM1 is important for the cell wall biogenesis. Furthermore, a 
novel role for RLM1 that was not described for S. cerevisiae was also detected. We observed that the 
absence of RLM1 significantly activated genes involved in cell adhesion and biofilm formation. 
Blankenship et al. (2010) had already observed novel functions in C. albicans conserved PKs 
compared to their orthologs in S. cerevisiae and Schizosaccharomyces pombe when studying cell wall 
remodeling, which included functions related to filamentation and biofilm formation. Despite the fact 
that our results do not point to a direct involvement of RLM1 in C. albicans filamentation an increase in 
proteins involved in adhesion and biofilm formation was clearly observed. Nobile et al. (2009) 
described Zap1/Csr1 as a negative regulator of biofilm formation and in a previous study Nobile and 
Mitchell (2006) identified Bcr1 as a transcription factor that governs biofilm formation in an in vitro 
catheter model. In this study, Rlm1 behaved as a negative regulator of biofilm in an in vitro polysteryne 
biofilm model, and the rlm1∆ mutant strain presented overexpression of ALS1, ALS3, HWP1, RBT1 
and ECE1, which includes the same Bcr1 targets (ALS1, ECE1, and HWP1), suggesting that BCR1 
activates genes directly involved in biofilm formation while RLM1 regulates negatively the same set of 
genes. Overall, with this study we were able to demonstrate the role of C. albicans RLM1 in cell wall 
remodeling and to show that, besides this important role, RLM1 presents extended functions in 
negatively regulating biofilm formation. 
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Abstract 
Candida albicans, as an opportunistic pathogen, is able to adapt its growth to a range of 
environmental changes, by modulation of expression of many genes in a coordinated manner. Many 
of the mitogen-activated protein (MAP) kinase pathway components are important for virulence and 
morphological transitions. For this reason the knowledge of the role of the transcriptional factors under 
the control of the MAP kinase pathways should help us to better understand the interaction between 
C. albicans and the host. The transcription factor Rlm1 has been shown to be involved in cell wall 
biogenesis. In this study the involvement of Rlm1 in the virulence of the human fungal pathogen 
Candida albicans was evaluated in a murine model of hematogenously disseminated candidiasis. The 
mutant rlm1∆/rlm1∆ strain was found to be less virulent than the wild-type (WT) and complemented 
strains, as displayed by the different survival time of mice, the lower kidney fungal burdens, and the 
histological observations. Additionally, in the murine macrophage-like cell line J744A, the TNF-α was 
lower in response to rlm1∆/rlm1∆ mutant and the cellular toxicity (LDH) caused by this mutant was 
significantly lower in comparison with the WT and complemented strains. On the other hand, qRT-
PCR determination showed that the expression of the cell wall related genes, CRH11 and PHR2, was 
clearly higher in rlm1∆/rlm1∆ mutant in relation to WT strain, in mRNA of kidney samples after 7 days 
post-infection. Since these proteins are part important of the cell wall and in vivo the yeast cells are 
under constant cell wall damage by the immune system it is not a surprease that the mutant present a 
higher expression of these genes, which may compensate the weakened cell wall. In relation to 
participation of the Rlm1 in the expression, we observed an increase of transcription of MKC1 in WT 
and rlm1∆/rlm1∆ mutant strains, suggesting that Rlm1 does not regulate this gene. Overall, these 
results showed that the transcription factor Rlm1 that is involved in the stability of the cell wall is 
important in the interaction with the host, being essential for the virulence of C. albicans and 
invasiveness of the kidneys during hematogenously disseminated candidiasis. 
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INTRODUCTION 
The ubiquitous Candida albicans is an opportunistic commensal, which exists as part of the normal 
flora of the mucocutanous, genitourinary, and gastrointestinal area in healthy humans, without causing 
disease (Calderone, 2002). The fungus colonizes the mucosal membranes of 30–60% of humans 
(Odds, 1988); however, when the normal host defense mechanisms are impaired (for example, in 
patients who are undergoing chemotherapy for malignancies, receiving immunosuppressants after an 
organ transplant, or patients with AIDS), C. albicans is capable of causing a range of infections, from 
superficial thrush to life-theatening systemic candidiasis, making it the most prevalent human fungal 
pathogen (Larriba et al., 2000).  
 
Host defense against systemic candidiasis relies mainly on the ingestion and elimination of C. albicans 
by cells of the innate immune system, in particular macrophages, monocytes and neutrophils (Romani, 
2000; Richardson and Rautemaa, 2009). Activation of leukocytes by C. albicans, triggers the release 
of pro-inflammatory cytokines (Th1 and Th17 responses), such as IFN-γ, TNF-α, IL-1β, IL-6, and IL-17 
that in turn activate phagocyte effector functions that promote the elimination of the invading yeast 
(Djeu, 1990; Netea et al., 1999; Huang et al., 2004). In contrast, anti-inflammatory cytokines (Th2 
response) such as IL-4 and IL-10 have immunosuppressive effects. Thus, the balance between pro- 
and anti-inflammatory cytokines is decisive in determining whether the host defense system is 
surpassed or able to eliminate the fungal pathogens (Cenci et al., 1995; Netea et al., 2006; Rozell et 
al., 2006). Although the status of the host immune system is the major factor balancing the transition 
from commensalism to pathogenicity (Pirofski and Casadevall, 2009), C. albicans expresses several 
virulence attributes that contribute for its successful behavior, both as a commensal colonizer and as a 
pathogen (Biswas et al., 2007). One of its major virulence traits is the ability to reversibly switch from 
unicellular budding cells to filamentous forms and the yeast uses this attribute during an infection that, 
not only provides invasion of tissues, but also allows escape from intracellular phagocyte death by 
inducing hyphal growth inside the phagosome, resulting in the destruction of the macrophage (Braun 
and Johnson, 1997; Kobayashi and Cutler, 1998; Calderone et al., 2000; Mansour and Levitz, 2002; 
Lorenz et al., 2004; Whiteway and Oberholzer, 2004). During these interactions C. albicans 
establishes contact with host cells through its cell wall, which is the outermost fungal structure. The 
cell wall of C. albicans is an essential structure that maintains cell morphology, providing protection 
from external pressure, aiding in colonization, host pathogenesis, as well as in immune-recognition 
and immune-avoidance (Klis et al., 2002; Netea et al., 2008). As the most external cellular structure of 
pathogenic microorganisms, it also carries important antigenic determinants and mediates adhesion to 
the host tissues, being therefore crucial in triggering and orchestrating the whole innate and adaptive 
immune response against the microorganism (Calderone and Fonzi, 2001). The cell wall is a 
multilayered structure composed by β-glucans (β1,3- and β1,6-glucan), chitin and mannoproteins (also 
called cell wall proteins - CWPs). Chitin and β-glucans provide the strength and rigidity to the cell wall, 
which ultimately determine the morphology of the cell, therefore their synthesis play a fundamental 
role in maintaining fungal cell integrity during growth, morphogenesis and in stress adaptation (Shaw 
et al., 1991; Munro and Gow, 2001; Klis et al., 2002; Roncero, 2002; Arana et al., 2009). 
Decreased virulence of Candida albicans CaRLM1 mutant in a murine model of hematogenously disseminated candidiasis 
81 
In C. albicans, four different MAP kinase pathways have been identified by genetic analysis, and 
phenotypic characterization of mutants (Monge et al., 2006). The cell wall integrity pathway is 
mediated by the Mkc1 (the homologue of the Saccharomyces cerevisiae Pkc1-Slt2/Mpk1), in a 
manner dependent on the presence of PKC1 and it seems to be important for virulence since the 
disruption mutant in MKC1, is less virulent than the wild-type (Diez-Orejas et al., 1997). Targets of 
Mkc1 have not yet been identified in C. albicans; however the presence of sequence homologues of 
the S. cerevisiae genes encoding Mkc1 transcription factors targets, SWI4, SWI6 and RLM1, in C. 
albicans genome suggests that these could act as final effectors of the pathogenic yeast signalling 
cascade. The RLM1 codes for a transcription factor from the MADS (Mcm1p-Agamous-Deficiens-
Serum Response Factor) box family that, in S. cerevisiae, is known to regulate the expression of 
genes involved in the cell wall integrity pathway (Schwarz-Sommer et al., 1990; Watanabe et al., 
1995; Dodou and Treisman, 1997; Jung and Levin, 1999; Garcia et al., 2004; Levin, 2005). 
 
In a previous work, both copies of the RLM1 gene of C. albicans were deleted using the SAT1-flipping 
strategy and phenotypic analysis of the resulting rlm1∆/rlm1∆ mutant was performed (this study, 
Chapter 3). Results showed that C. albicans RLM1 is important in cell wall remodeling, as well as in 
regulating biofilm formation (this study, Chapter 3). The present study was undertaken to address the 
importance of the RLM1 gene in C. albicans virulence, using the murine model of hematogenously 
disseminated infection. 
 
MATERIALS AND METHODS 
Mice. 
Female BALB/c mice, 8 weeks old, were purchased from Charles River (Barcelona, Spain) and kept 
under specific-pathogen-free conditions at the Animal Facility of the Instituto de Ciências Biomédicas 
Abel Salazar, Porto, Portugal. All procedures involving mice were performed according to the 
European Convention for the Protection of Vertebrate Animals Used for Experimental and Other 
Scientific Purposes (ETS 123), the 86/609/EEC directive, and Portuguese rules (DL 129/92). 
 
Candida albicans culture conditions 
The C. albicans strains used in this study are listed in Table 4.1. All strains were maintained as frozen 
stocks in 30% glycerol at -80°C. Yeast growth was tested in synthetic glucose minimal (2% w/v 
glucose, 0.67% w/v Bacto yeast nitrogen base without amino acids) and complex yeast-peptone-
dextrose (YPD, 2% w/v glucose, 1% w/v yeast extract, 2% w/v Bacto peptone) liquid media at 30°C 
and 37°C in a shaking incubator for 24 h. Growth was measured at 60-min intervals, and the 
generation time calculated for all strains. 
Table 4.1. Candida albicans strains used in this study. 
 
Strain Genotype Reference 
SC5314 Prototrophic wild-type strain Gillum et al. (1984) 
SCRLM1M4A rlm1Δ::FRT/rlm1Δ::FRT This study (Chapter 3) 
SCRLM1K2A rlm1Δ::FRT/RLM1-FRT This study (Chapter 3) 
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To test filamentation, C. albicans cells were first grown for 24h on modified Lee medium (0.5% w/v 
(NH4)2SO4, 0.02% w/v MgSO4.7H2O, 0.25% w/v K2HPO4, 0.5% w/v NaCl, 1.25% w/v D-galactose, 
0.05% w/v L-alanine, 0.13% w/v L-leucine, 0.1% w/v L-lysine, 0.01% w/v L-methionine, 0.007% w/v L-
ornithine, 0.05% w/v L-proline, 0.05% w/v L-threonine and 0.0001% w/v biotin, pH 5.0) at 26ºC and 
150rpm in order to maintain cells in the yeast morphology and then filamentation was induced by 
plating approximately 30 colony-forming units (CFU) in Spider medium (1% w/v nutrient broth, 1% w/v 
mannitol, 0.2% w/v K2HPO4, 1.35% w/v Bacto Agar, pH 7.2) or YPD medium supplemented with 10% 
(v/v) fetal bovine serum (FBS). Plates were incubated at 37ºC for 72h and photographed. 
 
To prepare the inocula for mice infection C. albicans strains were grown in a shaking incubator for 14h 
at 30°C in Winge medium (0.2% w/v glucose, 0.3% w/v yeast extract), then yeast cells were 
harvested, washed twice with sterile, nonpyrogenic phosphate buffered saline (PBS), counted in a 
hemocytometer, and resuspended at 2.5x10
6
 cells/ml. Inocula were confirmed by CFU counts on YPD 
agar after 48h at 37°C. 
 
Candida albicans hematogenously disseminated infections 
Mice (n=8/group) were injected intravenously (i.v.) in the lateral tail vein with 5x10
5
 C. albicans yeast 
cells in 0.2 ml PBS. To evaluate the progress of hematogenously disseminated candidiasis, mice were 
weighed and monitored twice per day. Moribund mice were humanely terminated, and their deaths 
were recorded as occurring on the following day. To analyze organ fungal burden, histology and gene 
expression by  quantitative (real-time) reverse-transcription PCR (qRT-PCR), groups of mice 
(n=4/group) were infected with the same inocula, 5x10
5
 yeast cells, and sacrificed 2 and 7 days 
postinfection. Control mice were injected i.v. with PBS. After infection, kidneys were aseptically 
removed, weighed, homogenized, and quantitatively cultured on YPD agar at 37ºC. Values were 
expressed as log CFU per gram of tissue. Alternatively, the other kidney, the liver and spleen were 
fixed in 10% phosphate buffered formaldehyde, followed by periodic acid-Schiff (PAS) reagent staining 
and counterstaining of the paraffin-embedded tissues with hematoxylin in order to evaluate both fungal 
morphology and composition and distribution of inflammatory infiltrates. 
 
Quantitative RT-PCR (qRT-PCR) 
Total RNA was isolated from kidney suspensions, homogenized in PBS, recovered from mice infected 
with C. albicans wild-type SC5314 or mutant SCRLM1M4A (rlm1∆/rlm1∆) strains. The suspensions 
were centrifuged at 1,500 x g at 4ºC for 10 min; pellets were washed twice with ice-cold RNase-free 
water, and frozen in liquid nitrogen. Total RNA was also obtained from C. albicans SC5314 and 
SCRLM1M4A cells incubated overnight in YPD at 30 ºC, and stored at -80 ºC. RNA extraction was 
performed using the hot acidic phenol method (Ausubel, 1993). 
 
Quantitative RT-PCR assays and data normalisations were performed according to Correia et al. 
(2010). Briefly, total RNA from kidneys after infection and YPD stationary phase, was incubated with 
DNase I, for 15 min at room temperature to eliminate genomic DNA contamination. DNase I was 
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inactivated according to the manufacturer’s instructions. The Superscript III Platinum two-step qRT-
PCR kit with SYBR green (Invitrogen) was used to generate first-strand cDNA from each DNase I-
treated RNA sample, as follows: 10 min at 65°C, 60 min at 37ºC, and 10 min at 65ºC. Quantitative 
PCR (qPCR) was performed with Platinum SYBR green qPCR SuperMix-UDG (Invitrogen). Three 
microliters of each cDNA sample were added to a 25 µl PCR mixture containing 12.5 µl Platinum 
SYBR green qPCR SuperMix-UDG, 0.5 µl of 10 µM specific forward and reverse primers (Table 4.2), 
and 8.5 µl RNase-free water. Each reaction was performed in a Corbett Rotor-Gene 6000 instrument 
(Qiagen). Thermocycling conditions for CRH11, PGA52, PHR2, RCT1, MKC1 and ACT1 quantification 
were 2 min at 50ºC (UDG incubation) and 5 min at 95ºC, followed by 40 cycles of 95ºC for 15 s, 60ºC 
for 30 s, and 72ºC for 30 s. The specificity of each primer pair was verified by the presence of a single 
melting temperature peak. The calibration and efficiency of all primers were assessed in titration 
experiments using C. albicans SC5314 genomic DNA (500ng to 5pg) in serial dilutions. A negative 
control (water) and a four-point curve of SC5314 genomic DNA were included in each run. CRH11, 
PGA52, PHR2, RCT1 and MKC1 gene expression was normalized to the housekeeping gene ACT1 
and analyzed using the standard curve method. Data are presented as ratio of normalized mRNA 
levels of rlm1∆/rlm1∆ mutant / wild-type. Each experimental condition was performed in duplicate. 
 
         Table 4.2. Primers used in this study. 
 
 
Gene 
Primer (5´-3´) Amplicon 
length (bp)               Forward                 Reverse 
CRH11 TCTGCATCTGTTTCCACTGC ACAAAGCCAAAAAGGGAGGT 209 
PGA52 AGAAGCGACATTCCTGCCTA CAGATCTCCAGCACGAACAA 196 
PHR2 AATGCTAACGGAACCACAGG CGGTTCTGACGGTACCAGAT 232 
RCT1 TGGTGTTGCTGGTGGTTATG CCACCATATTGTTGCTCGTG 165 
MKC1 ATGGGTCCAAAAAGGTTCC TTATGGCCCCTGAAGAACTG 163 
ACT1 TGCTGAACGTATGCAAAAGG TGAACAATGGATGGACCAGA 186 
 
Determination of lactate dehydrogenase activity and cytokine measurement 
The murine macrophage-like cell line J774A (American Type Culture Center number TIB 67), was 
routinely cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% v/v heat-
inactivated fetal calf serum (FBS), 1% w/v glutamine, 1% w/v sodium pyruvate, and 1% w/v HEPES in 
5% v/v CO2 at 37ºC in cell-culture flasks. After confluent growth, macrophage cells were washed and 
recovered. Viable cells were determined by Trypan blue (Sigma-Aldrich) exclusion, counted in the 
hemocytometer, and resuspended in DMEM to a final concentration of 5x10
5 
cell/ml. Candida albicans 
SC5314, SCRLM1M4A and SCRLM1K2A cells were cultivated in Winge medium, and resuspended at 
1.25x10
6
 cell/ml. 
 
The release of lactate dehydrogenase (LDH) from cells into the surrounding medium was monitored 
as a measure of J774A macrophage cell membrane damage. The amount of LDH released in the 
medium from macrophages cultures (negative control) and from macrophages co-incubated with C. 
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albicans suspension previously preparared (1.25x10
6
 cell/ml) was measured after 12h of co-incubation 
using the Cytotoxicity Detection KitPLUS (LDH) (Roche Diagnostics Corporation, Indianapolis, USA), 
according to the manufacturer’s instructions. This colorimetric assay is based on indirect reduction of 
tetrazolium salt when LDH is present in the cell culture supernatant. The percentage of cytotoxicity 
caused by the different Candida strains was calculated using the following formula: % cytotoxicity = 
[(experimental value – low control) / (High control– low control] x 100. 
 
Production of TNF-α by macrophages co-incubated with C. albicans SC5314, SCRLM1M4A and 
SCRLM1K2A strains and bacterial lipopolysacharide, LPS, (5ng/µl, positive control) was quantified 
with the ELISA ReadySETGo Kit (eBioscience, San Diego, CA, USA), according to the manufacturer’s 
instructions. The macrophage incubation medium used for TNF-α quantification was the same used in 
the LDH analysis. Determinations of LDH and TNF-α were carried out in triplicate, and the results are 
expressed as the mean of these results. 
 
Secreted aspartic proteinase and phospholipases 
The secretion of aspartic proteinases (SAPs) and phospholipases (PLs) by C. albicans strains was 
determined as previously described (Al-Abeid et al., 2004). Briefly, 10µl of yeast suspension (1.25x10
6
 
cell/ml) were spotted onto YCB-BSA plates (1.17% w/v yeast carbon base, Difco, Sparks, USA; 0.01% 
w/v yeast extract; 2% agar w/v, pH 5.0; containing 0.2% w/v bovine serum albumin) for proteinase 
determination, and onto sabouraud dextrose agar (SDA) plates (6.5% w/v SDA, 5.84% w/v NaCl, 
0.55% w/v CaCl2, 2% w/v agar) supplemented with 8% v/v egg yolk emulsion, for phospholipase 
determination. For SAPs assays, after 5 days of incubation at 37ºC plates were stained with an amido-
black water/alcohol solution (4.0% v/v methanol, 10.0% v/v acetic acid, 0.1% w/v amido black) and 
destained with the same solution without amido-black. The unstained zones around each colony were 
measured and the Pz values calculated using the following formula: Pz = (Colony diameter / Halo 
diameter). Production of PLs was determined as the precipitation zone around each colony and 
mesured after incubation at 37ºC for 72h using the same Pz formula. Pz values close to zero indicate 
maximum production of SAPs and LPs whereas values close to 1 indicate low enzymatic activity. 
Positive results were considered when Pz value was ≤0.5. Each assay was carried out in triplicate, 
and the results are expressed as the mean of these results. 
 
Statistical analysis 
Unless otherwise stated, results shown are from one representative experiment from three 
independent experiments. The statistical significance of results was determined by the unpaired 
Student t test, and survival data were analyzed with the log-rank test by using GraphPad Prism 4 
software (GraphPad Software, Inc., La Jolla, CA). Results were considered statistically significant with 
P values below 0.05. 
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RESULTS 
Influence of Rlm1 on C. albicans virulence in a murine model of hematogenously disseminated 
infection 
To determine whether RLM1 is required for virulence, we investigated the ability of the rlm1∆/rlm1 
mutant strain to establish an infection in the murine model of haematogenously disseminated 
candidiasis. Before performing the virulence studies, we determined the generation time for SC5314, 
SCRLM1M4A and SCRLM1K2A strains in synthetic defined and complex media at 30ºC and 37ºC and 
the ability to form hyphae in serum media as well as to secrete proteinases and phospholipases. No 
yeast growth defects were observed under the conditions tested, all strains presented similar 
generation times (Fig. 4.1A); and the filamentous growth under the hypha-inducing conditions 
analyzed was also similar between strains (Fig. 4.1B). Additionally, no significant differences were 
observed in the Pz values calculated for secreted aspartic proteinase and phospholipase production in 
the three strains (Fig. 4.1C and 4.1D). 
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Figure 4.1. Phenotypic characterization of C. albicans wild-type SC5314 (RLM1/RLM1), mutant SCRLM1M4A 
(rlm1Δ/rlm1Δ) and complemented SCRLM1K2A (rlm1Δ/rlm1Δ+RLM1) strains. A) Growth curve at 37ºC, B) 
morphology on Spider medium (B1) and YPD containing 10% of FBS (B2) after 6 days of incubation at 30ºC. C) 
secretion of proteinase on YCB-BSA containing 0.2% of BSA and D) fosfolipase activity on SDA supplemented 
with 8% egg yolk emulsion, after incubation at 37ºC. 
 
 
BALB/c mice were i.v. injected with 5x10
5
 cells of C. albicans wild-type (SC5314), rlm1∆/rlm1∆ mutant 
(SCRLM1M4A) or complemented (SCRLM1K2A) strains. All mice injected with WT succumbed to 
candidal infection within 24 days (Fig. 4.2). In contrast, at the end of the experimental period (70 
days), 75% of the mice infected with the mutant strain survived the infection. The median survival time 
of SCRLM1M4A-infected mice was undefined whereas, for WT-infected mice, the median survival time 
was 20 days. Significant differences in survival time were observed between mice infected with 
SCRLM1M4A strain and SC5314 (P<0.0001 by log-rank test) (Fig. 4.2). When RLM1 gene was 
reintroduced into SCRLM1M4A strain to form SCRLM1K2A, the virulence of the C. albicans organism 
was partially recovered. Mice infected with SCRLM1K2A had a median survival of 41 days, which was 
much higher than mice infected with WT (P=0.1132) but significantly shorter than that of mice infected 
with SCRLM1M4A (P=0.0463) (Fig. 4.2). These results indicate that the RLM1 gene is important for 
the virulence of C. albicans and that introduction of one copy of RLM1 gene did not restore completly 
the virulence phenotype observed in the WT strain. 
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Figure 4.2. Influence of RLM1 in C. albicans virulence in a murine model of hematogenously disseminated 
candidiasis. Female BALB/c mice were i.v. injected with 5 X 10
5
 cells of C. albicans wild-tipe SC5314, mutants 
SCRLM1M4A (rlm1Δ/rlm1Δ) or complemented SCRLM1K2A (rlm1Δ/rlm1Δ+RLM1) strain. Each strain was 
injected into eight mice per group, per experiment, and survival was monitored twice daily for 70 days. Results are 
representative of two independent experiments. 
 
The evaluation of the fungal ability to invade the kidneys has been frequently used to measure the 
virulence of C. albicans strains (MacCallum and Odds, 2005; Sampaio et al., 2010). In this study all 
strains tested produced a similar level of infection in the kidneys after two days of infection (Fig. 4.3). 
However, after 7 days of infection, the numbers of C. albicans CFU in the Kidneys of mice infected 
with SCRLM1M4A (rlm1∆/rlm1Δ) strain were significantly lower than those of mice infected with the 
SC5314 (RLM1/RLM1) and SCRLM1K2A (rlm1Δ/rlm1Δ+RLM1) strain (P=0.0345 for SC5314 versus 
SCRLM1M4A strain and P=0.0440 SCRLM1K2A versus SCRLM1M4A strain) (Fig. 4.3). 
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Figure 4.3. Kidney fungal burden of BALB/c mice 2 and 7 days after i.v. injection with 5 x10
5
 cells of wild-type 
SC5314 (▲), mutant SC5314M4A (rlm1∆/rlm1∆) (∆) and complemented SC5314K2A (rlm1∆/rlm1∆+RLM1) (●) C. 
albicans strains. Each symbol represents an individual mouse, and horizontal bars are means of CFU numbers 
for each group. 
 
The ability of WT, rlm1Δ/rlm1∆ mutant and complemented strains to infect and injure several organs 
were assessed by histopathological analysis of the kidneys, spleen and liver, 2 and 7 days after 
infection. Intralesional PAS-positive organisms both in yeast and hyphal morphology, septated and 
branched, were detected 2 days after C. albicans i.v. infection with strains SC5314 and SCRLM1K2A 
(Fig. 4.4). Concomitantly, these kidneys showed moderate multifocal renal medullary interstitial 
neutrophilic infiltration. In the kidneys of the mice infected with the rlm1Δ/rlm1∆ mutant strain, 
SCRLM1M4A, the fungi appeared as mixture of ovoid and hyphal cells with a more restricted 
infiltration in comparison with kidneys infection with the other strains. At the later time point tested, 7 
days after infection, analysis of WT-infected and complemented-infected mice showed severe, focally 
extensive to coalescing, renal medullary interstitial neutrophilic infiltration surrounding numerous PAS-
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positive organisms. These organisms were present mainly as septated, branched hyphal structures, 
which escaped the medulla and invaded the pelvis region (Fig. 4.4). In contrast, in kidneys of mice 
infected with the rlm1∆/rlm1∆ mutant strain, a clear reduction of yeast cells was observed and the 
remainding hyphal structures were present mainly at the pelvis region, surrounded by neutrophilic 
infiltration, which is in agreement with CFU results (Fig. 4.4). Invasion of spleen and liver was not 
consistently seen in all strains (data not shown). These differences regarding organ distribution are in 
accordance with the known higher ability of C. albicans to colonize kidneys after mouse systemic 
infection (Tavares et al., 2003; Correia et al., 2010; Sampaio et al., 2010). 
 
 
 
Figura 4.4. Representative photomicrographs of PAS-stained paraffin sections of kidneys recovered from BALB/c 
mice infected with 5x10
5
 cells of wild-type SC5314, mutant SCRLM1M4A (rlm1∆/rlm1∆) and complemented 
SCRLM1K2A (rlm1∆/rlm1∆+RLM1) C. albicans strains at 2 and 7 days post-i.v. injection. Arrows show hyphae 
invading the pelvis region. P - renal pelvis. Magnification of photographs: 100X. Bar: 100 µm for all photos. 
 
Decreased in vitro production of TNF-α and cell damage of macrophages in response to C. 
albicans rlm1∆/rlm1∆ cells 
To determine the effect of the disruption of RLM1 on the immune response elicited by C. albicans, the 
proinflamatory cytokine TNF-α was measured in murine macrophage-like cell line J774A challenged 
for 12h with C. albicans yeast cells from WT, mutant or complemented strain. Results (Fig. 4.5A) 
showed that TNF-α levels produced by macrophages were significantly lower in response to 
rlm1∆/rlm1∆ mutant cells in comparation with WT (P=0.0001). On the other hand, the complemented 
strain, although inducing a higher amount TNF-α than the mutant strain, did not reached the WT 
levels. As expected, a strong proinflammatory response was observed with the positive control (E. Coli 
LPS), whereas no detectable levels of TNF-α were found in non-stimulated macrophages.. 
Furthermore, to quantify the cell damage caused by the WT, rlm1∆/rlm1∆ mutant and complemented 
C. albicans strains, we determined the LDH released from macrophages after 12h of co-incubation. As 
depicted in Fig. 4.5B, the cell damage caused by rlm1∆/rlm1∆ mutant was significantly lower in 
comparison with the WT and complemented strains, which presented similar cell damage as the WT. 
These results indicate that the deletion of RLM1 has a significant impact in the immune response 
elicited by the murine macrophage-like cell line J774A. 
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Figure. 4.5. In vitro production of TNF-α and cellular damage (LDH released) caused by C. albicans wild-type 
SC5314, mutant SCRLM1M4 (rlm1∆/rlm1∆) and complemented (rlm1∆/rlm1∆+RLM1) strains. The murine 
macrophage-like cell line J774A was co-incubated with the indicated C. albicans strains or E. coli LPS. 
Concentration of TNF-α (A) and LDH (B) were mesuared in the culture supernatant after 12h of co-incubation. 
MΦ - macrophages. 
 
 
Quantitative RT-PCR 
In order to evaluate the role of important cell wall related genes, CRH11, PGA52, PHR2, RCT1 and 
MKC1, during the infection process, as well as the participation of the transcription factor Rlm1 in their 
expression, qRT-PCR was performed. These genes were selected from the list of genes in the cell 
wall compensatory cluster identified for S. cerevisiae (Lagorce et al., 2003). In C. albicans Crh11, 
Pga52 and Phr2 are glycosylphosphatidylinositol (GPI)-anchored cell surface proteins (Fonzi, 1999; 
De Groot et al., 2003; Pardini et al., 2006). Rct1 is an outer transmembrane protein produced in 
exponential and stationary growth phase culture (Kusch et al., 2008) and Mkc1 is a protein kinase of 
the cell wall integrity pathway (Navarro-Garcia et al., 1995). 
 
The expression of the genes encoding these proteins in the WT SC5314 and in the mutant 
SCRLM1M4A (rlm1Δ/rlm1∆) strains was evaluated by qRT-PCR in kidney samples after 2 and 7 days 
of infection (in vivo) and in YPD-cultivated cells in the stationary phase of grown (in vitro). Only the 
results for the latter time point analyzed in the kidneys are presented, since after 2 days of infection, 
either the fungal burden was insufficient or the gene expression was too low to obtain reproducible 
results. Results of qRT-PCR are representative of two independent experiments (Table 4.3 and Fig. 
4.6). 
 
Table. 4.3. Expression level of cell wall related genes. 
 
   CRH11 
(pg/µl) 
PGA52 
(pg/µl) 
PHR2 
(pg/µl) 
RCT1 
(pg/µl) 
MKC1 
(pg/µl) 
“in vivo” 
RLM1/RLM1 0.0086 0.0019 0.0083 0.0685 1.8624 
rlm1∆/rlm1∆ 0.0871 0.0010 0.0600 0.0204 2.3703 
“in vitro” 
RLM1/RLM1 0.2210 1.2313 0.2628 1.7166 0.0430 
rlm1∆/rlm1∆ 0.5059 3.7398 0.1878 1.2114 0.0445 
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Figure 4.6. Ratio of expression levels of CRH11, PGA52, PHR2, RCT1 and MKC1 in C. albicans wild-type 
SC5314 and mutant SC5314M4A (rlm1∆/rlm1∆) strains by qRT-PCR from kidney homogenates 7 days after i.v. 
injection with 5x10
5
 cells ( ) (in vivo) and YPD stationary phase cells (■) (in vitro). Results are presented as ratio 
of normalized mRNA levels of rlm1∆/rlm1∆ mutant / wild-type. 
 
 
MKC1, the putative activator of Rlm1, was the gene that presented higher expression in vivo, while in 
vitro the genes with the highest expression were PGA52 and RCT1 (Table 4.3). Considering the 
differences in in vivo gene expression, in the rlm1∆/rlm1∆ mutant in relation to WT, we observed that 
the genes with the highest differences in induction were CRH11 approximately 10x and PHR2 
approximately 7x. On the other hand, in in vitro the mostly altered were CRH11 and PGA52 that 
presented 2x and 3x higher expression, respectively, in the rlm1∆/rlm1∆ mutant in relation to WT. The 
RCT1 gene presented reduced expression in the mutant in both conditions. Regarding MKC1, results 
do not indicate differences in its expression level in the rlm1∆/rlm1∆ mutant cells in relation to the WT, 
in both experimental conditions (Fig. 4.6). 
  
Chapter 4 
90 
DISCUSSION 
Candida albicans, as an opportunistic pathogen, is able to adapt its growth to a range of 
environmental changes, by modulation of expression of many genes in a coordinated manner. Many 
of the mitogen-activated protein (MAP) kinase pathway components are important for virulence and 
morphological transitions (Ernst, 2000; Monge et al., 2006; Biswas et al., 2007). For this reason the 
knowledge of the role of the transcriptional factors under the control of the MAP kinase pathways 
should help us to better understand the interaction between C. albicans and the host. To the best of 
our knowledge, the influence of the RLM1 gene in C. albicans virulence has not been characterized 
yet. Therefore, in this study, the virulence of the rlm1∆/rlm1∆ mutant was examined in vivo and in vitro 
and compared with the WT and the complemented strains. In previous works, phenotypic analysis in 
rlm1∆/rlm1∆ mutants and WT showed that the role of C. albicans RLM1 is important in cell wall 
remodeling, and in regulating biofilm formation (Bruno et al., 2006; this study, Chapter 3). 
 
In this study, an increased median survival time was consistently observed for mice infected with the 
mutant lacking both alleles of the RLM1 gene, when compared with the median survival time observed 
in animals infected with the WT SC5314 and complemented strains. When another parameter 
associated with C. albicans virulence was analyzed, the CFU in the kidneys, differences among the 
different mouse groups were clearly observed at 7 days post-infection, where rlm1∆/rlm1∆ mutant 
presented a lower fungal burden. Curiously, despite the quantification of a reduced number of C. 
albicans rlm1∆/rlm1∆ mutant cells in the kidney by CFUs, it was very difficult to observe them in the 
histopathology analysis. This seems to indicate a reduced ability of the rlm1∆/rlm1∆ mutant to invade 
deeply into the kidneys. In contrast, mice infected with the WT and complemented strains showed 
extensive invasion into kidneys, with mycelial growth extending throughout the tissue. Addicionaly, a 
reduced number of inflammatory cells surrounding the C. albicans rlm1∆/rlm1∆ mutant cells were also 
observed. This paucity of inflammatory cells could be due to the low number of PAS-positive 
organisms invading the kidneys or to a diminished induced host response. 
 
The host response to infection by C. albicans is associated with the release of proinflamatory 
cytokines such as TNF-α (Mencacci et al., 1998). The comparative analysis of the interaction of the 
WT, rlm1∆/rlm1∆ mutant and complemented C. albicans strains with J774 macrophages cell line 
showed that at 12h of co-incubation the levels of TNF-α were much higher in response to WT and 
complemented strains in comparison with rlm1∆/rlm1∆ cells. These observations are in agreement 
with our previous histopathology results of kidney sections; revealing heavy infiltration of leucocytes 
around C. albicans cells, in mice infected with WT or complemented strains and few inflammatory cells 
around the rlm1∆/rlm1∆ mutant cells. Thus, we belive that the difficulty in observing C. albicans 
rlm1∆/rlm1∆ mutant cells in the histopathology of kidney and the lower kidney fungal burden may be 
mainly due to the lower ability of C. albicans mutant cells to resist host deffense mechanisms. These 
observations are in concordance with previous reports, indicating that pro-inflammatory cytokines are 
important for antifungal effector functions, particularly during the early phase of the inflammatory 
response (Huang et al., 2004; Romani, 2004; MacCallum and Odds, 2005). This may be the reason 
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why at 2 days post infection dispite the lower resitence to host defense mechanisms no significant 
differences in the kidney fungal burden were observed. Furthermore, a significant lower cellular 
toxicity (measured as extracellular LDH) was caused by the rlm1∆/rlm1∆ mutant cells in comparison 
with the wild-type and complemented strains. These results correlate well with the histopathological 
observations, in which cellular kidney tissue destruction is observed in mice infected with WT or 
complemented strains. 
 
We observed that some phenotypes were not totally complemented with the introduction of only one 
copy of the RLM1 gene. It was clearly observed that the complemented strain had a survival curve in 
between the WT and mutant strain (41 days), and the induction of TNF-α was significantly lower than 
the observed with WT. This intermediate behaviour was also observed in other studies with C. 
albicans mutants such as rad52 (Chauhan et al., 2005) where gene dosage is important for the WT 
phenotype. 
 
Since RLM1 is involved in the cell wall maintenance, several genes that were considered important for 
the cell wall formation and integrity, such as CRH11, PGA52, PHR2, RCT1 and MKC1, were 
evaluated by qRT-PCR in kidney samples after 7 days post-infection (in vivo) and in YPD stationary 
phase growth cells (in vitro). Our results indicated that in vivo gene expression of CRH11 and PHR2 
was cleary higher in rlm1∆/rlm1∆ mutant in relation to WT, while in vitro the higher expression in 
rlm1∆/rlm1∆ mutant in relation to WT were CHR11 and PGA52. Since these proteins are part 
important of the cell wall and in vivo the yeast cells are under constant cell wall damage by the 
immune system it is not a surprease that the mutant present a higher expression of these genes, 
which may compensate the weakened cell wall (Fonzi, 1999; Pardini et al., 2006). The higher 
expression of these genes in the mutant strins suggest that either Rlm1 acts as a negative regulator of 
these genes, or other transcription factors may be involved in the expression of these genes, so that 
the absence of the Rlm1 is compensated. It is known that in S. cerevisiae, the heterodimer complex 
Swi4/Swi6 transcription factors have been described to also participate in the remodelling and 
maintenance of cell wall (Igual et al., 1996; Kim et al., 2008). Furthermore, C. albicans presents SWI4 
and SWI6 orthologues (Nikolaou et al., 2009), for this we could suggest a similar role for these 
orthologues in the activation of genes encoding cell wall proteins. 
 
The reduced expression of RCT1 in rlm1∆/rlm1∆ mutant in relation to WT in both conditions, in vivo 
and in vitro, suggests that Rlm1 could be involved in the expression of this gene. It has been reported 
that Rct1 is present in exponential and stationary growth phase culture, which is in agreement with our 
in vitro results (Kusch et al., 2008). The induction observed in the PGA52 gene in vitro, in cells grown 
on YPD, is in accordance with the YPD microarrays assays that also showed an increase expression 
in the mutant cells (this study Table 3.4), however in in vivo experiments this gene presented reduced 
expression in the rlm1∆/rlm1∆ mutant. The reason for this diferent behaviour, in vivo and in vivo, could 
not be ascertained. 
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Studies with S. cerevisiae using LexA as a reporter gene showed that the ability of Rlm1 protein to 
regulate transcription is dependent on the activation of the Pkc1-Slt2/Mpk1 pathway (Watanabe et al., 
1997). In C. albicans MKC1, the SLT2 homolog, encodes a protein kinase of the cell wall integrity 
pathway (Navarro-Garcia et al., 1995) that is important for virulence, since the mkc1∆/mkc1∆ mutant is 
less virulent than the wild-type (Diez-Orejas et al., 1997). The much higher expression of MKC1 in vivo 
(1,862 pg/µl in the WT) when compared with in vitro experiments (0,043 pg/µl in the WT), agrees with 
the previous studies that showed its importance in the maintenance of the cell wall under constant 
damage by the immune system. However, since MKC1 expression is similar in WT and rlm1∆/rlm1∆ 
mutant strains in both conditions, in vivo and in vitro, we conclude that Rlm1 does not regulate MKC1. 
Overall, these results showed that the transcription factor Rlm1 is involved in the stability of the cell 
wall in the interaction with the host, being important for the virulence of C. albicans and invasion of the 
kidneys during hematogenously disseminated candidiasis. 
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Concluding remarks 
Candida albicans is mainly an opportunistic pathogen, whose incidence is increasing in 
immunocompromised patients. The cell wall, as the most external cellular component, plays a crucial 
role in the interaction with host cells mediating processes that are essential during infection, hence the 
importance of carrying out studies about cell wall molecules that participate in the virulence of this 
yeast. Cell wall has been characterized in the model organism S. cerevisiae, with which C. albicans 
shares many orthologous proteins, including Rlm1. 
 
Rlm1 belongs to the type II MADS-box proteins family characterized by a genetically variable C-
terminus due to the presence of a repetitive region of different sizes. Our results in Chapter 2 indicate 
that variability is due to a trinucleotide microsatellite encoding for glutamine, in which 35 alleles were 
indentified with repetitive units from 11 to 49. Another important point of this work is that strains with 
higher repetitions displayed more tolerance to cell wall stress agents. This characteristic may account 
for the different susceptibility pattern observed among strains. This diference could be explained if the 
interaction of accessory factors with Rml1 is somehow related with the C-terminus length, hence it is 
likely that polymorphisms in the microsatellite constrain the transcriptional activity. 
 
In view of these results, in Chapter 3 it was proposed to evaluate the funcionality of the RLM1 gene by 
using an approach based on mutant construction by the SAT1-flipping strategy. Candida albicans 
rlm1∆/rlm1∆ mutant, the complemented and WT strains were exposed to several cell wall stress 
agents and compared with S.cerevisiae rlm1∆ mutant and WT strains. Candida albicans rlm1Δ/rlm1Δ 
mutant displayed phenotypes associated to cell wall deficiency such as hypersensitivity to CR, CFW 
and CFG. Caspofungin phenotype was reverted in the presence of 1M of sorbitol. These results and 
the homology with MADS-box transcription factors suggest an involvement in a regulatory role of cell 
wall remodeling. This regulatory role is further evidenced by the nuclear localization of Rlm1-GFP 
fusion protein observed in this study. We have also observed cytoplasmic granular fluorescence, 
suggesting that Rlm1 might be present in the cytoplasm as well. A possible recruitment of Rlm1 to the 
nucleus upon activation requires further confirmation. The S. cerevisiae rlm1∆ mutant displayed 
several phenotypic differences: insensitivity to CR and CFG, more resistance to CFW, and more 
sensitivity to SDS. These results indicate that the regulatory role of C. albicans RLM1 presents 
differences when compared with S. cerevisiae RLM1. In accordance with a regulatory role, gene 
expression in the mutant lacking RLM1 significantly activated genes involved in cell adhesion like 
ECE1, ALS1, ALS3, HWP1 and RBT1, and decreased transcription of genes involved in the 
catabolism of carbohydrates, DAK2, GLK4, NHT1 and TPS1. The increased transcription of genes 
involved in cell adhesion was confirmed by adhesion and biofilm assays, suggesting that Rlm1 acts as 
a negative biofilm regulator. 
 
In Chapter 4, we present results of in vivo and in vitro assays with mutant and wild-type strains of C. 
albicans to investigate the importance of the RLM1 gene in virulence. Mice infected with the mutant 
strain presented a higher survival time than mice infected with the WT strain, these latter presenting 
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higher fungal burden and invasive micelial growth through tissues in hystopathological analysis of 
kidneys. In addition, decreased production of TNF-α, and lower cellular toxicity was observed in the 
absence of a functional Rlm1, suggesting that RLM1 has a significant impact on C. albicans virulence. 
Finally, qRT-PCR analysis showed that the expression of the cell wall related genes, CRH11 and 
PHR2, was clearly higher in the rlm1∆/rlm1∆ mutant in relation to the WT strain, in mRNA of kidney 
samples after 7 days post-infection. Since these proteins are part of the cell wall and in vivo the yeast 
cells are under constant cell wall stress by the immune system it is conceivable that the mutant 
presents a higher expression of these genes, which may compensate the weakened cell wall. Overall, 
these results showed that the transcription factor Rlm1 is involved in the stability of the cell wall in the 
interaction with the host, being important for the virulence of C. albicans and invasion of the kidneys 
during hematogenously disseminated candidiasis. 
 
Future perspectives 
The studies performed in this work allowed to achieve the main objectives proposed for this thesis. In 
spite of the advances obtained in this work, regarding molecular and functional characterization RLM1 
gene, new questions have emerged that should be covered in the future. 
 
Our studies regarding RLM1 CAI microsatellites have demonstrated that this gene presents more than 
35 alleles identified and classified into three different groups (I, II and III). We have shown that an 
increased number of repetitive units in the C. albicans RLM1 correlate with resistance to stress 
agents. In addition, we showed that the C. albicans RLM1 is involved in cell wall remodeling and is 
importance for the virulence. As the strain used (SC5314), presents both alleles belonging to group III, 
the construction of derived strain with RLM1 alleles from groups I and II would complement the studies 
of the influence of alleles on resistance against cell wall stressing agents, virulence and on the 
interaction with the host immune system. 
 
Previous studies with S. cerevisiae using LexA as a reporter gene showed that the ability of the Rlm1 
protein to regulate transcription is dependent on the activation of the Pkc1-Slt2/Mpk1 pathway 
(Watanabe et al., 1997; Jung et al., 2002). As C. albicans possesses homologous of all kinases of this 
signaling pathway it would be important to investigate whether a similar interaction between Rlm1 and 
Mkc1 (the C. albicans Slt2/Mpk1 orthologue). The same strategy could be used with a strain bearing a 
construct to direct the expression of a hybrid protein in which the MADS box of CaRLM1 is replaced 
with the DNA binding region of the bacterial LexA repressor (LexARlm1ΔN). The ability of the LexA-
Rlm1ΔN protein to activate transcription would be monitored by using a lacZ reporter gene containing 
lexA DNA binding sites in its promoter. To show that Rlm1 is dependent on the CWI pathway, cells 
with or without cell wall stress conditions can be assayed, the activity of β-galactosidase being a 
measure of Rlm1 as transcription factor. Alternatively, interaction between Rlm1 and Mkc1 can be 
investigated by Western analysis with phosphorylated Rlm1-specific antibodies to show the 
phosphorylation state in cells under cell wall stress, using a wild type strain and a mkc1∆/mkc1∆ 
mutant strain. 
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In agreement with a transcription factor function, we found evidence indicating nuclear localization of 
the Rlm1-GFP fusion protein. We have also observed cytoplasmic granular fluorescence, suggesting 
that Rlm1 might be present in the cytoplasm as well. It would be interesting to explore a possible 
recruitment of Rlm1 to the nucleus upon activation by cell wall stress agents such as calcofluor white 
and casporfungin. This investigation can be performed by immunofluorescence in stressed and non-
stressed cells and by Western blot with GFP-specific antibodies with the cytoplasmic and nuclear 
fractions of similar samples. 
 
Since that the microarray analysis showed that the absence of a functional C. albicans RLM1 
significantly decreased the transcription of genes involved in the catabolism of carbohydrates and 
increased genes involved in biofilm formation, it would be interesting to confirm these interactions with 
a different approach on selected genes. An approach based on the LexA-β-galactosidase reporter 
system can also be used; however Northern blot analysis or real time RT-PCR can contribute to 
reliable and fast results. 
 
Since that the thermal shock phenotypes (Fig. 3.6B), survival time of infected mice (Fig. 4.2) and TNF-
α levels production (Fig. 4.5A) were not totally complemented with the introduction of only one copy of 
the RLM1 gene, the double complemented strain is under construction for further analysis to confirm 
the important of gene dosage for the reversion to the WT phenotype. As mentioned above, 
complemented strains can be constructed with different RLM1 alleles, so that a collection of strains 
can be created with all combinations of alleles for studies of stress resistance and interaction with the 
host. In this way the importance of Rlm1 as a virulence factor can be further demonstrated which will 
open the perspective to new strategies of antifungal therapies targeting kinases of the CWI pathway 
and, in particular, the transcription factor Rlm1. 
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Appendix 1. Rlm1 up-regulated and down-regulated genes, with ratios above 2.0. 
 
Gene 
name 
Description 
YPD-Fold 
regulation 
ECE1 
Protein of unknown function; hyphal-specific expression increases with extent of 
elongation of the cell; regulated by Rfg1, Nrg1, Tup1, Cph1, Efg1, Hog1, farnesol, 
phagocytosis; may contribute to biofilm formation 
68,9 
HWP1 
Hyphal cell wall protein; covalently crosslinked to epithelial cells by host transglutaminase; 
opaque- and a-specific, alpha-factor induced; at MTLa side of conjugation tube; 
assessment of virulence role complicated by URA3 effects 
37,4 
-- Predicted ORF in Assemblies 19, 20 and 21 24,3 
-- Predicted ORF in Assemblies 19, 20 and 21; Plc1-regulated 17,0 
ALS3 
Adhesin; ALS family; role in epithelial adhesion, endothelial invasiveness; allelic variation 
in adhesiveness; immunoprotective in mice; promotes biofilm formation via binding to the 
SspB adhesin of S. gordonii 
14,1 
HGT10 
Glycerol permease involved in glycerol uptake; member of the major facilitator superfamily; 
induced by osmotic stress, at low glucose in rich media, during cell wall regeneration; 12 
membrane spans 
13,0 
-- 
Predicted ORF in retrotransposon Tca8 with similarity to the Gag region encoding 
nucleocapsid-like protein; transcription is downregulated in response to ciclopirox olamine; 
filament induced; regulated by Rfg1, Tup1; overlaps orf19.6078.1 
12,4 
RBT1 
Cell wall protein with similarity to Hwp1, required for virulence; predicted to be cell-wall 
attached and glycosylated; Tup1 repressed; serum, hyphal and alkaline induced; farnesol, 
alpha factor induced; Rfg1-, Rim101-regulated 
10,4 
PGA25 Putative GPI-anchored protein of unknown function; fluconazole-downregulated 8,0 
POL93 
Predicted ORF in retrotransposon Tca8 with similarity to the Pol region of retrotransposons 
encoding reverse transcriptase, protease and integrase; downregulated in response to 
ciclopirox olamine; induced upon biofilm formation 
7,7 
SOU1 
Enzyme involved in utilization of L-sorbose; has sorbitol dehydrogenase, fructose 
reductase, and sorbose reductase activities; has NAD-binding site motif; transcriptional 
regulation affected by chromosome 5 copy number 
6,3 
ALS1 
Adhesin; ALS family of cell-surface glycoproteins; adhesion, virulence roles; 
immunoprotective; in band at hyphal base; amyloid domain; biofilm-induced; Rfg1, Ssk1, 
growth-regulated; strain background affects expression 
6,1 
WH11 
Cytoplasmic protein expressed specifically in white phase yeast-form cells; expression in 
opaque cells increases virulence and frequency of opaque-to-white switching; null mutant 
shows wild-type switching; similar to S. cerevisiae Hsp12 
5,4 
-- Predicted ORF in Assemblies 19, 20 and 21 5,1 
CTN1 
Predicted carnitine acetyl transferase; required for growth on nonfermentable carbon 
sources but not for hyphal growth or virulence in mouse systemic model; transcription 
induced in macrophage; macrophage/pseudohyphal-repressed after 16h 
4,9 
-- Predicted ORF in Assemblies 19, 20 and 21; induced by Rgt1 4,6 
-- 
Predicted ORF in Assemblies 19, 20 and 21; induced in core caspofungin response; 
increased expression observed in ssr1 homozygous null mutant; induced by nitric oxide in 
yhb1 mutant; protein detected by mass spec in stationary phase culture 
3,8 
CIT1 
Protein described as citrate synthase; soluble protein in hyphae; biofilm induced; 
expression greater in high iron; upregulated upon phagocytosis; Hog1-downregulated; 
regulated by Efg1 under yeast-form but not hyphal growth conditions 
3,8 
GCV2 
Putative protein of glycine catabolism; downregulated by Efg1; Hog1-induced; upregulated 
by Rim101 at acid pH; transcription is activated in the presence of elevated CO2; protein 
detected by mass spec in stationary phase cultures 
3,7 
-- Predicted ORF in Assemblies 19, 20 and 21 3,5 
AGP2 
Protein described as an amino acid permease; hyphal downregulated; regulated upon 
white-opaque switching; induced in core caspofungin response, during cell wall 
regeneration, or by flucytosine; fungal-specific (no human or murine homolog) 
3,3 
-- 
Predicted membrane transporter, member of the vesicular neurotransmitter (VNT) family, 
major facilitator superfamily (MFS); downregulated in core caspofungin response 
3,3 
PES1 
Pescadillo homolog required for filament-to-yeast switching; mutation confers 
hypersensitivity to 5-fluorocytosine (5-FC), 5-fluorouracil (5-FU), and tubercidin (7-
deazaadenosine) 
3,2 
-- 
Predicted ORF in Assemblies 19, 20 and 21 
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SAP6 
Secreted aspartyl proteinase; expressed during hyphal growth, oral carriage, infection; 
sap4 sap5 sap6 triple mutant is defective in protein utilization as N source; assessment of 
virulence role complicated by URA3 effects 
3,2 
FRE7 
Protein similar to ferric reductase Fre10; transcription is downregulated in response to 
treatment with ciclopirox olamine or 17-beta-estradiol; transcriptionally induced by alkaline 
conditions or interaction with macrophage 
3,2 
FET3 
Multicopper oxidase; required for growth under low-iron conditions; null mutant shows 
decreased prostaglandin E2 production; functional homolog of S. cerevisiae Fet3; 
ketoconazole, caspofungin, amphotericin B repressed 
3,1 
-- 
Putative guanyl nucleotide exchange factor with Sec7 domain, required for normal 
filamentous growth; transcriptionally regulated upon yeast-hyphal switch; filament induced; 
regulated by Nrg1, Tup1, Mob2; mRNA binds to She3 
3,0 
HAP2 
CCAAT-binding factor regulates low-iron (chelation) induction of FRP1 transcription, and 
under these conditions CBF comprises Hap43 and probably Hap2 and Hap3; possibly an 
essential gene, disruptants not obtained by UAU1 method 
3,0 
-- 
Predicted ORF in Assemblies 19, 20 and 21; possibly spurious ORF (Annotation Working 
Group prediction); transcriptionally activated by Mnl1 under weak acid stress 
2,9 
TRM1 
Protein described as an N2,N2-dimethylguanine tRNA methyltransferase; induced upon 
adherence to polystyrene 
2,8 
MAL31 
Putative protein of unknown function, transcription is upregulated in clinical isolates from 
HIV+ patients with oral candidiasis; alkaline upregulated 
2,8 
HDA1 
Histone deacetylase; conserved deacetylation motif; regulates white-to-opaque switching 
frequency but not opaque-to-white switching; greater expression in white cells than 
opaque cells; inhibited by trichostatin-A; inducer of filamentation 
2,8 
-- Predicted ORF in Assemblies 19, 20 and 21 2,7 
CHS7 
Protein required for wild-type chitin synthase III activity; similar to (but not functional 
homolog of) S. cerevisiae Chs7, which effects ER export of Chs3; induced in homozygous 
cyr1 null mutant hyphae and ras1 yeast-form cells 
2,7 
-- Predicted ORF in Assemblies 19, 20 and 21 2,6 
UTP22 
Predicted ORF in Assemblies 19, 20 and 21; decreased expression observed in an ssr1 
homozygous null mutant; decreased expression in response to prostaglandins; 
heterozygous null mutant exhibits resistance to parnafungin 
2,6 
-- Predicted ORF in Assemblies 19, 20 and 21 2,6 
-- 
Predicted ORF in Assemblies 19, 20 and 21; upregulation correlates with clinical 
development of fluconazole resistance 
2,6 
-- 
Predicted ORF in Assemblies 19, 20 and 21; increased transcription is observed in an 
azole-resistant strain that overexpresses MDR1; transcriptionally activated by Mnl1 under 
weak acid stress 
2,6 
OPY2 Predicted ORF in Assemblies 19, 20 and 21 2,6 
-- Predicted ORF in Assemblies 19, 20 and 21 2,5 
CCC1 
Putative manganese transporter, required for normal filamentous growth; mRNA binds to 
She3 and is localized to hyphal tips; repressed by nitric oxide and alkaline pH; shows 
colony morphology-related regulation by Ssn6 
2,5 
ENA21 
Predicted ORF similar to S. cerevisiae sodium transporters Ena1 and Ena5; Gcn4-
regulated; flucytosine, amphotericin B, or ketoconazole-induced; osmotic stress-induced; 
overlaps orf19.5170.1, which is annotated as a blocked reading frame 
2,5 
-- 
Predicted ORF in Assemblies 19, 20 and 21; transcription detected in high-resolution tiling 
array experiments 
2,5 
-- 
Predicted ORF in Assemblies 19, 20 and 21; transcription detected in high-resolution tiling 
array experiments 
2,4 
LYP1 
Predicted ORF in Assemblies 19, 20 and 21; amphotericin B induced; flucytosine 
repressed; possibly an essential gene, disruptants not obtained by UAU1 method 
2,4 
-- Predicted ORF in Assemblies 19, 20 and 21 2,4 
TPO4 Putative sperimidine transporter; fungal-specific (no human or murine homolog) 2,4 
-- ORF Predicted by Annotation Working Group 2,4 
ACS1 
Putative acetyl-CoA synthetase, similar to S. cerevisiae Acs1; upregulated in the presence 
of human neutrophils; fluconazole-downregulated; regulated by Nrg1 and Mig1; shows 
colony morphology-related gene regulation by Ssn6 
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OPT6 
Putative oligopeptide transporter; fungal-specific (no human or murine homolog); 
expression of OPT6, OPT7, or OPT8 does not suppress defect of mutant lacking Opt1, 
Opt2, and Opt3; alleles are nonidentical 
2,3 
-- Predicted ORF in Assemblies 19, 20 and 21 2,3 
GAL4 
Transcription factor with zinc cluster DNA-binding motif involved in control of glycolysis; 
ortholog of S. cerevisiae Gal4, but not involved in the regulation of galactose utilization 
genes; caspofungin repressed 
2,3 
SHE3 
mRNA-binding protein that localizes specific mRNAs to daughter yeast-form cells and to 
hyphal tips; required for normal filamentous growth and host epithelial cell damage; 
ortholog of S. cerevisiae She3 but set of target mRNAs differs 
2,3 
PUT2 
Putative delta-1-pyrroline-5-carboxylate dehydrogenase; alkaline upregulated; protein 
detected by mass spec in exponential and stationary phase cultures 
2,2 
FLU1 
Multidrug efflux pump of the plasma membrane; MDR family member of the MFS (major 
facilitator superfamily) of transporters; preferred substrate may be mycophenolic acid; 
fungal-specific (no human or murine homolog) 
2,2 
-- Predicted ORF in Assemblies 19, 20 and 21 2,2 
CUP9 
Protein of unknown function, upregulated in clinical isolates from HIV+ patients with oral 
candidiasis; transcription reduced upon yeast-hyphal switch; ketoconazole-induced; Plc1-
regulated; shows colony morphology-related Ssn6 regulation 
2,1 
YTM1 
Protein similar to S. cerevisiae Ytm1, which is involved in biogenesis of the large ribosomal 
subunit; transposon mutation affects filamentous growth; protein level decreased in 
stationary phase cultures 
2,1 
NRP1 
Predicted ORF in Assemblies 19, 20 and 21; fungal-specific (no human or murine 
homolog) 
2,1 
-- Predicted ORF in Assemblies 19, 20 and 21 2,1 
CDR11 
Putative transporter of PDR subfamily of ABC family; Gcn4-regulated; upregulated by 
Rim101 at pH 8 
2,1 
ARP8 
Predicted ORF in Assemblies 19, 20 and 21; mutation confers hypersensitivity to toxic 
ergosterol analog, and to amphotericin B 
-2,1 
CYB2 
Protein described as precursor protein of cytochrome b2; transcriptionally regulated by 
iron; expression greater in high iron; alkaline downregulated; shows colony morphology-
related gene regulation by Ssn6 
-2,1 
-- Predicted ORF in Assemblies 19, 20 and 21 -2,1 
NTH1 
Neutral trehalase; hyphal induction in homozygous null mutant is delayed but not reduced 
overall; not required for virulence in mouse systemic infection; homodimeric enzyme; 
possible regulatory cAMP-dependent phosphorylation at S10 and S213 
-2,1 
RSN1 Protein induced during the mating process -2,2 
-- Predicted ORF in Assemblies 19, 20 and 21 -2,2 
-- Predicted ORF in Assemblies 19, 20 and 21 -2,2 
IFI3 
Predicted ORF in Assemblies 19, 20 and 21; constitutive expression independent of MTL 
or white-opaque status 
-2,2 
TPS1 
Trehalose-6-phosphate synthase; role in hyphal growth and virulence in mouse systemic 
infection; upregulated in presence of human neutrophils; macrophage/pseudohyphal-
repressed after 16h; detected by mass spec in stationary phase cultures 
-2,2 
CUP2 
Protein required for normal resistance to copper; similar to S. cerevisiae Cup2, which is a 
copper-binding transcription factor that activates transcription of metallothionein genes 
-2,2 
RIB3 
3,4-Dihydroxy-2-butanone 4-phosphate synthase; homodimeric enzyme of riboflavin 
biosynthesis; converts ribulose 5-phosphate to L-3,4-dihydroxy-2-butanone 4-phosphate; 
transcription regulated on yeast-hyphal switch, macrophage interaction 
-2,3 
-- Predicted ORF in Assemblies 19, 20 and 21 -2,3 
HNT1 
Predicted ORF in Assemblies 19, 20 and 21; protein level decreased in stationary phase 
cultures 
-2,3 
-- 
Predicted ORF in Assemblies 19, 20 and 21; transcription is repressed in response to 
alpha pheromone in SpiderM medium 
-2,3 
GLK4 
Protein described as a glucokinase; decreased expression in hyphae compared to yeast-
form cells 
-2,3 
MET3 
Putative ATP sulfurlyase of sulfate assimilation; repressed by Met or Cys, Sfu1, or in 
fluconazole-resistant isolate; strongly induced on biofilm formation, even in presence of 
Met and Cys; Hog1-, caspofungin-, possibly adherence-induced 
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NAT4 
Putative histone acetyltransferase, involved in regulation of white-opaque switching; 
predicted ORF in Assemblies 19, 20 and 21 
-2,4 
-- 
Predicted ORF in Assemblies 19, 20 and 21; increased transcription is observed upon 
benomyl treatment 
-2,4 
DAK2 
Protein described as similar to dihydroxyacetone kinase; transcription is decreased upon 
yeast-hyphal switch; fluconazole-induced; caspofungin repressed; protein detected by 
mass spec in stationary phase cultures 
-2,4 
-- 
Predicted ORF in Assemblies 19, 20 and 21; possibly spurious ORF (Annotation Working 
Group prediction) 
-2,4 
MSO1 
Predicted ORF in Assemblies 19, 20 and 21; expression is down-regulated during 
pseudohyphal growth in the presence of lysed macrophages 
-2,5 
-- 
Transcriptionally regulated by iron; expression greater in high iron; downregulated in core 
caspofungin response; ketoconazole-repressed; shows colony morphology-related gene 
regulation by Ssn6; possibly subject to Kex2 processing 
-2,5 
GPD1 
Protein similar to S. cerevisiae glycerol-3-phosphate dehydrogenase (enzyme of glycerol 
biosynthesis); biofilm-induced expression; regulated by Efg1; regulated by Tsa1, Tsa1B 
under H2O2 stress conditions 
-2,5 
-- Predicted ORF in Assemblies 19, 20 and 21; induced during planktonic growth -2,5 
-- Predicted ORF in Assemblies 19, 20 and 21; Hog1-downregulated -2,6 
SOD1 
Cytosolic copper- and zinc-containing superoxide dismutase, involved in protection from 
oxidative stress and required for full virulence; alkaline upregulated by Rim101; 
upregulated in the presence of human blood 
-2,6 
-- 
Predicted ORF in Assemblies 19, 20 and 21; shows colony morphology-related gene 
regulation by Ssn6 
-2,6 
-- 
Predicted ORF in Assemblies 19, 20 and 21; possibly an essential gene, disruptants not 
obtained by UAU1 method 
-2,6 
IFC3 
Oligopeptide transporter; transcriptionally induced upon phagocytosis by macrophage; 
induced by BSA or peptides; fluconazole-induced; upregulated by Rim101 at pH 8; 
virulence-group-correlated expression; no human or murine homolog 
-2,7 
-- 
Predicted ORF in Assemblies 19, 20 and 21; induced in core caspofungin response; 
increased expression observed in an ssr1 homozygous null mutant; induced by nitric oxide 
in yhb1 mutant 
-2,7 
RAD32 
Protein similar to S. cerevisiae protein with role in nucleotide excision repair; down-
regulation associated with azole resistance 
-2,9 
FDH3 
Putative protein of glycine catabolism; downregulated by Efg1 under yeast-form but not 
hyphal growth conditions; transcriptionally activated by Mnl1 under weak acid stress 
-2,9 
-- 
Predicted ORF in Assemblies 19, 20 and 21; induced upon adherence to polystyrene; 
oxidative stress-induced via Cap1 
-3,1 
RNR22 
Protein described as ribonucleoside diphosphate reductase; shows colony morphology-
related gene regulation by Ssn6; RNA abundance regulated by tyrosol and cell density 
-3,4 
-- Transcription is positively regulated by Sfu1 -6,5 
-- 
Predicted ORF in Assemblies 19, 20 and 21; fluconazole-induced; filament induced; Hog1-
induced; regulated by Nrg1, Tup1; increased expression in response to prostaglandins 
-7,2 
LYS12 
Protein described as mitochondrial homoisocitrate dehydrogenase; clade-associated gene 
expression; protein level decreased in stationary phase cultures 
-20,1 
 
